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Inflammatory abdominal aortic aneurysms (IA) constitute approximately
15% of all abdominal aortic aneurysms. Macroscopically, they are
characterised by a thick white rind of fibrous tissue, which may extend in the
retroperitoneum to encase and obstruct adjacent hollow organs. This may
require major changes and modifications in exposure and operative technique.
Currently, diagnostic accuracy is poor in inflammatory aortic aneurysm
disease, and little is known of its pathogenesis. This leads to many such
aneurysms remaining unsuspected pre-operatively, and contributes to the
increased operative morbidity and mortality of this disease.
A review of the history of vascular surgery and radiology is undertaken,
with a particular emphasis on aneurysm disease. Current theories of the
aetiology of both simple (SA) and inflammatory aneurysm are discussed. An
account is given of the current state of radiological techniques in the diagnosis
of inflammatory aneurysm disease, and a brief technical synopsis of magnetic
resonance imaging (MRI) is provided.
A retrospective series was studied, comprising 47 patients with IA and 162
patients with SA of matched age and sex distribution. No differences were
found in the incidence of diabetes, smoking, symptomatic occlusive vascular
disease or hypertension. Pain was slightly more common in the IA group, but
weight loss was not. Plasma viscosity was the only measured hasmatological
parameter which differed significantly between the groups, being higher in the
IA group compared to the other. Biochemical evidence of renal failure was a
poor predictor of ureteric involvement in fibrosis.
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Pre-operative ultrasound failed to make the diagnosis of IA in all cases
subsequently confirmed at operation. Computerised tomography (CT) made
the diagnosis in only 13 of 25 cases. All aortic replacements were carried out
using the transperitoneal route. In 4 cases of IA however, unexpectedly
extensive abdominal inflammatory change required the abdominal incision to
be extended as a left eighth rib thoracotomy. 63% of patients with IA required
bifurcation grafts rather than tube grafts, the figures being almost exactly
reversed for patients with SA.
Operations involving IA took significantly longer, and required more
blood and colloid infusion than operations on simple aneurysms.
Operative (30 day) mortality for the IA group was 13%, but only 4.3% for
SA.
A further series was prospectively studied comprising 15 patients with IA,
85 with SA and 37 with occlusive disease (OCC). Findings of the retrospective
study in risk factors, clinical findings, symptomatology and haematological
criteria are confirmed.
Peripheral blood from all groups was assayed for a number of biochemical
attributes. Higher levels of acute phase proteins and neutrophil elastase were
found in the IA group, and initial findings suggest that elastin fragment assay is
also higher. Elastase inhibitory activity was also greater in the IA group,
although there was no difference in antitrypsin phenotypes.
Radiological diagnosis of inflammatory change, diagnosis of aneurysm
level and the visualisation of the renal arteries were all poor using CT and
ultrasound. Seen on MRI scans, the walls of IA have a characteristic
appearance of concentric layering. This enabled MRI to make the diagnosis of
LA in all studied cases. MRI also offered improved visualisation of the upper
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extent of aneurysms, and of renal artery origins.
The results of this work support the current theories of aetiology of
inflammatory aneurysms. There is evidence of an increase in active elastin
breakdown in IA secondary to increased elastase activity rather than any
defect in elastase inhibition mechanisms. This suggests a theory of self
perpetuation in LAwhich is discussed.
A previously unreported appearance of inflammatory aneurysm walls has
been noted using Magnetic Resonance Imaging. This modality was also found
to offer improved definition of the upper limit and the renal artery origins of
all aneurysms. This enhanced diagnostic ability led to an improvement in
operative mortality.
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The work which is described in this thesis is my own. The
experimental work included has been carried out by myself, except for the
following -
Acute phase protein assays were carried out in the Department of
Chemical Pathology, Bristol Royal Infirmary, by Mrs. June Morgan, Senior
M.L.S.O. She also carried out all Antitrypsin Phenotyping procedures.
Magnetic Resonance Imaging was carried out by the Radiographic
Staff of Frenchay Hospital, Bristol, under the Supervision of Dr. G. G.
Hartnell, Consultant Radiologist. Other radiological investigations were
performed in Bristol Royal Infirmary's Department ofRadiodiagnosis.
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AIMS. INTRODUCTION AND HISTORICAL REVIEW
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The aims of this thesis are as follows:
1. To study the differences in presentation, clinical features,
diagnosis, operative details, and subsequent outcome in a large retrospective
series of inflammatory and non-inflammatory aneurysms of the abdominal
aorta.
2. To prospectively study the biochemical and radiological
characteristics of groups of inflammatory and non-inflammatory aortic
aneurysms. To define differences in these attributes and to discuss their use in




Inflammatory aortic aneurysms comprise 2.5 - 23% of all
abdominal aortic aneurysms. In common with simple aortic aneurysms, they
occur principally in males, but in a population approximately a decade
younger. Characteristically, inflammatory aneurysms are covered in a thick
white coat of fibrous tissue which may extend laterally into the
retroperitoneum to involve other organs, encasing them in fibrosis. Organs
which may be so encased include the duodenum, ureters, left renal vein and
inferior vena cava. It is this feature which may cause difficulty at operation
and require considerable modification of operative technique.
Many inflammatory aneurysms go unsuspected. As a consequence,
an appropriate operative approach cannot always be planned. The aneurysm
may be deemed inoperable at laparotomywith subsequent fatal consequences.
It is clearly in the best interest of both patient and surgeon to be
aware of the presence of inflammatory aneurysm pre-operatively.
Current diagnostic tests for inflammatory aneurysms are unreliable
and non-specific. These have been reviewed in a large retrospective series of
inflammatory and non-inflammatory aneurysms highlighting differences in
presentation, clinical features, investigation, operative details, and subsequent
outcome.
Other sections of this thesis relate to a prospectively studied series.
They deal with contrasting biochemical and radiological characteristics of
inflammatory and non-inflammatory aneurysms and aorto-iliac occlusive
disease. These contrasts are presented in relation to the pathogenesis of
inflammatory aneurysms, and their possible use in diagnosis is discussed.
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For the purposes of this thesis, the following definitions shall apply:
1. Inflammatory aneurysm. An aortic aneurysm over 4 cm in
diameter, which presents the white 'sugar-icing' appearance of dense mural
fibrosis at operation. Other organs may or may not be involved in this fibrosis.
The cut wall is thick, and histologically meets previously published criteria.1
2. Simple aneurysm. An aortic aneurysm over 4 cm in diameter,
which does not present the typical appearances of (1.) above. There is a thin
wall with little mural fibrosis, and no adherence or involvement of adjacent
organs.
3. Aorto-iliac occlusive disease. Stenosing or occlusive
atheromatous disease affecting the infra-renal aorta, the aortic bifurcation, or
the common iliac arteries, presenting with severe lower limb ischaemia.
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THE DEVELOPMENT AND EMERGENCE OF ANEURYSM SURGERY
Early Arterial Surgery
Disorders of the blood vessels whether through injury or
degeneration often present with physical signs of an easily discernible and
frequently dramatic nature. It is not surprising therefore, that details of the
treatment of bleeding, and of aneurysmal dilatation of the peripheral arteries
are found in the earliest records of surgical intervention.
Vascular surgery probably has its roots in Susruta's use of a ligature
on the umbilical cord in 1500 B.C.2 Ligatures were subsequently described to
arrest bleeding by placing them around a limb (Chrysippus of Crudes 340 BC).3
They were certainly described in Alexandrian times (approximately 200 BC)4
by Celsus (25-50 BC)5 and by Archigenes (48-117 AD)6, but the haemostatic of
choice remained cautery. It was not until Pares rediscovery of the ligature in
15527 that the technique came into popular use.
Peripheral Arterial Aneurysms
Aneurysms have been known from at least Egyptian times, the
Ebers Papyrus describing what are likely to have been traumatic aneurysms of
the extremities.8 Galen (AD 131-200) was probably the first to formally
document aneurysms in his work "De Tumoribus", recognising that they arose
from arteries, and were filled with blood.9
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The treatment of peripheral arterial aneurysms is the foundation
upon which modern vascular surgery was built. Such aneurysms were not only
readily visible, but surgical access was relatively simple in the pre-anaesthesia
era. Aneurysms of the abdominal aorta were first described by Vesalius in the
16th century, but because of the impossibility of surgical treatment, aroused
little interest for three hundred years thereafter.10
Antyllus (AD 48-117) appears to have described the first technique
for the surgical treatment of peripheral aneurysm, tying off the vascular mass
at both ends close to the sac, then evacuating the contents.11,12 His detailed
description of the surgical technique acknowledges the folly of treating
aneurysms of the neck, axilla or groin by ligation, and comments on the
increase in ligature security gained by leaving the aneurysm sac in situ, rather
than excising it. This principle was ignored by Aetius in the 6th century, who
followed Antyllus' technique, but in addition recommended division of the
feeding vessel.13
The Antyllian operation of bipolar ligation and incision of the
aneurysm persisted as one of the principle procedures for the treatment of
peripheral aneurysms until the 18th century.14
The next major advance in aneurysm treatment was made by Pare
in the second half of the 16th century. In addition to investigating the
pathology of aneurysms15 and proposing syphilis as a cause, he is thought to
have been the first to use a single proximal ligature in the treatment of
aneurysm. This change in technique appears to have gone largely unnoticed at
the time, but clearly precedes its successful use by Anel in 1710.16
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The treatment of aneurysms remained rooted in the use of a
number of broadly similar operations from the time of Antyllus until the
middle and late 18th century. Techniques were described using proximal or
bipolar ligation, with or without incision of the aneurysm sac and evacuation of
its contents.17 Pressure applied and maintained by bandages was often used as
a first line treatment in an attempt to induce thrombosis in the aneurysm.
Only if this had no appreciable effect did the surgeon resort to open
operation.18
Ligation of the aneurysm sac was frequently carried out for
advanced disease, where the technical difficulties were considerable, and the
sac was often ruptured accidentally by the surgeon. Even if ligation could be
achieved without the patient exsanguinating, suppuration of the incised sac or
wound regularly led to fatal secondary haemorrhage. The outcome of
aneurysm surgery was so frequently fatal that Percival Pott was of the opinion
in 1779 that amputation was the best policy.19 An improvement in surgical
technique was clearly required, and was supplied by the experimental surgeon,
John Hunter.
It is surprising that John Hunter is popularly credited with the first
use of the single proximal ligature, in view of the availability for some decades
of Heisters (1683-1758) account of the technique20, and its use by Guillemeau
and Anel21. The chief differences in Hunters technique were:
1. The omission of evacuation of the aneurysm sac.
2. Placement of the proximal ligature at a much higher level than had
previously been the norm.
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Hunter reasoned that infection and fatal haemorrhage would be
reduced if the vessel feeding the aneurysm was ligated at a remote site,
through healthy tissue, without disturbing the sac. Following a period of
experimentation , the first operation based on his findings was performed by
Hunter, in 1785, on a coachman with a popliteal aneurysm. Hunters
operation was rapidly adopted by other surgeons, and remained a standard
operative treatment for popliteal aneurysm until the early 1950s.22 24
Figure 1 (overleaf).
This shows the preserved popliteal aneurysm of the 45 year old
coachman upon whom Hunter operated in 1785. The obliterated femoral
artery and the femoral vein are preserved in connection with the remains of
the aneurysm sac.
The specimen is shown by kind permission of the Hunterian
Museum of the Royal College of Surgeons of England. A full account of the
case can be found in the Museum catalogue.
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Alternatives to ligation: Reconstruction and Grafting
The operation of obliterative endaneurysmorrhaphy was
introduced by Matas in 1888.25 He had performed the Antyllian operation on a
young man who had presented with a traumatic brachial artery aneurysm, but
noted that bipolar ligation did not reduce the arterial pulsation. He opened
the aneurysm sac, to reveal three orifices; the two polar vessels which he had
ligated, and a collateral which was still openly bleeding. He oversewed the
collateral, then closed the sac. The patient made a good recovery. This
obliterative operation was then extended to restorative and reconstructive
procedures preserving flow through the artery.26,27 Although Matas reported
good results, the operation did not gain wide acceptance, and was little used.
From the late 19th century onwards, work had been proceeding on
the direct suture of blood vessels and on allografting.
By the end of the 19th century, a number of experimental surgeons
including Jassinovski28 and Dorfler29 had succeeded in direct arterial suture
using aseptic technique. These were all lateral sutures. Simultaneously, work
was being performed on non-suture techniques of blood vessel anastomosis
using a variety ofmaterials.30 This work was later adapted and developed by
Blakemore31 for use in war casualties, and persists in current surgical technique
in the use of non-sutured aortic prostheses.32 Nevertheless, work continued on
the technique of sutured blood vessel anastomosis, and the first successful
circular suture of an artery in a human was performed by J.B Murphy in 1896.33
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Figure 2a.
Angiogram of Case 2 in Blakemores paper31 from 1945.The patient
was a 15 year old boy whose left arm had been damaged when falling through a
plate glass window. There was segmental loss of the brachial artery, which was
bridged using the non-suture technique pioneered by Blakemore. The
angiogram was performed 34 days after the operation, and shows a Vitallium
tube at each end of the vein segment used to bridge the left brachial artery.
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Figure 2b.
The technique used by Blakemore in the non-suture anastomosis of
arteries, taken from the same source as Figure 2a.
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In 1902, Alexis Carrell published his first paper on vascular
anastomosis and transplantation.34 He was the first to demonstrate that end to
end arterial suture was consistently possible using his triangulation technique,
and the first to use venous autografts in dogs, work for which he was awarded
the Nobel Prize in 1912. From this, Carrell proceeded to use interposition vein
autografts for trauma, and developed organ transplantation.35'36
In the years following Carrells original publication, autogenous
vein grafting was used by Goyannes (1906)37 and Pringle38 (1913) for popliteal
aneurysm, and by Lexer (1907)39 for repair of an axillary aneurysm. Vein grafts
were used in World War 1 in cases of arterial trauma in German casualties,
and a large series was reported by Weglowski.40
Although these developments in anastomosis and autografting were to
have widespread implications later in the 20th Century, they went largely un¬
noticed in the first two decades. Progress in aneurysm surgery was slow, and
surgical procedures for peripheral aneurysms was almost entirely obliterative.
Reids paper from the Johns Hopkins Hospital details the entire experience of
that unit in aneurysm surgery from 1889 to 1922 as 142 cases.41 It is interesting
to note that in Reids opinion, the Antyllian operation remained the best
procedure for femoral aneurysms.
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Abdominal Aortic Aneurysms
Aneurysms of the body cavities remained neglected and
untreatable following their initial description by Vesalius. It was not until the
early 19th century that the first steps were taken to effect cure of abdominal
aortic aneurysms, beginning in 1817 with another renowned experimental
surgeon, Astley Paston Cooper. Following his proof that aortic ligation in the
dog was compatible with survival, Cooper performed the first ligation of a
human aorta for a leaking iliac aneurysm.42 The patient, a man, was in
extremis from the extent of the bleeding. Bearing in mind the absence of
asepsis and anaesthesia from the surgical repertoire, the decision to attempt
operation was a courageous one for both patient and surgeon. Cooper
entered the abdomen through a four inch incision in the linea alba centred on
the umbilicus. Through this, he encircled the patients aorta with his finger,
passed a ligature, and tied it. The patient unfortunately died of shock and
probable respiratory failure some 40 hours after operation.




The preserved aorta of the patient whose aorta Astley Cooper
ligated as treatment for a leaking iliac aneurysm. The ligature can still be seen.
Specimen shown by kind permission of the United Medical &
Dental Schools of Guy's and St. Thomas's Hospitals, London. The specimen
still resides in the Pathology Department of St. Thomas's Hospital.
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In the wake of historical experience of obliterative therapy in
peripheral aneurysms, thrombosis of aortic aneurysms was attempted by a
number of methods. In 1831, Velpeau attempted to produce thrombosis of an
abdominal aortic aneurysm by placing three pairs of sewing needles in the
sac.43 This was followed in 1864 by Moore's introduction of 26 yards of fine
iron wire into the ascending aortic aneurysm of a young man in order to
produce thrombosis within the sac.44
Refinements of the technique of aneurysm thrombosis by wiring
were produced by Matas, Hunner and Blakemore in the period up to 1947.
These mainly depended on the insertion of a length of wire in the aneurysm
sac, and the passage of a current through the wire to produce electro¬
coagulation.45"47
The practice of aneurysm wiring persisted until very recently,
especially as an option in patients considered to be unfit for prosthetic
replacement. In 1968 Peacock described a series of 14 patients in whom
aneurysms were wired, with good post-operative results.48
An aneurysm wired by Professor J.H. Peacock, formerly Professor
of Surgery at Bristol University is illustrated below (Figure 4a). The




An aortic aneurysm wired by Professor J. H. Peacock of Bristol
Royal Infirmary. The coils ofwire can be clearly seen within the aneurysm sac.
The patient survived for more than 10 years after the wiring until
he collapsed and died of rupture of the aneurysm.
Specimen shown by kind permission of the Department of Surgery,
Bristol University, in whose museum the specimen resides.
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Figure 4b.
The machine used by Peacock to wire aneurysms. A spool of wire
is contained in the proximal end. The wire then passes between two milled
wheels, the lower of which is turned by a small handle. Counter force is
applied by manual pressure on the upper wheel. By this mechanism the wire is
'friction fed' through the hollow needle into the aneurysm.
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Simultaneously, attempts were continuing to successfully ligate the
abdominal aorta as treatment for aneurysm. This was eventually achieved by
Matas in 1923, although the ligation was found to be incomplete.49 The first
complete ligation with a satisfactory outcome was performed by Barney
Brooks in 1926.50 There followed a number of reports of aortic ligation with
survival of the patient, including one restorative endaneurysmorrhaphy carried
out by Bigger in 1940.51
Figure 5.
The method of aortic ligation used by Matas in 1923.49 Two linen
tapes were used, tied at the aneurysm neck. The tapes were themselves
transfixed with silk ligatures.
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As for the treatment of peripheral aneurysms, the treatment of
aortic aneurysms was limited to obliteration of the aneurysm by thrombosis,
albeit by a number of different methods, until the late 1940s.
With the introduction of heparin into clinical use by Murray in the
1940s52 came the ability of surgeons to operate during a prolonged 'safe'
period. Following the description of femoral endarterectomy by J.C. dos
Santos,53 and its development by Cannon and by Bazy,54,55 this procedure was
used for the treatment of aortic occlusive disease by Freeman and Leeds in
195156 following the technique of Blakemore.57 In the same year, Wylie
reported a series of aortic endarterectomies for aneurysm and occlusive
disease, using fascia lata wrap to reinforce the aortic reconstruction.58
In common with Matas' restorative endaneurysmorrhaphy,26
Wylie's method persisted in its use of native, diseased arterial wall to restore
arterial continuity.
Concurrently with the success of Wylie and others in reconstructive
techniques, other groups were considering the other option - replacement of
the aneurysmal segment with an alternative conduit.
During his early work, Carrell had had some success in the
preservation of aortic allografts using refrigeration.59 This work was further
developed by Gross, who used preserved allograft aorta in the replacement of
long aortic coarctations in 1948. He used a preservative solution of antibiotics
and glucose, together with cooling between 1 and 4 degrees C., and achieved
good results.60,61 Significantly, it was Gross's preservation technique which was
used for the grafts employed in the first operations for replacement of an
occluded aorta (Oudot 1951) and aortic aneurysm (Dubost 1952). Work on
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the preservation of aortic homografts by rapid freezing in air initially pioneered
by Hufnagel62 was continued by Deterling.63 This led to the development of
other preservation techniques,64,65 with progression to banks of allograft
arteries in the early 1950s.
The first human artery bank in the world was installed at St. Mary's
Hospital, London, as a result of collaborative work between Hufnagel and
Eastcott, and used a rapid deep freezing technique allowing indefinite
storage.66
In 1951, successful replacement of an occluded aortic bifurcation
was reported by Oudot using a preserved aortic allograft.67 His patient was a
51 year old female who had claudication, rest pain and aortic occlusion. There
was ulceration and tissue loss over the left lateral malleolus. Oudot adopted a
retroperitoneal approach to the aorta and bifurcation, and excised the
thrombosed vessel from inferior to superior, hampered by some peri-aortitis.
The allograft, which had been preserved in the manner of Gross, was sutured
to the aortic stump and distally to the external iliacs. Good flow was achieved
down the left leg of the graft, but the right had thrombosed by the end of the
operation. The patient developed some patchy blueness of the right leg, which
resolved over 48 hours with heparin therapy. The left sided ulcers healed, and
the patient did well.
In the face of developing enthusiasm for aortic surgery it was
simply a matter of time before similar techniques were used to replace aortic
aneurysms. This was accomplished successfully by Dubost on the 29th of
March 1951, again using allograft aorta, following Schaffers unsuccessful
attempt earlier the same month.68,69
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Thereafter there was a rapid adoption of Dubosts techniques by
Julian, Brock, and DeBakey & Cooley in Houston in the late 1950s and early
60s.70"72 By 1953, Bahnson had reported a series of 17 patients from Johns
Hopkins who had undergone replacement of aortic aneurysms. Five of the six
patients who had undergone replacement of infrarenal aneurysms had
survived.73
Initial justification for the explosion of aortic surgery in the early
1950s was not difficult. In 1950, Estes published a pivotal paper on the natural
history of abdominal aortic aneurysms, showing a five year survival rate
without treatment of under 20% 74. Gleidman went on to show that the
mortality for symptomatic aneurysms was considerably higher at 80% in 6
months; much greater than in the group of patients with asymptomatic
aneurysms75. These findings have subsequently been confirmed by a number of
other authors. Szilagyi's appraisal in 1966 emphasises the success of the
surgical treatment of aneurysm in the elective situation, and confirms the
earlier findings of Estes.76 The rapid increase in aortic aneurysm surgery has
decreased the ratio of patients presenting with ruptured aneurysms to patients
undergoing elective surgery, and has improved the mortality figures for such
elective surgery considerably.
Currently aneurysm surgery is carried out almost as a routine
following diagnosis. Trends to earlier and earlier diagnosis are leading to the
detailed examination of the use of ultrasound screening for aortic aneurysms
among the increasingly elderly population.77
Once the diagnosis is established, the operative mortality for
elective prosthetic replacement of an aortic aneurysm is about 5% in most
centres. Following successful replacement, the patient can look forward to a
lifespan virtually identical to normal individuals of the same age.78
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Aortic Replacement - alternatives to the allograft.
Aortic allografts played a major role in early programmes for aortic
replacement. Patency rates were good, at 90% in the short term,79 but there
were a number of important drawbacks to the use of allograft material. Not
only was the availability of allografts limited, but preparation and storage were
time consuming and expensive, although developments in rapid freezing had
improved this.
Long term follow-up suggested that allograft aorta deteriorated
after long periods of implantation. Carrell had suggested that the long term
performance of allograft aortic replacements in dogs was good, despite the
replacement of the muscle and elastic tissue of the graft wall with connective
tissue.80 A larger study, again using the dog model, was performed by Coleman
and revealed a high incidence of significant thinning, calcification and loss of
elastic tissue in allograft segments. There was, however, in confirmation of
Carrels findings, no apparent haemodynamic consequence of these findings of
degeneration.81 In view of equivocal reports emerging in the use of synthetic
fabric prostheses, Coleman continued to recommend the use of allografts.
In the light of increasing evidence that early elective surgery was
indicated in aneurysm disease of the abdominal aorta, there was pressure to
find a cheaper, more readily available alternative to allograft substitutes for the
aorta. Clearly the answer to most of the problems associated with the
availability of allografts could be answered by the use of synthetic prosthetic
grafts.
Early attempts in the use of synthetic prostheses for vascular
replacement met with little success and had a prohibitive occlusion rate.82"84
Some encouraging results were obtained by Hufnagel in 1947 using methyl
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methacrylate tubes in dog aortas,85 but a singular lack of success was reported
by Moore and Donovan using polyethylene.86,87
Voorhees revived interest in synthetics as arterial grafts, and by
1952 had demonstrated the viability of fabric arterial substitutes made of
Vinyon-N (a co-polymer of vinyl and nylon) in the aorta of experimental
animals.88
In the wake of Voorhees work, rapid development of synthetic
fabric arterial substitutes took place. A number of materials were tried,
including Nylon, Terylene, Orion, Ivalon, Teflon and Dacron in a variety of
sites, but most were found to be unsatisfactory.89,90
Two reports reflect the active search for acceptable vascular
prostheses, and reach conclusions based on sufficient numbers.79,91 Both of
these major studies found that, in view of the long term loss of tensile strength
that occur with Orion and Nylon, and the formidable thrombogenicity of
Ivalon, that Dacron and Teflon were clearly the best of the available materials.
Since that time, basic materials used in arterial surgery have
changed little, most products being a slight modification on the original
P.T.F.E. and Dacron.
Thoraco-abdominal aneurysms
In 1955, Ellis demonstrated that repair of the aorta was possible
when the renal vessels were involved, and that renal function could be
preserved.92 The patient, a 64 year old male, presented with a symptomatic
aortic aneurysm. The level of the left renal artery was normal, but the right
arose well below the inferior mesenteric artery. The right renal artery was
clamped, then re-anastomosed to the aortic allograft following its insertion.
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The total renal ischasmic time was 135 minutes. The patient made a full
recovery with arteriographic and urographic evidence of continued renal
artery patency and renal function.
In the same year, Etheridge undertook the replacement of a large
thoraco-abdominal aneurysm with re-implantation of the coeliac and superior
mesenteric vessels.93 Etheridge's patient was a 37 year old construction worker.
At operation, the aneurysm was found to include the origins of the superior
mesenteric and coeliac vessels, and to involve the left kidney in a mass,
requiring resection of the kidney with the aneurysm. The inferior limit of the
aneurysm lay above the level of the right renal artery, and a polythene shunt
was used to bypass the aneurysm from the thoracic aorta to the bifurcation.
Thus the right kidney was perfused throughout the operation. Post-operatively
the patient did well apart from a successfully managed episode of acute renal
failure, and was back at work and well a year later.
The anatomy of the aneurysm described above, and the techniques
used in its repair are illustrated in Figures 6a-6c.
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Figure 6a.
The anatomy of the aneurysm repaired by Etheridge in 1955.The
aneurysm was densely adherent to the left kidney, and involved the origin of









The technique which Etheridge used to repair the aneurysm. The
polythene shunt can be seen sutured in place, and the aorta has been divided
proximal to the neck of the aneurysm.
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Figure 6c.
A detail of the operative technique used by Etheridge, showing
completed anastomosis of the coeliac artery to the graft. An opening is being
made for anastomosis of the superior mesenteric artery.
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This was followed by a number of papers describing methods for
the re-anastomosis of visceral branches. The culmination of the technical
approach to thoraco-abdominal aneurysms was achieved by Stanley Crawford ,
with the publication of his paper 'Thoraco-abdominal and abdominal aortic
aneurysms involving renal, superior mesenteric and coeliac arteries' in 1974.
The classification of thoraco-abdominal aneurysms, and the operative
techniques pioneered by Crawford have not been bettered. Both are still in
routine use.94,95
Figure 7a & b show Crawfords technique for the repair of a
ruptured thoraco-abdominal aneurysm in a patient who had previously
undergone repair of an abdominal aortic aneurysm. The illustrations are
reproduced from the original paper.94
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Figure 7a.
In E and F. clamps have been applied proximal and distal to the
aneurysm, and the aneurysm opened longitudinally. The edges of the sac are
retracted to display the orifices of the major visceral arteries.
G-I show the proximal aortic anastomosis being made, and the
coeliac artery anastomosis to a circular opening in the graft.
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Figure 7b.
J & K illustrate the serial completion of anastomoses between
major visceral arteries and the aortic graft. The lower aortic anastomosis and
closure of the aneurysm sac are shown in L & M.
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Inflammatory Aneurysms
What is probably the first recorded case of inflammatory aneurysm
was published in the British Journal of Urology by T.G.I. James in 1935,% (See
Appendix 1). He documented a case of uraemia in a female patient, who was
also found on examination to have an aortic aneurysm. At post-mortem
examination, the aneurysm was found to be thick walled and to extend from
the bifurcation up to the level of the superior mesenteric artery. The renal
arteries were encased in the aortic wall and the ureters densely adherent. The
size of both kidneys was reduced. The Wasserman reaction had been noted to
be negative.
In 1955, De Weerd et al.97 undertook the first operative treatment
of ureteric obstruction by inflammatory aneurysm fibrosis. Bilateral
ureterolysis was performed, but the aneurysm not resected. The patient did
well, with resolution of the uraemia. Later that year, Shumaker and Garrett98
performed the first resection of an inflammatory aneurysm. Their 60 year old
male patient presentedwith pulmonary oedema and uraemia in the presence
of a 10 cm. aortic aneurysm. Fibrotic tissue surrounded the aneurysm, and
involved the sigmoid colon, jejunum, and both ureters. Prosthetic replacement
of the aneurysm was carried out with a fused nylon/polyethylene Y graft, and
bilateral ureterolysis was performed.
Over the next few years several case reports and small
retrospective series of abdominal aortic aneurysm in association with severe
fibrosis and ureteric obstruction appeared in the literature.99"101 It was only
following Walkers detailed review of the clinical features and pathology of 19
cases in 1972 that the term 'inflammatory aneurysm' was coined, and the
disease formally recognised.102
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Despite the emergence of inflammatory aneurysm as a distinct
clinical entity little interest was aroused in its clinical or pathological features.
Owing to the rarity of the condition, even vascular surgeons encountered
inflammatory aneurysm only moderately infrequently. This is reflected at least
in part in Goldstones103 inability to find any specific referral to inflammatory
aneurysm in the American literature prior to 1977, save a brief mention by
Wylie in a textbook in 1975.104 The pattern of small retrospective reviews and
literature reviews has persisted, highlighting the difficulties of detailed study.
Goldstone103 in 1977 reviewed a smaller series of inflammatory
aneurysms than did Walker (10 patients as opposed to Walker's 19), but went
some way further to pointing out the dangers of operating on such aneurysms.
He also suggested some modifications to operative technique which might be
used to surmount these problems. In particular, he suggested the minimal
dissection technique which is still standard practice today.
The topic of inflammatory aneurysms was briefly reviewed by
Olcott in 1978, in a paper outlining unusual clinical manifestations of
abdominal aortic aneurysms.105 In 1981, Rose & Dent first proposed that
inflammatory aneurysms may simply represent an extreme manifestation of
atherosclerotic aortic aneurysm disease, in their review of the pathological
features of 51 aortic aneurysms including six of the inflammatory type.106
Theirs was the first attempt to produce a histopathological study comparing
inflammatory and non-inflammatory aneurysms on the basis of a pathological
grading system. Their review, although detailed, was descriptive only, and
made no firm commitment to the possible aetiology of inflammatory aneurysm.
More recently a number of authors have proposed aetiological mechanisms for
inflammatory aneurysms, and these are dealt with in detail in chapter 3.
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DEVELOPMENT OF AORTIC IMAGING TECHNIQUES
The practice of surgery has been revolutionised in the past 20 years
by advances in radiological techniques, and now the optimisation of vascular
surgical treatment is heavily reliant on the results of radiological investigations.
Plain Radiography
Plain radiographs are of limited use in the diagnosis of aneurysm of
the aorta. The lumen cannot be imaged, and the walls of the vessel can only be
seen if they contain calcified atheroma. Other cheap and easily available
methods are available which provide more information in cases of suspected
abdominal aortic aneurysm. In this circumstance, and for follow-up
assessment of aneurysms, plain radiology may rightly be viewed as an un¬
necessary radiation exposure. Aneurysmal dilation of a calcified aorta may be
seen incidentally on plain radiographs taken for other suspected pathology, and
prompt clinicians to investigate further, but this is the only 'use' of plain films.
For this reason, plain radiography is not discussed further in this or succeeding
chapters.
Aortography
Following Roentgens discovery of x-rays in 1895, it was a matter of
a few weeks until Haschek and Lindenthal performed arteriography in a
cadaver using chalk as a contrast medium.107 There followed a delay of 34
years before arteriography was performed in a live human subject by Dos
Santos et al., who used direct intra-aortic injection of sodium iodide to produce
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the first aortogram.108 A similar technique was used by Nuvoli in 1941, who
chose the ascending aorta as his injection site.109
In 1941, Farinas used a percutaneous catheter in a human subject
to carry out transfemoral aortography uo, but it was not until Seldingers
introduction in 1953 of the technique which still bears his name, that
arteriography advanced substantially.111
The basis of the Seldinger technique is the introduction of a guide
wire into the arterial lumen through a small needle. A catheter is then passed
over the wire and into the artery. In this way, the catheter can be of greater
diameter than the needle, and the wire can be used to assist and direct its
passage in the arterial lumen. It is this technique which has become the
cornerstone of modern arteriography.
Since the use of organic iodide in 1929 by Swick, a number of intra¬
arterial contrast media have become available.112 Most of the immediate
successors of Swicks organic iodide were variations on that theme, producing
allergy and a variety of neurological, renal and cardiopulmonary toxic effects.
In the early 1970's, Almen developed metrizamide, a non-ionic contrast
medium of low toxicity.113 Newer agents, such as iohexol, of the same general
characteristics have since become available, and are cheaper and easier to
handle.
The development of digital subtraction angiography (DSA) in the
late 1970's has changed the use of aortography in aneurysm disease. The
technique uses fluoroscopy to collect intensified images. The image
information is subsequently processed to subtract extraneous details such as
bone, and to enhance contrast. Although the dose of contrast medium needed
is considerably reduced in DSA, images still may suffer from motion artifact,
and from a lack of spatial resolution for this reason.114113
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Aortography is an invasive technique, and has complications
related to the delivery of contrast into the arterial tree, some of which are due
to the contrast medium, and some to arterial catheterisation. Adequate
hydration and the use of non-ionic contrast media have limited the incidence
of renal failure due to contrast media, as has the increasing use of DSA, with
the resulting use of small doses of contrast. Allergic, neurological and
cardiopulmonary complications continue to occur, but their incidence is
extremely small.116,117
Catheter related problems include haemmorhage, pseudoaneurysm
formation, thrombosis, arteriovenous fistula formation and embolisation.118
The complication rates are approximately 0.5% for transfemoral
catheterisation, 0.6% for the translumbar route, and 2% for transaxillary
catheterisation.117
Ultrasound
Originally derived from sonar, (sound navigation and ranging),119
ultrasound was first used to demonstrate aortic diameter in 1961 by Donald
and Brown using a technique similar to present day M-mode ultrasound.120
Since then, the development of B-mode image production, and the advent of
grey-scale ultrasonography have increased image definition. Ultrasound can
easily differentiate aortic aneurysm from aneurysm of the visceral arteries, and
can measure aortic diameter with accuracy in clinical practice.121 The
combination of B-mode and pulsed Doppler velocimetry known as Duplex
scanning is now being used in the evaluation of the aorta, its major branches,
and the arteries of the lower limb.122
Page 46
Because of the wide availability and increasing improvement of
machines, ultrasound has become the investigation of first choice in suspected
aneurysm of the abdominal aorta. Frequently however, distortion and
cephaloid displacement of the aneurysm sac, technical limitations due to probe
shape and size, sound transmission through bowel gas and patients' obesity
may limit the information available from ultrasound. Improvements in this
area may be made in the near future when colour coded ultrasound imaging
becomes more widely available.
Perhaps the most exciting use of ultrasound in the diagnosis of
aneurysm of the aorta is still under scrutiny. Over the past five years
increasing use of portable ultrasound machines has been made in community
screening for aortic aneurysm disease. Major advances have been made in the
selection of 'at-risk' populations, and studies of cost-effectiveness have
suggested the advantages of screening.123,124
Computerised Tomography
In 1968, Godfrey Hounsfield suggested that computers and
mathematics could be used to reconstruct images from the integration of sets
of x-ray measurements taken from different angles. Development was so
rapid, that by 1972 a computerised tomography scanner was available to image
the central nervous system, and its clinical potential being explored. There
followed a whole body instrument in 1975 with satisfactory resolution, and
Hounsfield was awarded the Nobel prize in 1979. Since then, advances in
computer technology have led to increased resolution, and a reduction in the
time taken to produce the images.
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C.T. uses circumferentially acquired radiographic data to
reconstruct a cross-sectional image. The C.T. image represents a cross-
sectional tissue slice of selected thickness from 2 mm. to 1 cm. Thinner 'slices',
produce greater spatial resolution and fewer artefacts. Infusion of contrast
material is necessary for adequate imaging of hollow organs such as the ureters
and blood vessels. Highly accurate imaging of the renal arteries is possible,
but multiple doses of contrast medium and the acquisition of many closely
spaced C.T. 'slices' in the appropriate region are required. This increases the
radiation dose sustained by the patient, and the time taken for scanning.
Computerised tomography is a safe procedure. Complications are
related to intravenous contrast administration, and are very rare. The
radiation dose sustained by patients is less than that for a barium enema in
normal circumstances.
Magnetic Resonance Imaging. (MRI)
One of the newest radiological techniques, magnetic resonance
imaging was first used as an analytical tool in chemistry in the 1949s.125 The
localisation of resonating nuclei in one dimension was reported by Gabillard in
1952,126 and in 2 dimensions 20 years later by Lauterbur.127 The first use of
M.R.I, in human imaging studies was by Hinshaw et al. in 1977, when they
produced a cross-sectional image of a human wrist.128 The earliest reference to
the use of M.R.I, in vascular disease was in 1983 by Higgins et al.129
The assessment of M.R.I, as an imaging technique in aortic
aneurysm disease, and particularly inflammatory aneurysms forms the basis of
part of this thesis.
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CHAPTER 2




The question of the aetiology of aortic aneurysms has been a
continuing source of interest to both vascular surgeons and pathologists.
Atherosclerosis is still thought by pathologists to be the most likely cause, but
this has been recently challenged by a number of authors.
The factors precipitating abnormal dilation of the abdominal aorta
may be considered under a number of categories.
1. Mechanical factors leading to structural weakening of
the aortic wall, or producing abnormal flow or
pressure patterns within the aortic lumen. This
includes the effects of atherosclerosis in
thinning the aortic media or narrowing the aortic
lumen.
2. Abnormalities of the blood supply of the aortic wall.
3. Metabolic aberrations. This includes factors leading
to flaws in the structural proteins of the aortic wall
in quantity or at the molecular level. Manufacture of
abnormal elastin or collagen, or increased proteolysis
of either protein should be considered.
4. Genetic associations.
The true aetiology of aortic aneurysms is unknown. It is likely, however,
that more than one factor is involved, making clarification of the cause highly
complex.
The theories of aneurysm formation which have been investigated
and which form the basis of current speculation about aneurysm formation in
general are discussed under the four headings listed above.
The specific pathological and clinical features of inflammatory




The systolic surge of blood delivered to the aorta is met in young
individuals by an elastic dilation and recoil of the aorta, a mechanism which
effectively smooths the pulsatile cardiac output for delivery to the major
viscera.130 Changes may occur in the aortic diameter, wall thickness, and
elasticity which reduce this capability and may predispose to the formation of
aneurysmal dilation. These changes must be seen in the context of the normal
dynamic function of the aorta which is an elastic tube subjected to pulsatile
flow.
In the virtual absence now in Britain of syphilitic aortitis and
mycotic aneurysms of the aorta, aortic aneurysms are most frequently
associated with age and atheroma. Both of these may change the mechanical
characteristics of the aortic wall either singly or in combination.
Age
Ageing arteries dilate, stiffen and develop thicker walls.130"132 These
changes are due to an age related reduction in the percentage of collagen and
elastin in aortic wall, and an increase in the collagen - elastin ratio.






There is no doubt that risk factors for stenosing atheromatous
disease and aneurysmal disease are largely the same. There are minor
differences, such as the increased prevalence of diabetes in stenosing disease
as opposed to aneurysmal disease, and the increased prevalence of
hypertension and smoking in patients with aneurysmal disease compared with
occlusive disease.133 It is therefore not possible to distinguish between patients
with aneurysmal disease and occlusive disease on the basis of risk factors.
Study of the pathology of end stage occlusive and aneurysmal disease gives
little information on the differences in aetiology or pathogenesis.
Three possibilities exist in aneurysm disease, linking atheromatous
change and aneurysm formation :
1. That atheromatous change is a common root for the
development of occlusive disease and aneurysmal disease, and that patients in
each group differ in some fundamental way in their response to the initial
lesion. Some patients progress to aneurysm formation, some to occlusive non-
aneurysmal disease.
The aneurysm is caused by the atheroma.
2. That the co-existence of atheromatous change and
aneurysmal dilation is seen because of the secondary development of
atheroma in an artery already dilated by some other mechanism. The
atheroma is caused by the dilation.
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3. That atheroma and aneurysmal dilation develop by
completely separate mechanisms, and one does not cause the other.
Animal studies provide the best available evidence that
atheromatous change leads to aneurysm formation. Studies of primates, dogs
and fowl all suggest that the development of atheromatous plaques predates
the development of aneurysm.134-136
Initial changes in aortic diameter caused by atheroma may produce
favourable conditions for continued aneurysmal dilation, and it is in this case in
which haemodynamic factors may be crucial.
The role of reflected pulse waves in the development of aortic
aneurysm was first proposed by Blakemore and Voorhees in 1954,137 and was
later taken up by a number of other authors. The terminal portion of the
abdominal aorta is unique in its proximity to the bifurcation. Such a region
does not exist in any other part of the vessel. Blakemore & Voorhees
suggested that two characteristics of the abdominal aorta predisposed to
aneurysm formation. The first was that the aorta is tethered at both ends - at
the diaphragm and at the common iliac arteries. Atheromatous change
produces gradual stiffening, elongation and kinking of the aorta. This in turn
results in a 'water hammer' pulse wave in the aorta, with abnormally high
systolic pulse pressures. This abnormal pressure wave is transmitted to kinked,
and therefore partially obstructed iliac arteries, producing a reflected pulse
wave and increased wall stresses in the lower aorta predisposing to aneurysm
formation.
Practical confirmation of this mechanism was provided between
1971 and 1973 by Newman and Gosling in a series of papers.138"140
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Gosling138 calculated that for minimal pulse wave reflection at a
bifurcation, the area ratio (the sum of the cross sectional areas of the branches
divided by the area of the parent vessel) should be 1.15. In this case, the
bifurcation can be said to be 'matched'. They also showed that with age, the
aorto-iliac bifurcation of man becomes progressively 'unmatched' with a
decrease in the area ratio, and a corresponding increase in the magnitude of
the reflected pulse wave. The aorto-iliac bifurcation in man is only 'matched'
in infancy, when the ratio is 1.11, and reaches a ratio of 0.75 at age 50.
Figure 8a.
This illustrates the principle of Area Ratio. The magnitude of the
reflected pulse wave varies with the area ratio.
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Figure 8b.
The relationship between area ratio and magnitude of the reflected




Newman139 has shown in the fowl model that an increase in
distensibility of the cockerel aorta occurs in the early stages of atheromatous
change. This is associated with an increase in aortic diameter, and consequent
mismatching of the aortic bifurcation.
Two years later, he went on to show that in direct pressure
measurements in dogs with mismatched aortic bifurcations, the magnitude of
the reflected pulse wave increased with decreasing area ratio.1,10 An excellent
distillation of this work is made in the paper from Lallemand.141
2. Abnormalities ofBlood Supply
Structural features have been identified in the wall of the
abdominal aorta which may not only explain the propensity of the infrarenal
aorta to dilate, but also why it should do so more commonly than the thoracic
aorta.
The formation of aneurysmal dilation of the aorta implies a
localised inability of the artery wall to withstand the tensile stress imposed by
the pulsatile column of blood. This inability may result from disturbance in the
architecture or composition of the wall, or interference with its blood supply.
In 1967, Benjamin and Becker compared the number of vasa
vasora in the thoracic and abdominal aorta.142 They found that these vessels
were abundant in the thoracic aorta, but that there was a relative paucity in the
infrarenal abdominal aorta. They suggested that, following occlusion of one of
the vasa vasora of the thoracic aorta by atheroma, the medial blood supply was
maintained by collaterals, whereas in the abdominal aorta, such an occlusion
led to medial necrosis and a tendency to aneurysm formation.
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Wolinsky & Glagov and Zatina arrived at similar conclusions when
they examined the medial lamellar structure of the aorta of several species of
mammals and man.143144
The mammalian aortic media is made up of an orderly and
integrated system of fibromuscular lamellae. Regardless of species, the
number of lamellae is proportional to the aortic diameter, such that each
lamella sustains a tension of approximately 2000 dynes per square centimeter.
Nutrition of the aortic wall by diffusion from the vessel lumen appeared to be
sufficient to sustain only the inner 29 lamellae. The aortae of mammals with
more than this number of aortic lamellae possessed vasa vasora to nourish the
outer layers.
The appearances of the elastic lamellae described by Wolinsky and
Glagov are shown below in Figure 9.
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Figure 9.
Microscopic appearance of the media of the adult mamalian
thoracic aorta after fixation during distention by physiological intraluminal
pressure. Lamellar units consist of relatively straight elastic bands and
intervening fine elastin fibres collagen fibres and smooth muscle cells. A is
stained by the Weigert-Van Gieson method, and elastic fibres appear black. In
B, the wall is stained with H & E. Cell nuclei appear black, and elastic fibres
appear white.
Photograph from original paper byWolinsky & Glagov.143
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The thoracic aorta of man is furnished with a number of lamellae
and vasa vasora commensurate with its diameter, and is comparable with other
mammalian morphology. In marked contrast however, the human abdominal
aorta contains only 28 lamellae, when, from animal studies, it should contain
many more. This results in each lamella sustaining an abnormally high tension,
of approximately 3000 dynes per square centimeter. In addition, in
confirmation of the work of Benjamin & Becker, there is little evidence of vasa
vasora. The net result is that in the human abdominal aorta there exists an
unusual situation in that each aortic lamella carries an abnormally high load in
the virtual absence of vasa vasora. This would suggest why the human
abdominal aorta is particularly susceptible to aneurysm formation.
3. Metabolic Abnormalities
The tensile strength of the aortic wall is due to the presence not
only of smooth muscle fibres, but also of considerable quantities of the
structural proteins collagen and elastin. A decrease in the quantity, structural
or functional integrity of any of these components may lead to weakening of
the aortic wall and a tendency to aneurysm formation. In order to explain the
changes in the aortic wall leading to aneurysm formation, which may be due to
changes in elastin or collagen, a brief review of the contribution of each to
normal vessel mechanics is required.
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Elastin and Collagen - Their role in normal vessel mechanics
In normal vessels, at physiological pressures, arterial walls undergo
distension and recoil in response to the arterial pressure wave. In this
situation, the arterial wall is extremely compliant, a property due to the wall
content of elastin. Elastin fibres can be stretched to 50-70% of their resting
length, acting like folded-up chains. As the fibres are loaded, length increases
as the chains become unfolded. As the fibres reach the limit of their ability to
stretch, they become progressively stiffer, limiting further extension. Collagen,
the other major structural protein, has a fundamentally different structure.
Because of extensive cross-linking, collagen has a maximum extensibility of
only 2-4% of resting length.
In physiological conditions, elastic and collagen fibres are stretched
but bear load to different degrees. Cox has estimated that, in canine arteries
under normal conditions, only 8-25% of the collagen is load bearing.145
With increasing age and hypertension, human arteries become
stiffer. This correlates with an increased ratio of collagen to elastin in the wall.
This change in connective tissue content does not account entirely for the
change in stiffness. As arteries dilate with age, elastin fibres reach their
extension limit, and become stiffer. At the same time, there is recruitment of
collagen fibres, which are inherently stiffer, in both the media and the
adventitia. In addition, there is increasing calcification of elastic fibres, further
raising stiffness.
The effects of collagen and elastin destruction have been
extensively studied by Philip Dobrin.14* In essence, he has studied the
behaviour of arteries at physiological distension pressures following selective
destruction of either protein. Arteries exposed to elastase dilate aneurysmally
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and become stiffer as collagen is recruited, but do not rupture. If exposed to
collagenase, vessels dilate slightly, and tend to rupture at low pressures. These
findings suggest that under physiological conditions, elastase is responsible for
maintaining the normal dimensions of the artery, whilst collagen provides the
tensile strength.
Removal of appreciable proportions of either structural protein
will weaken the aortic wall, and might be expected to predispose to aneurysm
formation.
Elastin Destruction
Elastin is a stable protein, with a slow turnover in adult humans,
having a half life estimated at 70 years.147 Most elastin is synthesised early in
the postnatal period and is not replaced. With increasing age, elastin
degenerates and is removed from tissues, a process responsible for the ageing
changes in skin, and for age related aortic dilation.
Aortic aneurysm formation is histologically associated with marked
elastin loss. The degree of elastin loss is greater than in non-aneurysmal aorta
displaying the same degree of atheromatous change, implying that the
exaggerated elastin loss is related specifically to the presence of aneurysm
disease.148
Elastase activity is normally extremely small in the peripheral blood
in adult humans. Circulating elastase normally exists as an inactive complex,
principally with alpha-l-antitrypsin. Decreased levels of alpha-1-antitrypsin
(a-l-at) or its activity leads to increased free elastase activity.149
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Smoking has been noted to reduce antitrypsin levels by two main
mechanisms. Oxidants in cigarette smoke oxidise methionine residues on
alpha-l-antitrypsin, inactivating it. Inhibition of a-l-at by neutrophil
myeloperoxidase has also been described.150,151
Cannon and Read investigated elastase activity in peripheral blood
in 1982.152 They suggested that in patients with aneurysm, serum and
neutrophil elastolytic activity was increased, and antiproteolytic activity
reduced, compared with patients with aorto-iliac occlusive disease. The
validity of the data in their paper, was marred however by small numbers and
dubious statistical significance values. Attention was drawn to the importance
of homeostasis between elastase activity and its inhibition by antiproteolytic
agents, such as alpha-l-antitrypsin.
Hornebeck et al separated the total elastase activity in human
serum into that due to serine proteases, such as neutrophil elastase, and
metalloproteases, but found no increase in total elastase activity in
atherosclerotic patients compared to normal controls.153 Contradictory
findings were made by Brown in 1985, who, using the same assay, found raised
levels of serum proteolytic activity in patients with aorto-iliac occlusive disease
and aneurysms compared with controls.154 Like Hornebeck, Brown found that
human serum could not hydrolyse insoluble bovine elastin, and it is likely that
the new proteolytic enzyme that Brown describes is the metalloprotease
component originally described by Hornebeck.
Endopeptidases capable of hydrolysing insoluble elastin have been
isolated from various tissue types, including pancreas, spleen, neutrophil
polymorphs, macrophages, fibroblasts, and vascular smooth muscle cells.155"157
Hornebeck et al. in 1976 correlated increasing aortic elastase activitywith
increasing age and arteriosclerosis.158 They went on to isolate an elastase-like
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enzyme from human aorta immunologically distinct from human pancreatic or
neutrophil elastase, which was responsible for 36% of total elastolytic activity
in the wall.159
Further studies of aortic tissue elastase activity were undertaken by
Busuttil in 1982. His group demonstrated an increase in total elastase activity
in the walls of aneurysmal aorta compared to atheromatous, non-aneurysmal
aorta.160 The findings of increased elastase activity in aneurysmal aortic wall
were confirmed by Cohen in 1987, who also reported an increase in elastase in
ruptured aneurysmal aortic wall.161 Cohens group went on to characterise the
elastase in aneurysmal aortic wall, concluding that it was a neutral serine
protease. In view of the findings of Hornebeck, ie. that there are clearly more
than 1 elastases in aortic wall, it is likely that the aortic wall extract used by
Cohen contained a heterogeneous mix of serine elastases. Despite this, and to
the detriment of the work, he compares his rather crude aortic wall elastase
extract to the elastase extract used by Hornebeck. This was an aortic protease
refined by affinity chromatography, and therefore the comparison is invalid.
The elastase used by Cohen had similar properties to smooth muscle elastase
isolated from rat and pig smooth muscle cells. This identification lacked
immunological proof, but may indicate that at least some part of the elastase
activity of the aneurysmal aortic wall may be produced by smooth muscle cells.
An excellent and recent review of the state of research into the
enzymatic basis of aneurysm disease can be found in the paper by Powell and
Greenhalgh in 1989.162 One point made in this review is that in inflammatory
aneurysms, 30% of the elastase which can be precipitated by antibodies to
human neutrophil elastase. In the case of non-inflammatory aneurysms, 90%
of the elastase is not precipitated by this antibody. The problems remain,
however, that in established aneurysm disease, the presence of increased
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elastase activity in either serum or aortic tissue may be a cause or an effect of
the aortic dilation.
Collagen Destruction
The part played by collagen in aortic function had already been
outlined. Collagenase was first detected in aneurysmal aortic wall by Busuttil
in 1980.163 It appeared from this study that collagenase activity was limited to
the walls of aneurysms, and was not present in the walls or atheromatous, non-
aneurysmal aorta. Collagenase activity correlated to aneurysm size, and was
particularly high in the single ruptured aorta studied. In cases where the
location of maximum collagenase activity within the wall was studied, this was
found to be in the inner layers of the wall.
Discovery of collagenase in the wall of aortic aneurysms and its
correlation with size tends to confirm the findings of a number of other
authors. The work of Dobrin referred to above in the mechanical role of
collagen, and his findings in arteries exposed to collagenase related rupture
with loss of collagen. As rupture also correlates with size, the correlation of
collagenase activity with size (and rupture) is significant.
Collagenase activity localised to the inner layers of the aneurysm
wall confirms the findings of Strandness and Sumner that collagen is
concentrated in the outer layers.164 The finding of collagenase also tends to
confirm the findings of Swanson that rupture of aneurysms is commoner
following laparotomy, owing to a proposed but unproven increase in systemic
collagenase.16S
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In addition to confirming other authors findings on increased
collagen to elastin ratios in aneurysmal aorta, Menashi suggested that low
levels of type 3 collagen may be important in the genetic predisposition to
aortic aneurysms seen in some families.166 Deficiency of type 3 collagen has
been shown to be associated with arterial aneurysm formation in Ehlers
Danlos type 4 and in some patients with cerebral aneurysm formation.167,168 It
may be then that alterations in the quality as well as the quantity of collagen
may be implicated in the formation of aneurysms.
Defects in Elastin and Collagen Formation
Defects in both collagen and elastin have been linked with
deficiencies in trace elements such as copper, zinc and magnesium.169'170 The
biochemical basis of these theories has been extensively investigated, but their
place in the pathogenesis of aneurysms in humans is less clear.
The mechanical properties of both collagen and elastin are due to
extensive covalent cross-linking between protein chains within each fibre.
These cross-links are formed between lysyl residues present on adjacent chains
by the action of lysyl oxidase. Copper is an essential cofactor in lysyl oxidase171,
and therefore in the formation of normal collagen and elastin. Copper
deficiency has been associated with aneurysm formation and aortic rupture in
lathyritic turkeys, blotchy mice, swine and rats. Tilson has found that the
collagen formed in the congenitally copper deficient blotchy mouse is
abnormally soluble because of reduced collagen cross-linking. This animal
model also displays reduced activity of lysyl oxidase, in keeping with the copper
deficiency. A human model of lysyl oxidase deficiency is available,
documented byDi Ferrante, in Ehlers-Danlos Syndrome type 5.172
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A number of studies in humans have associated aneurysms of the
abdominal aorta with low copper levels in various tissues.
More recently, Tilson has refuted his own, earlier findings, and
Senapti has failed to confirm Tilsons original findings on hepatic copper levels
in aneurysm patients.173"176
The only recognised defect of copper metabolism in humans is
Menkes Syndrome. This rare genetic defect leads to an abnormality in copper
absorption and transport, and the formation of aneurysms. In view of the
other findings outlined above, it is likely that in man, copper deficiency never
reaches such severity that it plays a significant part in abdominal aortic
aneurysm formation.
Copper deficiency has however been implicated in other
mechanisms which may lead to aortic damage. During normal electron
transport to molecular oxygen in the metabolic respiratory chain, toxic partial
reaction products are formed which cause damage to many biomolecules.
Such products include oxygen free radicals. Superoxide dismutase is an
enzyme responsible for the conversion of oxygen free radicals to water and
molecular oxygen, and which therefore protects against tissue damage from
free oxygen radicals. Copper is an essential cofactor in superoxide dismutase,
without which the enzyme will not function. In the avian model, copper
deficiency leads to marked reduction of superoxide dismutase activity, which is
reversed by the administration of copper in the intact animal. It is conceivable
that severe copper deficiency in humans could lead to reduced superoxide
dismutase activity, and a rise in levels of tissue-toxic free oxygen radicals.177
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4. Genetic Associations
The genetic association of aortic aneurysms in the animal model
has been recognised for some time.171178 The predisposition to aneurysm
formation in blotchy mice is closely linked to copper metabolism. This
mechanism has not been confirmed in humans, except in the extremely rare
condition of Menkes Syndrome. It is of doubtful significance in the genesis of
non-specific aneurysm disease in man.
A familial tendency to aortic aneurysm formation was first
proposed by Clifton in 1977.179 He described the familial clustering of ruptured
abdominal aortic aneurysms. Following this report, the genetic predisposition
to aortic aneurysm formation attracted little attention until the mid 1980's.
Tilsons studies of the genetics of aortic aneurysms in 1984 were
strongly suggestive of a genetic basis for aneurysm disease. There was
inconsistency in the mode of transmission, some families displaying strong
evidence of X-linkage, and some of an autosomal pattern. The point is made
by Tilson that this situation is not unique, and that differing genotypes may
give rise to the same phenotype in other human diseases.180 Tilson also noted
an association of carcinoma and aortic aneurysm, which he explains on the
basis of changes in tissue matrix consequent upon inherited abnormalities in
collagen metabolism.181
The finding of familial clustering was confirmed in later work with
greater numbers by Norrgard and Johansen, but the likelihood of genetic
heterogeneity remained.182"184
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The phenomenon of sex predisposition must be accounted for, and
X-linkage of a relevant susceptibility gene would provide at least a partial
explanation. Williamson and others have found changes in collagen cross
linking in animal models attributable to modulation of lysyl oxidase activity by
sex steroids,185186 and the potential mechanism has been described above.
Genetic variations in the activity of protease inhibitors have also
been implicated in aneurysm disease. The two most thoroughly investigated
are alpha-l-antitrypsin (a-l-at) and Tissue Inhibitor of Metalloproteases
(TIMP).
As the major inhibitor of neutrophil elastase, the activity of a-l-at is
genetically determined. The possible relevance of protease inhibitor
deficiency has been stated above, but there is conflicting evidence as to the
role of heredity. Tilson has documented a deficiency allele phenotype of a-l-at
in 3 of 13 patients with aortic aneurysm, while Powell has detected only 1 such
patient in 50.187188 While manifest a-l-at deficiency may be a cause of a small
and defined subset of aortic aneurysms, it clearly cannot account for the
majority. Neither would it account for male sex predominance, as the a-l-at
gene is autosomal.
TIMP is a recently discovered and characterised antiprotease
present in human tissues. It is a large and highly stable molecule, and has been
identified as a major inhibitor of at least three connective tissue proteases:
Collagenase, gelatinase and proteoglycanase.189 190 TIMP has been
demonstrated in aortic tissue,191 and its gene has recently been assigned to the
X-chromosome.192 There may be some evidence to suggest that patients with
aortic aneurysms demonstrate a relative deficiency in TIMP in skin biopsies,
but research in this field is at an early stage.191
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SUMMARY
Aortic aneurysms are associated with age and atheroma. Both of
these factors predispose to aortic dilation and decreased aortic compliance
because of changes in structural proteins in the aortic wall. Initial changes in
aortic diameter and compliance may predispose to continued dilation, as
increased pulse wave reflection from the aortic bifurcation leads to increased
aortic stressing.
The structure of the abdominal aorta in man is such that it sustains
a disproportionally high tension per medial lamellar unit in the face of an
almost total absence of vasa vasora. Because of a lack of 'reserve' capacity in
mural blood supply, occlusion of a few vasa vasora by atheroma may lead to
medial degeneration and predispose to aortic dilation.
Loss of the structural proteins elastin and collagen has been
associated with aneurysmal dilation and rupture of the aorta.
Increased elastase activity has been found in aneurysm wall, and is
due to a heterogeneous group of elastase enzymes. Neutrophil elastase has
been associated with inflammatory aneurysms, in which it constitutes some
30% of total elastase activity. Increased elastase activity is also present in the
peripheral blood of patients with aneurysms.
Collagenase activity is raised in tissue from aneurysm wall, and is
correlated with size and rupture.
Decreased levels of protease inhibitors have been found in the wall
and peripheral blood of patients with aneurysms.
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Two mechanisms implicating Copper deficiency in aortic aneurysm
formation have been proposed. Reduction in activity of the copper dependent
enzymes lysyl oxidase, and superoxide dismutase. These mechanisms have
been strongly associated with aneurysm formation in animal models, and in
very rare conditions in humans. It is highly unlikely that copper deficiency
develops in adult humans to such a degree that either of these mechanisms are






The early history of inflammatory aneurysms, and its emergence as
a distinct clinical and pathological entity have been dealt with in Chapter 1.
This chapter will summarise the pathological features of inflammatory
aneurysm, including current theories of aetiology and will go on to discuss the
clinical features and treatment options in inflammatory aneurysm disease.
Figure 10.
Inflammatory aortic aneurysm. The thick white fibrous coat and
adherent viscera can be seen.
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1. Pathology
Inflammatory aneurysms make up 2.5%-23% of all aortic
aneurysms.193,194 The condition, like simple atherosclerotic aneurysms of the
aorta, is more common in males, but occurs in a population approximately a
decade younger.195,196 Inflammatory change is usually confined to the infrarenal
aorta, but cases of inflammatory aneurysm of the thoracic aorta and iliac
arteries have been reported.193,195,197 The characteristic finding is of an aortic
aneurysm covered on its anterior and lateral aspects in a thick pearly white
fibrous coat. This fibrosis may extend laterally in the retroperitoneum to
encase a number of retro-peritoneal structures, such as ureters, renal vessels,
duodenum, inferior vena cava, small bowel mesentery and sigmoid
colon.193,105,195,198
Macroscopically, inflammatory aneurysms present a pearly white
appearance. The wall is extremely thick, and may exceed normal thickness by
3 or 4-fold, the excess fibrotic thickening being external to the media.195
Microscopically, there are features of severe atheromatous disease,
with ulcerated fibrolipid plaques, and intimal proliferation and fibrosis. There
is marked disruption and loss of the internal elastic lamina. The media is
extremely attenuated and fragmented, with loss and fibrous replacement of
smooth muscle cells and elastic fibres. The adventitia is thickened and
infiltrated by chronic inflammatory cells, lymphocytes and plasma cells, so
intensely in places that germinal centres are formed. This infiltrate often
extends into the media and obscures the demarcation between media and
adventitia. There is frequently severe inflammatory endarteritis of adventitial
and medial blood vessels. Adjacent peripheral nerve fibres, lymph nodes and
other structures may be seen entrapped in the adventitial fibrosis. Findings by
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a number of authors are remarkably consistent.102,106,195,197
Figure i la.
Lymphocytic infiltrate in the mid-media of an inflammatory
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Early germinal centres in the wall of an inflammatory aneurysm.
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Perivascular infiltrate and haemosiderin laden macrophages in
wall of an inflammatory aneurysm.
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Figure lid.
Perineural infiltration with plasma cells and lymphocytes in
adventitia of an inflammatory aneurysm.
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Figure lie.
Giant cells in the wall of an inflammatory aneurysm.
Figure 1 If.
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Approximately three quarters of aortic aneurysms exhibit some
degree of inflammatory cell infiltrate and adventitial fibrosis, a finding absent
from Goldstone's series, but confirmed by a number of authors including Rose
& Dent and Mitchinson. Aneurysms which display the macroscopic features of
inflammatory aneurysm, and are classified as such, show an excessively intense
cellular and fibrous response. In their extensive work, Rose and Dent (1981)
and Mitchinson (1984) conclude that inflammatory aneurysm is the result of
atherosclerosis, and that it represents the extreme end of a spectrum of
disease.106,197
The precise aetiology of inflammatory aneurysm is unknown,
although several theories have been proposed. The two most commonly
proposed theories are:
1. That aortic aneurysms develop, and go on to become
inflammatory, developing the typical macroscopic, clinical
and histological features of inflammatory aneurysm.
i.e. Aneurysm causes fibrosis
2. That the inflammatory response develops around the
abdominal aorta, which then causes aneurysm formation.
i.e. Fibrosis causes aneurysm
Most authors favour the former possibility, in that it can account for two
phenomena associated with inflammatory aneurysm. These are listed below.
1. The presence in some cases of inflammatory aneurysm of localised plaques
ofmature fibrosis, rather than the more complex 'frozen' aorta with multiple
organ involvement.
2. The existance of an intermediate type of aneurysm, in which organs are
adherent and difficult to dissect, but without the presence of plaques of mature
fibrous tissue.
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It does not however, account for the existance of non-aneurysmal
periaortic fibrosis, which is most often seen as part of idiopathic
retroperitoneal fibrosis (IRF).
A common aetiology has been proposed for IRF and inflammatory
aneurysm, but there seems little doubt that inflammatory aneurysm is a distinct
pathological entity in its own right. In both Crawfords and Goldstones series,
they are described as "a close relative, but distinct clinical entity" and "a
distinct clinical entity"193193 The gross distribution of fibrosis differs; in IRF the
fibrosis is maximal over the sacrum,193 199 whilst in inflammatory aneurysm,
fibrosis is often confined to the aneurysm wall itself,193 with no other
distribution in the abdomen.
Inflammation has been noted by several authors to be related to
severe atheroma, and changes localised to sites of medial breaching by
atheromatous plaques.200"202 The concept of inflammatory aneurysm as a
separate entity is supported by a number of authors.193,197'203
Leakage of blood components has been proposed as an important
factor in the aetiology of inflammatory change. No studies, however, have
shown either the leakage of fibrin or haemosiderin to be consistently present in
large series.106,195'204
Although Goldstone108 acknowledges the presence of characteristic
gross and microscopic features in inflammatory aneurysm, he regards the
inflammatory response as nonspecific, and attributes no aetiological agent.
West & Ryan205 report a case suggesting an athero-ischaemic aetiology.
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Currently, the most credible and popularly accepted theory of the
aetiology of inflammatory aneurysm is that proposed by Mitchinson. In a
number of publications, he suggests that the cellular and fibrous response seen
in inflammatory aneurysms is due to an immune response to antigen breaching
the attenuated and eroded media. The antigen is thought to originate in
atheromatous plaque, and may be related to oxidised lipoproteins.197,201,202 The
role of immunological mechanisms has also been anticipated by Munro et al.,
who found the presence of immunoglobulin A - bearing plasma cells in aortic
aneurysm wall increased in proportion with aneurysm wall thickness.206
If immunological hypotheses prove correct, the theories of aetiology
of inflammatory aneurysm could be unified:
(a) Atherosclerosis as the root cause of the aneurysm.
(b) Inflammatory change in the wall of the aneurysm dependant
upon the severity of the atheroma, and therefore on the
degree of antigen presentation. This would explain the
presence of mild inflammatory infiltrate in 'simple'
aneurysms, and the impression ofmany authors of a spectrum
of disease.
(c) Clinically recognised inflammatory aneurysm resulting from
severe atheroma, large volume of antigen presentation, and
correspondingly excessive cellular and fibrous response.
2. Clinical Features of Inflammatory Aneurysms
There is remarkable consistency in the description of clinical
features of inflammatory aneurysms between all the major reviews. Pain in the
abdomen or back is an extremely constant finding,102'1®3 193 195 198'207'208 and may be so
severe as to be mistaken for a leaking aneurysm. The pain may be caused by
vertebral erosion, or by visceral obstruction by the inflammatory mass,102,195,207
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which may lead to the patient being treated by urgent operation. 193 196,199
Weight loss is a frequent complaint,193195'207 and there may be signs of
systemic illness 207. On examination the aneurysm is often very tender in the
absence of rupture or leak.193
3. Laboratory Investigation
The most common finding on haematological examination is of a
raised ESR ltt2'm207,208, and anaemia has been noted in some series.198 The white
blood count is usually normal.109 Obstruction of the ureters may lead to a
raised blood urea.193
4. Radiological Diagnosis
The radiological diagnosis of inflammatory aneurysm is a subject of
considerable controversy, and most of the currently available modalities have
been assessed. The diagnosis of aneurysmal change and inflammatory change
are closely linked. Because of this, and because radiological diagnosis forms a
large part of this thesis, radiological techniques of diagnosis are discussed in
detail in the following chapter.
5. Operative Findings
The extensive fibrosis associated with inflammatory aortic
aneurysms frequently requires extensive modifications of surgical technique
during aneurysmectomy. In florid cases, the left renal vein, inferior vena cava,
ureters and duodenum may be included in the peri-aneurysmal mass of
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fibrosis. The incidence of duodenal involvement in fibrosis has been reported
as 62-100%,209,210 with involvement of the inferior vena cava almost as
frequent.103 209. The ureters are drawn into the peri-aortic fibrosis less
frequently, the incidence ranging from 12% to 30%.207,210 The fibrosis renders
dissection of the neck of the aneurysm for cross-clamping hazardous, with a
high risk of damage to other organs.
6a. Operative Technique - Exposure and resection.
Several factors have precluded the extensive study of operative
techniques in inflammatory aneurysm. Not only is the recognition of
inflammatory aneurysm relatively recent, but also the incidence is low, and
current radiological diagnostic accuracy is poor.
Most surgeons, even those with a specific vascular interest
therefore see relatively few of these aneurysms and the diagnosis is unlikely to
be made pre-operatively. In these circumstances, a detailed plan for operation
cannot be made, and the operative mortality for inflammatory aneurysm is
much higher than for simple aneurysms.
In all of the substantive reviews of inflammatory aneurysms where
operative technique has been considered, aneurysm repair has been
undertaken by the transperitoneal route. Several studies report cases where
operation has been abandoned because of the extent of fibrosis, with resort to
alternative methods of treatment. The incidence of abandonment however is
low in most series, ranging from none203 to 60% (three of the five cases
reported by Stringer).196 Crawford's series193 includes 10 patients who, having
undergone laparotomy elsewhere, were referred for operation. In all cases
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this was successfully performed. In the small series reported by Stringer, two
of the three patients had radiological features on intravenous urography
suggestive of inflammatory aneurysm, but no other radiological investigation
apart from ultrasound was performed.
Analysis of the results from several large series show the overall
incidence of abandoned operation to be 4.2%.
In exposing the neck of the aneurysm for cross-clamping, most
authors agree on a technique involving minimal dissection of adherent viscera,
particularly the duodenum and inferior vena cava. Both Crawford's and
Pennell's series include patients dying from graft infection secondary to
duodenal injury at the time of injury. No attempt should be made to separate
any viscus from the inflammatory mass, and proximal control of the aneurysm
should be gained in an area free from fibrosis. In most cases, the
supraduodenal aorta is relatively uninvolved in fibrosis and permits
clamping.195,209 Where this is not the case, and fibrosis extends to encase the left
renal vein, renal arteries and supra-renal aorta, the alternatives are to
abandon the operation for non-operative treatment,1%'208'209 or to extend the
incision to gain access to the aorta more proximally. Crawford gives a
comprehensive description of the techniques of aortic clamping in the intra-
abdominal/suprarenal and thoracic sites, and reports good results.193
More recently, the retroperitoneal approach has been advocated
for routine use in cases of inflammatory aneurysm.211 Although the advantages
of this approach are controversial in cases of simple aneurysm,212213 it may be
useful where there is marked inflammatory change. The planned use of the
retroperitoneal approach for all inflammatory aneurysm assumes reliable pre-
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operative diagnosis. As will be demonstrated in the following Chapter, current
radiological techniques are incapable of providing this level of diagnostic
accuracy.
6b. Operative technique - Ureterolysis.
The necessity of a minimal dissection technique in exposure of the
aorta seems clear, but the need for operative ureterolysis is less so. The
ureters are frequently drawn medially by fibrosis, and may be difficult to
recognize. Sterpetti and Pennell both advocate catheterisation of the ureters
pre-operatively to aid in identification, and avoid the small but documented
incidence of ureteric damage.
Study of the 212 patients included in the studies by Sterpetti,
Goldstone, Baskerville, Pennell and Crawford, reveals that 52 were noted at
operation to have ureteric involvement in the inflammatory mass, an overall
incidence of 24.5%. 32 patients underwent ureterolysis, either on one side or
both, and had a satisfactory outcome. In fourteen patients, no action was
taken apart from prosthetic replacement of the aneurysm, again with an
apparently satisfactory outcome in all cases. Three patients were treated with
steroids rather than laparotomy (Baskervilles series); all had resolution of
radiological signs of ureteric involvement. Of the remaining three, two
sustained ureteric damage at operation, proceeding to ligation of the ureter,
and one had a nephrectomy for advanced obstructive damage and recurring
infections.
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There seems therefore to be a case for expectant management
when the ureters are involved in the fibrosis surrounding inflammatory
aneurysm. Ureterolysis should be reserved for cases of hydronephrosis. Not
only does this avoid increased blood loss, as highlighted by Goldstone, but it
also prevents the incidence of ureteric damage reported by Pennell, an
enthusiastic advocate of ureterolysis.
Cases of ureteric obstruction which continue or occur de novo
following replacement of inflammatory aneurysms are rare. Both Penned195
and Crawford193 comment that this has never been reported, and in Sterpetti's
later paper in 1989 he comments that only two were found on review of the
literature.203 One such patient not quoted by Sterpetti was reported by
Baskerville in 1987.214 Their patient underwent aortic replacement for a typical
inflammatory aneurysm, but presented 4 months later with bilateral ureteric
obstruction. The obstruction resolved following treatment with steroids.
There is therefore a paucity of direct experience in the treatment of failed
conservatism in post-operative ureteric obstruction in inflammatory aneurysm
disease. With the apparent success of pre-operative steroid treatment in
ureteric obstruction, the little evidence available suggests that, where
conservative therapy fails, steroids may be used post-operatively to relieve
ureteric obstruction.
Non-Operative Treatment
Steroid treatment has been used both as an adjunct to laparotomy,
and as a sole treatment for inflammatory aneurysm. In the series reported by
Clyne in 1977215 and by Baskerville in 1983208 corticosteroids were used to
reduce the fibrotic reaction surrounding inflammatory aneurysms which were
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deemed inoperable following investigation or at laparotomy. All 7 patients in
these two studies recovered well. Unfortunately Baskerville had the
opportunity to re-examine only one of their series at laparotomy following
steroid treatment. It does seem reasonable, however, to suppose that steroid
treatment can be used to reduce the inflammatory mass, and expedite
operation in cases where facilities or expertise are limited.
There is no real evidence to suggest, however, that routine primary
steroid treatment of inflammatory aneurysms is necessary. Sterpetti has
proposed that it may in fact be theoretically dangerous, and predispose to
acute rupture by thinning of the fibrotic wall.203 Evidence to lend support to
this hypothetical possibility is provided by Baskerville's findings of marked
thinning of the inflammatory aneurysm wall following steroid treatment.208
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SUMMARY
Inflammatory abdominal aortic aneurysm is a distinct clinical entity,
which frequently presents as a painful tender aneurysm in younger patients.
Patients may also complain ofweight loss or features of a systemic illness. The
aortic aneurysm is associated with peri-aortic fibrosis, displaying severe
destruction of the formed elements of the wall and a marked chronic
inflammatory cell infiltrate. The fibrotic reaction may include and encase
adjacent organs, and may render operative treatment hazardous.
Operative techniques are described to minimise difficulty and
morbidity, but their planned use depends upon the accurate pre-operative
diagnosis of inflammatory aneurysm and assessment of its extent. Currently,
diagnostic accuracy is poor, and the diagnosis of inflammatory aneurysm is
often made first at laparotomy, leading to a small incidence of abandoned
operation because of 'inoperability' and an increased morbidity and mortality
where reconstruction is attempted.
The primary treatment of choice for inflammatory aneurysms
remains operative replacement, there being no well defined place for steroids
in this role. Despite this, there is evidence that steroids may be useful in highly
selected patients as an adjunct to operation.
Operative exposure of inflammatory aneurysms should be
performed using a minimal dissection technique, and operative ureterolysis
retained for cases of hydronephrosis. An alternative retroperitoneal approach
is an advantage where the inflammatory process extends proximally to involve
the renal vessels and duodenum.
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CHAPTER 4.
RADIOLOGICAL INVESTIGATION OF AORTIC ANEURYSMS.
WITH SPECIAL REFERENCE TO INFLAMMATORYANEURYSMS.
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INTRODUCTION
The radiological diagnosis of inflammatory aneurysms is closely
linked with the diagnosis of simple aneurysm disease. This chapter
summarises the ability of currently popular radiological techniques to provide
information necessary to the clinician in both simple and inflammatory
aneurysms.
An appraisal of the abilities and current uses of MRI is included.
The principles of MRI are outlined in a brief technical synopsis, and the
rationale for the screening sequences used in this study are discussed.
The principal requirements of any radiological investigation used in
aortic aneurysm disease are that reliable and reproducible visualisation can be
achieved of the following:
1. The presence of aneurysmal dilatation of the aorta.
2. The upper extent of aneurysmal dilation, and its
relationship to other vessels, particularly the renal
artery origins.
3. The diameter in both anteroposterior and transverse
dimension of the main body of the aneurysm.
4. The thickness of the aneurysm wall, and the retroperitoneum
of the mid-abdomen.
Following a discussion of the exact radiological definition of an
aneurysm, each of these will be considered in turn, and the abilities of
conventional radiology reviewed for each.
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1. The definition and measurement of aneurysmal aorta.
The precise definition of an aneurysm of the abdominal aorta
remains unresolved, and there is no universal agreement. Working criteria
have been used by some authors in population screening. Allen et al. consider
an aneurysm to be present when the diameter of the infrarenal aorta is greater
than 3 cm., or 5 mm greater in diameter than the suprarenal aorta.216 These
criteria are also used by Collin, but the upper limit of the infrarenal aorta is
extended to 4 cm.217 The ratio of infra to supra renal diameter218 has been used
in the study of aneurysm growth rates.
Aneurysm measurement may be made in either transverse
diameter or anteroposterior (AP) diameter. Transverse diameter is measured
clinically, but AP diameter is more accurately measured on ultrasound than
transverse diameter.219 Cronenwetts actuarial analysis suggests that the initial
measurement of AP diameter is a better predictor of eventual outcome than
the transverse diameter or the ratio between the diameters of the aneurysm
and the proximal aorta.220
The diameter at which operative treatment of small aneurysms
should be recommended is currently the subject of a National trial.
2. The presence of aneurysmal dilatation
In the past, aortography has been used in the assessment of both
the size and extent of aortic aneurysms.221"224 It has been found to be a reliable
method for aneurysm diagnosis, detecting over 93% of aneurysms in Gordon-
Smiths series225 and up to 100% in other series such as that of Brewster et al.224,
but many authors have been unable to match these results.226,227 Whilst Rich et
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al. and Brewster224228 advocate routine angiography in aneurysm disease, others
favour its selective use.229,230 Conventional aortography is highly invasive, and
associated with a number of complications. This, and the development of
other modalities, such as ultrasound, have rendered conventional angiography
obsolete as a method for the initial diagnosis of aortic aneurysm.227,231
Ultrasound is a cheap, highly accurate, and completely non-invasive
examination and confirms the presence of aortic aneurysm in well over 95% in
all series.232
3. The upper extent of the aneurysm, and its relation to the renal arteries
The level of the upper extent of the aneurysm and its relation to the
renal arteries is well shown by aortography in most authors hands using both
conventional aortography and intravenous subtraction techniques.23*1233 The
presence of double renal arteries is also demonstrated in the majority of
cases,233 as are aorto-caval fistulas and aortic dissection.234,235 Inflammatory
aneurysms are notoriously poorly defined on aortography.236
Failure to reliably show the upper end of aortic aneurysms is the
main limitation of ultrasound. Diagnosis of the level of the renal arteries is
often made by inference, using the level of the superior mesenteric artery as a
reference point. Overlying bowel gas prevents the visualisation of the
aneurysm neck in the majority of cases.
Computerised tomography (C.T.) combines the abilities of both
aortography and ultrasound. It is less invasive than angiography in its use of
ionizing radiation and intravenous contrast media. Aneurysm detection by
C.T. approaches 100%, but demonstration of the relationship between renal
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arteries and the upper end of the aneurysm may be unreliable.
Renal arteries are not infrequently seen on C.T. scans for
aneurysm, but some authors suggest that the origins of the arteries are less
easily seen.233 Other studies report excellent results with contrast enhanced
C.T. in the diagnosis of renal artery involvement, similar to that of
angiography.2261237 In their recent paper, Vowden et al.230 report considerable
underestimation of the level of the renal arteries, and overestimation of the
incidence of juxta or supra renal aneurysm extension using contrast enhanced
C.T. They attribute this to aortic buckling and cephaloid extension of the
aneurysm sac.
It would seem appropriate to conclude that in the investigation of
involvement of the renal arteries and their relationship to the upper end of
aortic aneurysm, the most accurate investigation is aortography. Recent
evidence suggests that intravenous D.S.A. provides as much anatomical
information as the conventional technique, whilst obviating some of the
(infrequent) complications thereof.
4. Aneurysm size
Ultrasound has been shown consistently to be accurate in
measuring aneurysm size in a number of studies,226,227 though recently doubt
has been cast on its reproducibility.238 Its cheapness and non-invasive nature
have made it the method of choice in the initial confirmation of clinical
findings in aneurysm disease. Similarly the ability of contrast enhanced C.T. to
demonstrate aneurysm size is largely established and undisputed.
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Aortography by any technique displays only lumenal diameter: It
may suggest the diagnosis by demonstration of an ectatic lumen but objective
measurement of aneurysm size is impossible by this method.
5. Aneurysm wall thickness and retroperitoneum
Assessment of both of these characteristics is of particular
relevance to the diagnosis of inflammatory aneurysm and will be discussed in
this context.
Intravenous urography has been used to demonstrate the medial
indrawing of ureters by peri-aneurysmal fibrotic change. This is, however, a
non-specific sign, and only accurate in 30% of cases of inflammatory
aneurysm.195
Aortography is notoriously unreliable in showing peri-aortic tissues
and cannot be used for the diagnosis of inflammatory aneurysms.236 It may
however produce a urogram of some diagnostic value.193,203
Considerable variability exists in estimates of the ability of
ultrasound to detect inflammatory aneurysms. Characteristic findings of an
echo-free peri-aortic halo anterior to an enlarged aorta were reported by
Henry et al. in 1978,239 and by Cullenward in 1986.240 These have, however,
been inconsistent and infrequent diagnostic signs. Cheatle et al.210 failed to
make the diagnosis of inflammatory aneurysm by ultrasound in all 4 of their
cases, as did Stringer & Bentley196 in their series of 5, and Plate et al.198 in their
series of 6. Fitzgerald and Blackett in a retrospective review of 17 patients
quote an ultrasound detection rate of only 22%,241 and there is now general
consensus that ultrasound is of little value in detecting inflammatory
Page 92
change.196,198,203
The presence of inflammatory aneurysm may be suggested by the
demonstration of ureteric obstruction and hydronephrosis in the presence of
an aortic aneurysm. Pennell et al.195 documented an incidence of
hydronephrosis in 18% of their series of 127 patients with inflammatory
aneurysms.
Computerised tomography has been the only reliable radiological
method available for the direct diagnosis of inflammatory aneurysms. The
diagnosis and characteristic signs of inflammatory aneurysm were first
reported by Ramirez in 1982,242 and by the mid 1980s, C.T. was the radiological
diagnostic method of choice.
Vint et al.243 and Johnston et al.244 also comment on the
characteristic signs of inflammatory aneurysm on C.T. scan. Subsequently,
C.T. has become the gold standard for the diagnosis of inflammatory change.
In Cheatles series however, C.T. proved useless for pre-operative diagnosis.
This is somewhat surprising, as other studies suggest figures ranging from 41%
in the prospective part of Fitzgerald and Blacketts study to 50% (Pennell et
al.) and 100% (Plate et al., Crawford et al.,). It should be noted that Plates
series was of 5 patients, and 6 of Crawfords 10 patients had had the diagnosis
of inflammatory aneurysm made by laparotomy before C.T. scanning was
performed. In reality then, the diagnostic accuracy of C.T. in large series
rarely exceeds 50%. No series has been able to match the 100% accuracy of
C.T. diagnosis from Baskerville's series in 1983.208
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Figure 12.
Ultrasound scan of inflammatory aortic aneurysm. The thickened
wall can be seen (arrow). Thrombus is presentwithin the lumen (L).
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Figure 13.
Contrast-enhanced CT of inflammatory aneurysm. The thick
contrast enhancing wall (arrow) is seen surrounding calcification in the aortic
media. The patient also has a large left hydronephrosis (H) secondary to
ureteric obstruction from inflammatory fibrosis.
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MAGNETIC RESONANCE IMAGING - ABILITIES AND CURRENT USE.
Magnetic Resonance Imaging (M.R.I.) is an entirely non-invasive
investigation which produces images in a unique way. The tissue to be
examined is stimulated to emit a radiofrequency signal by the induction of the
phenomenon of nuclear resonance. Images are produced by integration and
localisation of this emitted signal. M.R.I, images therefore do not represent
attenuation of an external beam, as in conventional x-ray, or reflection, as in
ultrasound.
M.R.I, can provide images of any part of the body in virtually any
plane with few limitations. Resolution is as good as C.T., and differentiation of
soft tissue planes considerably better. No intravenous contrast is required for
vascular imaging.245,246
Because of the high contrast between fast flowing blood and
surrounding tissues, the aortic lumen, wall and branch vessels are all well
defined.247 The technique is capable of displaying saggital and coronal images
in addition to transverse, and can therefore delineate vascular anatomy along
the long axis of the vessel.
The role ofM.R.I, in aortic imaging has been investigated since the
early 1980s. As with any new diagnostic technique, considerable study is
needed before its place in any given area can be defined.
The only truly non-invasive radiological technique for the diagnosis
and monitoring of aneurysm disease until now has been ultrasound. In the
thoracic cavity, these functions have been carried out by C.T. and
arteriography, both ofwhich require intravenous injection of contrast material.
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Because of its non-invasive nature and unique capabilities M.R.I,
has established a place in the investigation and monitoring of thoracic
aneurysm disease.
Figures 14a-c show MRI images in transverse, coronal and saggital plane.
Figure 14a.
Abdominal MRI image in the transverse plane. The non-inflammatory
abdominal aortic aneurysm is indicated by an arrow.
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Figure 14b.




Coronal abdominal MRI scan.
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M.R.I, has been shown to be reliable in the diagnosis of both
aneurysmal and dissecting disease of the thoracic aorta. Entry/re-entry points
i
and true and false lumdna of dissection, thrombus adherence and branch
involvement can all be demonstrated.247,248 Akins has suggested that M.R.I, can
provide more clinically relevant information than arteriography in cases of
thoracic aortic dissection,249 and both Amparo250 and Geisinger 251 suggest that
M.R.I, is superior to CT in this context.
The series reported by Dinsmore confirms that M.R.I, findings on
morphology, location and extent of thoracic aortic aneurysms agree completely
with other radiological modalities, and give more information regarding the
aneurysm wall.252
Although C.T. and angiography will continue to be the most
frequently used investigations for the assessment of thoracic aortic disease for
some time, imaging using M.R.I, carries many advantages, and may be looked
upon in the future as the diagnostic investigation of first choice in thoracic
aortic disease.
The role of M.R.I, in the investigation of abdominal aortic
aneurysm disease is more difficult to define.
Studies comparing imaging techniques in abdominal aneurysm
disease find that M.R.I, compares favourably with both ultrasound and C.T.,
and Amparo is of the opinion that all the necessary information for aortic
surgery can be provided by M.R.I.253
Despite this, it is unlikely that M.R.I, will become established as a
routine investigation in abdominal aneurysm, at least in the short term,
because of cost and availability. Ultrasound remains the ideal non-invasive
modality for making the initial diagnosis ofAAA and for subsequentmonitoring.
Necessary information not provided by ultrasound can be gained from
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conventional C.T. or arteriography.
There is, however, one aspect of the use of M.R.I, in the diagnosis
of abdominal aortic aneurysm which has not been investigated, and in which its
particular strengths may prove useful. In inflammatory aneurysms of the
abdominal aorta fibrous tissue is prominent in the thickened aortic wall and
retroperitoneum. It has been suggested that the ability ofM.R.I, to distinguish
soft tissue planes is superior to C.T., and it is this ability which requires to be
assessed in the diagnosis of inflammatory aneurysms.
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MAGNETIC RESONANCE IMAGING - TECHNICAL ASPECTS
While no attempt will be made to provide a detailed technical
account of the principles of a brief description of the mechanisms
involved is presented.
Basic Principles
Certain atomic nuclei that have an odd number of protons or
neutrons possess a characteristic known as 'spin'. Since the nucleus is
positively charged, it generates a magnetic field, and behaves like a small bar
magnet. The most important nucleus of this type is the proton, a hydrogen
nucleus, because of its abundance in tissues.
When tissues are placed in a static external magnetic field, protons
align along the long axis of that field, according again to their analogy with bar
magnets. In this state, the tissue is said to be 'magnetised'. Full magnetisation,
i.e. the time taken to assume a new, aligned equilibrium, takes place
exponentially over a finite period. The time taken to reach 63% of full
magnetisation is called T. At equilibrium, protons may assume one of two
energy states, high or low. In normal circumstances, there is a slight excess of
low-energy protons.
If a radiofrequency (r.f.) pulse of energy is applied to fully
magnetised tissue, some low energy protons are propelled into the high-energy
state, where they remain until cessation of the r.f. pulse. When the r.f. pulse
stops, these high energy protons 'relax' back into the low-energy state, emitting
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a pulse of r.f. energy at the same frequency as the 'exciting' pulse.
The strength of this emitted energy decays exponentially with a
time constant T2. It is the amplification, localisation and processing of this
emitted r.f. energy pulse which is the basis of N.M.R. imaging.
The frequency of the radiofrequency pulse which is required to
make a nucleus resonate is dependant on the type of nucleus and the strength
of the static magnetic field. In clinical M.R.I., the nucleus examined is always
the hydrogen nucleus, a proton, and so the resonating frequency (the Larmor
Frequency) varies only with the static field strength.
Figure 15 shows, in diagrammatic form, the phenomena described above.
15a. The nucleus is rotating about an axis aligned along the static
external magnetic field. H indicates the direction of the static magnetic field.
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15b. When a radiofrequency magnetic field is applied to this
system, aligned in the horizontal plane, the nucleus moves out of the vertical,
and wobbles about the vertical axis with a circular path. This wobble is called
precession, and takes place only when the horizontally applied magnetic field
is at a frequency determined by the type of nucleus and the static external
field. The frequency required to produce this resonation is the Larmor
Frequency. The amount of tilt produced in the nucleus (angle a) depends on
the strength and duration of the radiofrequency pulse.
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15c. The radiofrequency pulse may be sufficient to tilt the axis of
nuclear rotation 90°, or 180° from its original vertical. It can be seen that
following a 90° tilt, the magnetic moment is maximal in the horizontal plane,




15d. When the radiofrequency pulse is removed, the nuclei begin
to relax back to their original position. Immediately after cessation of the r.f.
pulse, the nuclei continue to precess around the vertical axis while relaxing.
During this time, they are moving around the vertical in a large perpendicular
static magnetic field, and so emit a radiofrequency signal of their own, once
again at the characteristic Larmor Frequency. It is this signal which is
detected, and forms the basis for image production.
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Immediately following a 90° r.f.pulse, the vertical component of
nuclear magnetisation falls to zero. The return to vertical equilibrium is
exponential, with a decay constant referred to as the T relaxation time. This
time constant is dependant on the transfer of energy from precessing nuclei to
other, non-precessing nuclei in the material.
The T2 relaxation time is the time constant describing the
exponential decay of the emitted signal, following cessation of the r.f. pulse.
This time constant depends upon loss of phase coherence of precessing nuclei
due to interactions between adjacent precessing nuclei.
The biological nature of the Tt and T2 time constants are poorly
understood, but are considered to be related to the proportion of 'free' tissue
water.
In any tissue, some water exists bound to proteins, D.N.A. and
other large macromolecules, whilst some water is free. The Tt of pure water is
in the order of 3 seconds: The T of tissue is much lower than this, and
depends upon the proportion ofwater which is 'free'.
T times vary markedly with the resonant frequency of the tissue
being examined. As resonant frequency increases with magnetic field strength,
so Tx increases.
Variation in T2 also occurs with differences in tissue free water, but
the variation with changes in magnetic field strength are less marked.
Every tissue in the body can be characterised by its unique value for
the time constants T and T . Both of these values are determined by
characteristics of the tissue at molecular level. Of particular relevance to
imaging of the diseased aorta are the T; values of fat and water. Medium sized
molecules, such as cholesterol have an inherently short T time. Long chain
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fatty acids, on the other hand, have a short time because of rotation about
the terminal carbon-carbon bond. The small, rapidly moving molecules of
water have a long T time, amounting to some 3 seconds for pure water.
Pulse Sequences
The M.R.I, signal which is recovered from any sample is a function
of the way in which the nuclei have been perturbed from their equilibrium
state in the static magnetic field. Differences in the timing and duration of
radiofrequency pulses will produce differing degrees of nuclear movement and
therefore differing M.R.I, signals.
Saturation Recovery
This is the simplest of M.R.I, pulse sequences. In this sequence,
repeated pulses are applied, each sufficient to 'flip' the sample nuclei 90°. The
time between pulses, (the repetition time, or TR) is made longer than the T of
the sample. As a result the nuclei have time to return to equilibrium between
each pulse, and the signal is proportional to the number of nuclei (protons) in
the sample. The M.R.I, signal contains no information about the T or T, of
the sample.
If however, the TR is shorter, for instance equal to the Tx of the
sample, the nuclei do not have time to return to eqilibrium between pulses,
and the M.R.I, signal is smaller in amplitude. As the speed with which the
sample nuclei regain equilibrium depends on its T , the signal, despite being
smaller, will contain information about the T of the sample.
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Inversion Recovery
This sequence is similar to Saturation Recovery except that the
pulses are paired, two pulses being applied every TR. As for Saturation
Recovery, the nuclei are not permitted time after the first pulse to return to
equilibrium before the second pulse is applied.
The initial pulse in inversion recovery rotates the sample nuclei
through a complete 180°, the magnetic moment being rendered large and
negative. After the 180° pulse, there is a time delay (Tau) while the nuclei tend
to return to equilibrium. Following this delay, and before equilibrium is
achieved, a further 90° pulse is applied. This produces an M.R.I, signal with
more T information than on simple saturation recovery sequences.
A more detailed description of the physical principles of M.R.I.,
and other pulse sequences can be found in the excellent review by Bailes and
Bryant.254
In selecting the pulse sequences to be used in investigation of
inflammatory aneurysms, a number of factors were considered.
With the aim of defining the thick wall of inflammatory aneurysms,
it was felt that T differences would be relevant. Fibrous tissue has a high
water content when compared to the lowwater / high fat content of atheroma.
The pulse sequence most able to highlight T contrasts is inversion recovery.
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Disadvantages ofM.R.I.
The relatively long scan times necessary for the acquisition of very
high resolution images in M.R.I. make it prone to degradation by movement
artifact. The intensity and linearity of the magnetic field needed in M.R.I.
scanners require patients to be placed in a long tunnel, the walls of which are
only a few inches away from their face. Some claustrophobic patients find this
unacceptable, and are unable to commence or complete their scan. The
enclosed nature of the M.R.I. apparatus also renders M.R.I. less applicable to
the investigation of restless or unco-operative patients. The proximity to a
large and powerful magnet excludes the scanning of patients requiring
ventilators or other extensive monitoring or support equipment which is
composed ofmetallic parts.
The hazards of M.R.I. are produced by the three types of magnetic
field used in examination: (a) A strong, static magnetic field, (b) Small,
rapidly changing fields, (c) Radiofrequency fields.
As blood flows at right angles to a strong static magnetic field, small
electrical charges are set up. This has been observed to result in asymptomatic
and harmless E.C.G. changes in some patients.255 In patients who have recently
undergone clipping of cerebral aneurysms, the torque force produced by a
strong magnetic field on a high-nickel aneurysm clip may be enough to avulse
the clip from the vessel.256 By the same token, free ferromagnetic material in
the proximity of a strong static field can be accelerated to lethal velocity, and is
banned from M.R.I. suites.
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Small rapidly changing magnetic fields not only may induce current
in the leads of cardiac pacemakers, but may change their pacing mode.257 For
this reason, patients with pacemakers should not be scanned. Currents
induced by these rapidly changing fields may heat metallic prostheses, and may
also lead to tissue effects such as benign visual flashes, muscle contraction and
even ventricular fibrillation.
The only potential health hazard posed by radiofrequency magnetic
fields are those of prosthesis and tissue heating. This has been shown to be
insignificant in clinical use.255,258,259
Because of the potential hazards of static and oscillating magnetic
fields, restrictions upon strength, rate of field change and radiofrequency
exposure are enforced in clinical practice.255
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SUMMARY
Ail the information necessary for the surgical repair of abdominal
aortic aneurysms is available from ultrasound, angiography, computerised
tomography or a combination of these techniques.
M.R.I, allows imaging in all 3 axes, and produces excellent soft
tissue definition without the use of contrast material and without having to
move the patient. It is likely that M.R.I, alone can provide all relevant
information for abdominal aneurysm surgery non-invasively, and give
additional information about the peri-aortic soft tissues. The enhanced ability




BIOCHEMICAL INVESTIGATION OF AORTIC ANEURYSMS
- THE ACUTE PHASE PROTEIN RESPONSE
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INTRODUCTION.
The interest which has been aroused over recent years in the
biochemical changes in aortic aneurysm disease has been reviewed in the
preceding chapter concerned with theories of aetiology.
In this chapter, the acute phase response is outlined, and the
participating proteins reviewed. The rationale for assay of the acute phase
proteins is discussed, as it is for the other biochemical assays which form part
of this thesis.
The acute phase protein response
The so-called acute phase reaction comprises a general and
nonspecific response to most forms of infective and non-infective
inflammatory processes, cell or tissue necrosis, and malignant neoplasia, in
which there is a rise in the plasma concentration of certain proteins. The
proteins in question are mainly glycoproteins synthesised in the liver, and the
available evidence suggests that they act as mediators in the inflammatory
process.260
Elevation of acute phase proteins occurs in any situation in which
there is tissue damage, and is often a more sensitive indicator than ESR,
plasma viscosity of leukocytosis. The peak of the acute phase protein rise
occurs at about the third day post-injury. In general, the levels of all the acute
phase proteins rise in parallel in any given situation, but in some cases certain
members of the group are more useful. Casruloplasmin for example reflects
the degree of disease activity in Hodgkins disease, whereas other indices may
be normal.261
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It is likely that products of tissue damage and cell lysis initiate
synthesis of acute phase proteins. Such products probably include lysosyme,
prostaglandins and interleukin 1, a product ofmacrophages.
The assay of acute phase proteins in patients with abdominal aortic
aneurysms was first carried out by Powell et al. in 1987. They found an
increase in levels of alpha-1-antitrypsin, C-reactive protein and casruloplasmin
in patients with aortic aneurysms compared to patients with stenosing aortic
disease.262 As indicated in their paper, this suggests the presence of some
degree of inflammation or tissue destruction in all aneurysms.
Proteins involved in the Acute Phase Response
C-reactive Protein (CRP).
C-Reactive protein is a large complex glycoprotein normally
present in plasma with a concentration of approximately 6 mg/ml.261 In
evolutionary terms, CRP is one of the most primitive acute phase proteins. An
almost identical protein is found in the Horseshoe Crab, indicating the
presence of such a protein for 400 million years.
Levels of CRP rise substantially within hours of the onset of
inflammation or tissue damage, and it is widely used in this context in clinical
practice. Little is known of the function of CRP, but it is thought to act as an
non-specific opsonin.263 C.R.P. binds strongly to many of the polysaccharides
commonly found in bacterial cell walls. Once bound, it becomes an extremely
potent activator of the classical complement pathway and can therefore
initiate cell damaging and inflammatory reactions. Because of its large
glycoprotein structure, it is especially effective for capsulated micro-organisms
such as pneumococcus. It is also likely that CRP plays a part in platelet
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activation and aggregation in the presence of inflammation.
Cceruloplasmin
Casruloplasmin is synthesised in the liver, and binds approximately
95% of plasma copper. The role of this binding is obscure, as casruloplasmin
does not appear to act as a physiological transport protein for copper. It is a
slow reacting acute phase protein, of particular use as an indicator of disease
activity in Hodgkins disease, but rises are associated with all inflammatory
processes.261 Casruloplasmin has been shown to possess anti-oxidant
properties, inhibiting peroxidation by both iron and vitamin C. It is also likely
that caeruloplasmin inactivates free oxygen radicals produced by phagocytosis.
These protective characteristics may justify its acute-phase behaviour.
Alpha-1-antitrypsin (a-l-at).
Alpha-1-antitrypsin is a low molecular weight protein which is able
to pass freely throughout all body fluids. In human plasma it is normally
present in concentrations of approximately 2 g/1, but rises in inflammation with
a response time of approximately 24 hours. It is a protease inhibitor which is
most active against serine proteases such as elastase and trypsin, but which is
also known to bind to and inhibit other proteases such as cathepsins B1 and D,
and collagenase, a metalloprotease. Inhibition of proteases corresponds with
the formation of a complex between a-l-at and the protease.
It seems probable that a-l-at scavenges proteases in tissue fluids
and then returns to the plasma space from which the proteases are eliminated.
Reduction in the activity of a-l-at is known to be associated with a series of
disease states as a result of unopposed protease activity, which are outlined
below.
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Alpha- 1-antitrypsin shows marked genetic polymorphism, and
some 30 allotypes have been isolated.261 The various phenotypes can be
separated by electrophoretic techniques, most commonly isoelectric focussing.
Differences in the allotypes may depend upon the post-transcriptional
carbohydrate heterogeneity superimposed upon charge differences resulting
from inherited substitutions in the polypeptide chain. The clinical interest
surrounding a-l-at has centred on the association of certain allotypes with
disease states.
The genes and corresponding phenotypic variants of a-l-at are
assigned names prefixed with Pi (Protease inhibitor). The most clinically
relevant genotypes are PiM, PiW, PiS, PiP, PiZ and Pi null. Inherited in
Mendelian fashion, these genes give rise to phenotypic variants of a-l-at
including PiMM, PiMZ and PiMS. The population incidence and relevant








The reasons for variation in hepatic secretion of a-l-at depending
upon phenotype probably relate to structural differences between phenotypes.
The ability of hepatocytes to secrete a-l-at varies with phenotype (and
therefore structure), accounting for differences in plasma levels, and the
accumulation of a-l-at within the hepatocytes of some PiZZ infants (see
below).
Clinical disease is associated with the phenotypes PiZZ and PiSZ,
both of which are poorly secreted by the liver, leading to considerably reduced
plasma levels of a-l-at. In the presence of low levels of a-l-at, protease activity
is poorly opposed, leading to increased proteolysis.
In the lung, any stimulus associated with phagocytosis results in a
local increase in leukocyte proteases. In the presence of adequate levels of
antiproteases such as a-l-at, these proteases are quickly inhibited, and their
potential for damaging other tissues limited. When there are low levels of a-l-
at, unopposed proteolysis leads to damage to elastin, and results in
emphysema.
About 20% of infants with the PiZZ phenotype develop neonatal
hepatitis. The livers of all the affected individuals show PAS positive granules,
found on immunofluorescence to be composed of a-l-at. It is this finding
which supports the suggestion that decreased production is secondary to
failure of hepatic secretion of a defective protein.
A-l-at is an important inhibitor of elastase. Serum activity of a-l-at
is genetically determined, and depends on phenotype. Certain phenotypes
which result in markedly reduced activity have been associated with clinical
disease secondary to unopposed action of protease.
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Alpha-2-macroglobulin (a-2-mg).
Alpha-2-macroglobulin is also an important antiprotease.264 As
with a-l-at, protease inhibition is the result of binding of the a-2-mg to the
protease to form an inactive complex. A-2-mg is a large protein, entirely
confined to the vascular compartment. Its half life, when complexed with
proteases is in the order of 10 minutes. A-2-mg probably acts as a secondary
carrier and inhibitor of protease molecules following their transfer from a-l-at.
Its role as an acute phase protein is dubious, but its interaction with a-l-at, and
its function as a plasma antiprotease justify its measurement in investigation of
inflammatory aneurysm for the same reasons as for a-l-at.
Use ofAcute Phase Protein Assay in Aneurysm disease.
From the evidence presented in chapters 2 and 3, aortic aneurysms
have been associated with decreased elastin in their wall together with
increased elastase activity in both wall and peripheral blood. Decreased levels
of antiprotease activity capable of inhibiting elastase have also been found in
patients with aneurysm disease. In inflammatory aneurysms there is an active
inflammatory cell infiltrate and severe elastin destruction accompanied by
increased levels of neutrophil elastase.
The measurement of the acute phase proteins, and plasma levels,
activity and phenotype of alpha-1-antitrypsin may therefore be of use in the
investigation of inflammatory aneurysm of the abdominal aorta. Raised levels
of acute phase proteins may indicate an inflammatory response and suggest
metabolic activity within the aneurysm wall.
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The detection of low antiprotease activity levels or phenotypes of a-
1-at associated with poor production might indicate deficiencies in the
antiprotease system and an increase in unopposed proteolysis in the aortic
wall. Such defects, resulting in a net increase in proteolytic activity, would be
compatible with the fierce and active elastolysis seen in inflammatory
aneurysms.
Elastase Complex Assay
Assay of the complex of a-l-at and neutrophil elastase has been
described as a useful clinical indicator in other inflammatory diseases.265,266 As
this elastase has been associated with inflammatory aneurysms, its
measurement in peripheral blood may be of use in determining the
pathogenesis of inflammatory aneurysm disease, and also in its diagnosis.
Any alteration in the protease/antiprotease balance which may be
detected could be implicated in the elastolysis seen in inflammatory
aneurysms. The evidence that this is the case would be strengthened by the
biochemical confirmation that increased elastin breakdown is taking place.
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Summary
The acute phase proteins are a group of glycoproteins the levels of
which rise non-specifically in inflammation. They may therefore respond in
this capacity to the presence of an inflammatory aneurysm. Of particular
interest are alpha-1-antitrypsin and alpha-2-macroglobulin. In addition to
their participation in the acute phase response, they have an important role in
the anti-protease system.
Inflammatory aneurysms are particularly associated with marked
elastin destruction in the tunica media of the aorta by elastase. Any local or
systemic alteration in antiprotease activity can be expected to result in
increased, unopposed elastase activity, and may be of relevance in the
pathogenesis of inflammatory aneurysms.
The biochemical investigations included in this Thesis are therefore
the following:
1. Acute phase protein assays. The proteins assayed will be c-reactive
protein, caeruloplasmin, alpha-l-antitrypsin and alpha-2-macroglobulin.
2. Neutrophil elastase. This will be assayed in the peripheral blood in its
complexed form with alpha-l-antitrypsin.
3. Electrophoretic phenotyping of alpha-l-antitrypsin.
4. Functional assay of alpha-l-antitrypsin in the peripheral blood (elastase
inhibitor assay).






The following chapter contains details of the patients studied in this
work. The techniques used for the collection, storage and retrieval of
pertinent data are specified.
Experimental techniques and equipment used in each of the




The experience of the Bristol Vascular Studies Unit in aortic
aneurysm surgery was reviewed over a 5 year period. Information was taken
from the computerised prospective surgical audit system, B.I.P.A.S. Also
reviewed were patients case notes, including anaesthetic records and operation
notes. For long-term follow-up data, each patients General Practitioner was
contacted either by telephone or letter.
In the cases where the diagnosis of inflammatory aortic aneurysm is
used, this diagnosis was made on the grounds of inspection at operation,
together with histopathological examination using previously published
criteria.1
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47 patients with inflammatory aortic aneurysms are included. In all
cases, aneurysmal change was limited to the infrarenal aorta. For comparison,
a group of 162 patients with simple, non-inflammatory aneurysms presenting
over the same time period are included.
This group does not represent the entire caseload of simple
aneurysms in the five year period, but only those in whom aneurysmal change
was limited to the infrarenal aorta. It is only in this way that valid comparisons
of operative time and blood loss can be made, and an impression gained of the
degree to which inflammatory change demands changes in operative
technique.
Prospective Patients
All patients presenting for elective aortic surgery were considered
for inclusion in the study. Specific exclusion from study was made in the
following cases:
(a) Those who refused consent for any reason, or unable to
understand the implications of consent.
(b) Those with known malignant disease.
connective tissue disease,
inflammatory bowel disease.
In patients with aorto-iliac occlusive disease, no specific
radiological investigations were undertaken for the purposes of the study.
Patients with aneurysms underwent radiological investigation by
three modalities: Ultrasound, contrast-enhanced computerised tomography
and magnetic resonance imaging. Following diagnosis, each patient was sent
the letter in appendix 2 seeking information relevant to M.R.I, investigation.




Data Storage and Retrieval
Computerised data handling was used throughout, although written
copies of all information were retained.
All patient details were stored in a structured database file using
dBase 3+ software. Numerical data was stored in spreadsheet form using
Lotus 2.1, which was also used to calculate regression lines for some of the
protein assays.
From the spreadsheet, selected data was transferred to Oxstat for
analysis.
Completion of questionnaire
A questionnaire was completed for each patient at a pre-operative
interview, the style of which can be seen in appendix 3. At the same interview,
permission was sought from the patient for use of blood and aortic specimens
for research purposes. The format, which was verbal consent only, was
approved by the Ethical Committee of Bristol & Weston Health Authority.
Details of medical history, drug intake, concomitant disease etc.,
were confirmed from medical records in all cases.
Collection ofBlood Samples
All samples were collected immediately pre-operatively from
fasting patients using the Vacutainer system.
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Samples for enzyme and acute phase protein assays were then
separated by centrifugation within Vz hour of collection at 2000 rpm for 15
minutes. Serum and plasma were kept at -80 degrees centigrade in aliquots of
1 ml until used for analysis.
Appropriate samples were sent to the hospital laboratory for full
blood count and plasma viscositymeasurement.
Collection ofTissue Samples
Samples of aortic wall were taken from the anterior part of the
aneurysm sac opposite the inferior mesenteric artery origin, or at the point of
maximum dilation in suprarenal or thoracic aneurysms.
The tissue was cut into small pieces and snap frozen in liquid
nitrogen for histological studies. Larger pieces were subjected to MRI
examination in the fresh state.
Acute Phase Protein Assays
Principle.
All assays of acute phase proteins were carried out using
immunoturbidimetry.
Immunoturbidimetry is an immuno-assay technique which depends
upon the optical qualities of an antigen/antibody interaction in solution. Using
this technique, a fixed volume of antigen-containing serum is added to a fixed
volume of a standard solution of antibody, with antibody excess. As antigen
and antibody combine to form aggregates, the optical density of the solution
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increases. As there is antibody excess, the rate of the reaction is rapid at first,
but plateaus as antigen is consumed in the formation of antigen/antibody
aggregates. The maximum rate of change in optical density observed over the
reaction period is proportional to the amount of antigen present in the original
sample.
Standard absorbance curves are constructed for all assays by first
assaying serial dilutions of standard calibrators.
The calibrators contain known concentrations of the protein
antigen under assay. Serial dilutions of calibrator are made and assayed using
standard antibody. The maximum rate of change of optical density over the
reaction period is defined for each dilution. As antigen concentrations in the
dilutions are known, the relationship between maximum reaction rate and
antigen concentration can be made.
In this way, a standard curve is derived, according to the protocols
below, relating maximum rate of change in absorbance to absolute antigen
concentration. Antigen concentrations in patient samples can then be assayed.
Patients.
Serum samples from 15 patients with inflammatory aneurysms, 82
with simple aneurysms, and 37 with severe aorto-iliac occlusive disease were
assayed for each of the acute phase proteins.
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Procedure.
All acute phase protein assays were carried out using the computer
orientated random access immunoturbidometer shown below in Figure 17
(COBAS MIRA, F. Hoffman-LaRoche, Basle, Switzerland).
Figure 17.
LaRoche COBAS MIRA analyser used in acute phase protein
assays.
Stored serum samples taken from study patients were thawed at
room temperature. In all assays, samples were diluted using 0.9% sodium
chloride to a dilution of 1:20 - 1:30. 6% Polyethylene glycol was used as an
enhancement reagent in all cases.
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A list of the reagents used in each of the assays is given below.
1. Serum alpha-1-antitrypsin assay.
Antibody - Atlantic antibodies anti alpha-l-antitrypsin.
Calibrator - Atlantic antibodies Calibrator 3, in 6 serial dilutions.
Controls - Atlantic antibodies Calibrator 1, SPSOl
2. Serum Caeruloplasmin assay.
Antibody - Atlantic antibodies anti caeruloplasmin
Calibrator - Atlantic antibodies Calibrator 1 in 6 serial dilutions.
Controls - Atlantic antibodies Calibrator 3, Behring protein standard
plasma.
3. Serum alpha-2-macroglobulin assay.
Antibody - Atlantic Antibodies anti alpha-2-macroglobulin.
Calibrator - Atlantic Antibodies Calibrator 1 in 6 serial dilutions.
Controls - Atlantic Antibodies Calibrator 3, Behring standard human
serum.
4. Serum C-reactive protein assay.
Antibody - Atlantic Antibodies anti C-reactive protein.
Calibrator - Atlantic Antibodies Calibrator 7 in 6 serial dilutions in bovine
serum albumin.
Controls - Atlantic Antibodies Calibrator 7 prediluted 1:2 and 1:4 with
bovine serum albumin to bring into range of standard curve.
[N.B. C-reactive protein is present in serum in very small concentrations.
Undiluted serum must therefore be used for assay. When constructing
standard curves with calibration standards (in this case Atlantic Antibodies
Calibrator 7), it has been found that reaction kinetics of saline-diluted
calibrators at high dilutions do not compare with the 'neat' serum samples
being analysed. These matrix effects are obviated by using bovine serum
albumin as a diluent for standards.]
Standardisation.
In normal laboratory use, calibration of the the analyser is
maintained to give a coefficient of variation for protein assays of 2-3%. The
Page 129
procedure used to calibrate the COBAS MIRA is illustrated below in Figure
18.
For each assay run, 1 sample in 10 was a control specimen of
known antigen content. Their absorbance and concentration was used to
validate the standard absorbance curve
Figure 18.
Calibration of the COBAS MIRA, using increasingly dilute
solutions of a calibrator of known assay. Reaction rate is plotted, and the
maximum rate noted for each concentration. Maximum reaction rate is then
plotted for each antigen concentration. This graph is used to calculate antigen















Results obtained from the acute phase protein assays were stored
on computer for later statistical analysis. Both the results and analysis can be
found in Chapter 8.
Elastase-Antitrypsin Assays.
Principle.
Elastase-Antitrypsin Assays were performed using Enzyme-Linked
Immunosorbent Assay, the principle ofwhich is described below.
Plastic tubes coated with sheep antibody to neutrophil elastase are
used. A standard volume of serum is added to the tube, and the contained
elastase-antitrypsin complex is bound to the tube wall by its elastase moiety.
The amount of binding is proportional to the amount of elastase-antitrypsin
complex present in the sample. The tube is then washed, and a conjugate of
antitrypsin antibody/alkaline phosphatase added. This binds in turn to the
antitrypsin moiety of elastase-antitrypsin complex, forming a complex with an
enzymatic 'tail' of alkaline phosphatase. After washing, the tube-bound
enzyme activity is measured by its action on 4-nitrophenyl phosphate,
producing a colour change at 405 nm. The colour change is measured by
absorbance spectrophotometry and is proportional to the amount of elastase-
antitrypsin complex in the original sample.















Anti antitrypsin / alkaline
phosphatase conjugate added
binds to antitrypsin part of
complex









Colour change detected by absorbance
spectrophotometry at 405 nm
Reaction stopped at one hour
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Patients.
Elastase-antitrypsin complex assays were carried out on stored
plasma samples from 15 patients with inflammatory aneurysms, 66 with simple
aneurysms, and 32 with severe aorto-iliac occlusive disease.
Procedure.
A commercially available assay kit was found to be suitable,
available from Merck Immunoassay, kit number 12589 (2h version), for
Polymorphonuclear Leukocyte Elastase. The assays were carried out using the
kit in a rack of 48 pre-prepared plastic test-tubes. Each kit contained two
racks each of 24 test tubes coated as detailed above. This provided for the
simultaneous assay of 1 reagent control, 4 assay calibrator standards, 1 control
plasma, and 18 patient samples all in duplicate.
The 4 standard calibrator solutions of known elastase/antitrypsin
complex content were assayed in order to produce a standard line of
absorbance versus elastase-antitrypsin concentration. The accuracy of the line
was verified by assay of a control serum, and then used to determine the
elastase antitrypsin content of the unknown samples.
A detailed protocol for this assay is found below. A list of reagents
for the assay is given, followed by an illustration of reaction tube allocation
(Figure 20), and a detailed protocol for the assay.
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List of Reagents required for elastase antitrypsin assay
Calibrator standards - X4: Gelatine containing TRIS buffer, stabilizer, PMN
Elastase-al proteinase inhibitor complex. Each diluted with 5 ml of dilution
medium.
Control Plasma - Human plasma of known E-alAT complex assay. Diluted
with 500/xl of dilution medium.
Sample Dilution Medium - Phosphate buffer pH 7.52
Wash Solution - Water, detergent. Diluted 1:1 with distilled water.
Substrate Buffer - Diethanolamine pH 9.8 (1 mmol/1), MgCl2(0.5 mmol/1).
Substrate - Tablets containing 20 /xmol 4-nitrophenyl phosphate. Each
dissolved in 10 ml substrate buffer.
Stop solution - Sodium hydroxide 2 mmol/1
Antibody/enzyme conjugate - Antibodies to al proteinase inhibitor from
human serum, coupled to alkaline phosphatase. Diluted with reconstituted
Antibody-Enzyme conjugate buffer.
Antibody/enzyme conjugate buffer - TRIS pH 7.5, MgCl2Reconstituted to 25
ml with wash solution.
Antibody coated tubes - polystyrene tubes coated with sheep antibodies to
human granulocyte elastase.
Samples of stored plasma from patients were thawed at room
temperature and diluted using a mechanical diluter.
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Figure 20.
Allocations for reaction tubes in the elastase antitrypsin assay kit.
Four standard solutions of antigen are assayed with a control plasma also of










All assays carried out in duplicate
Final volume 600 /A.
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Table of Procedure for elastase antitrypsin assay.
TUBE
Reagent Calibrators Control Samples
Control 1-4 Plasma
Wash Solution 1000/xl 1000/xl 1000/xl 1000/xl
Incubate at at 20-25°C.for 5-20 min then draw off to dryness
Dilution medium 500 /xl
Calibrators 1-4 500 /xl
Control Plasma 500 /xl
Samples 500 /xl
Incubate at 20-25°C. for 60 min, then draw off to dryness
Wash Solution 1000/xl 1000/xl 1000/xl 1000/xl
Draw off to dryness, then repeat wash X 2 with 1000/xl aliquots of wash
solution. Draw off to dryness.
Antibody/enzyme
solution 500/x 1500/xl 500/xl 500/xl
Incubate for 30 min, then draw off to dryness
Wash Solution 2000/xl 2000/xl 2000/xl 2000/xl
Draw off to dryness, then repeat wash X 2 with 2000/xl aliquots of wash
solution. Draw off to dryness.
Substrate
Solution 500/xl 500/xl 500/x 1500/xl
Incubate for 30 min protected from light.
Stop Solution 100 /xl 100 /xl 100 /xl 100 /xl
Mix thoroughly. Prepare mixture of 500 /xl of substrate solution and 100 /xl
stop solution, and read absorbances of all tubes against this, at 405 nm.
Absorbances were measured at 405 nm using a Pye Unicam
spectrophotometer, and a light path of 1 cm.
Samples were read against the blank prepared above, of substrate and stop
solution.
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The results of each assay run were stored on Lotus 123 spreadsheet
software. A standard line was plotted using the absorbance results and known
concentrations of the four standards. The regression function of Lotus was
used to calculate the equation of the best fit straight line for these four points.
This equation was used to calculate elastase/antitrypsin concentration from
absorbance readings of both unknown samples and the control plasma.
Standardisation ofAssay.
Standardisation of this assay was ensured by the assay of four
calibration standards and one control plasma sample in each kit. All samples
were assayed in duplicate. Kits in which the control plasma value as assayed
deviated unacceptably from its known value were rejected, and the results of
patient samples from that kit were not used.
The table below shows the details of each assay kit in terms of the
known value as given in the kit literature, the value calculated from the assay.
The difference between the two values is expressed as a percentage. Asterisks
are placed beside kits from which results were disregarded.
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2. Control Plasma Values (ng/l)
Kit No. Known value Calculated
Value
% D
*1 125 169 35.2
*2 60 72.24 20.4
*3 60 75.77 26.2
4 135 145.99 8.1
5 135 128.24 5.0
6 60 65.61 9.3
7 60 66.62 11.0
8 60 65.75 9.5
9 60 64.37 7.2
10 60 55.99 6.6
11 60 61.91 3.1
*12 60 45.86 23.5
13 55 52.04 5.3
14 60 56.53 5.7
15 55 59.79 8.7
16 55 61.6 12.0
Kits marked with * were deemed inaccurate, and results not included in study
The results of reproducibility studies, and the results of patient assays can be




This assay was originally devised in the University of Sheffield
Protein Reference Laboratory. A number of changes have been in the
procedure with regard to reagent dilution and incubation times, but the
technique remains the same.
The principle of the assay depends on the inhibitory power of
patients serum on a standard elastase load. Patients serum is added to a fixed
amount of porcine elastase, and incubated. During incubation, the standard
elastase load is inhibited to a degree proportional to the amount of anti-
elastase activity in the patients serum. The resultant serum/elastase mixture is
then used to digest a fixed amount of elastase substrate. The more substrate
digested the less elastase inhibitor present in the patients serum.
Digestion of the substrate produces a colour change detectable by
absorbance spectrophotometry at 405 nm which is proportional to the amount
of elastase inhibitor in the patients serum.
Patients.
This assay was carried out on the stored serum of 15 patients with




The assay was carried out on 96 well microtitre plates. On each
plate, five wells were used to assay known dilutions of stock elastase solution.
Three calibrator samples (see below) were also included on each 96 well plate.
Using this format, 40 unknown samples may be assayed on each 96 well plate.
An account is given below of the preparation of the reagents
required for this assay. It is followed by a detailed protocol including an
illustration of reaction well allocation of the 96 well microtitre plates. (Figure
21)
Reagents for Elastase Inhibitor Assay.
TRIS buffered saline: 0.9% sodium chloride, 0.1M TRIS, pH 8.5.
Elastase: Type 4 chromatographically purified porcine pancreatic
elastase. (Sigma Chemicals).
Elastase Substrate: N-succinyl-ala-ala-ala-p-nitroanilide (S.A.N.A.).
(Sigma Chemicals).
Preparation of Elastase.
Purified porcine pancreatic elastase (Sigma) 70 iu/mg made up in
TRIS buffer to 0.02 mg/ml.
Preparation of S.A.N.A. Elastase Substrate




Samples taken into E.D.T.A. from fasting patients. Stored at -80°
until used. Thawed to room temperature. Diluted 1:30 with TRIS buffer using
mechanical diluter.
Preparation of Elastase Dilutions.
Stock elastase solution of 0.02 mg/ml was diluted in TRIS buffer to
produce 25%, 50%, and 75% dilutions. TRIS only and elastase solution 0.02
mg/ml only were used for 0% and 100% elastase activity calibrators. These
dilutions therefore represented 0% - 100% elastase activity, and were used in
calibration wells 1-5 (see below).
Wells in the microtitre plate were assigned numbers from 1-96
running vertically from top left.
Well 1: Zero control. 100/xl TRIS.
Wells 2-5: Elastase dilutions 25% -100% 50/xl, TRIS 50/xl.
Wells 6-8: Standard sera 50/xl, elastase 50/xl.
Wells 14-16: Standard sera 50/xl, TRIS 50/xl. (Blanks for
standard sera.)
Wells 17-24, 33-40, 49-56, 65-72, 81-88: Test wells. Diluted
serum 50/xl, elastase 50/xl.
Wells 25-32, 41-48, 57-64, 73-80, 89-96: Blank wells.
Diluted serum 50/xl, TRIS 50/xl.
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Figure 21.
Well numbering for elastase inhibitor assay. The wells are
numbered from 1-96. Contents of each well are given above.
17 25 33 41 49 57 65 73 81 89
96
The plate was then incubated for 30 minutes at 37°C, following
which, 100/ul of SANA was added to each well. The plate was then incubated
at room temperature in the dark for a further 1 hour. Absorbance was read at
405 nm.
All results were obtained by reading the absorbance of the samples
on a Novoclone microplate spectrophotometer controlled by dedicated
software running on a BBC Archimedes 310 computer. (Figure 22)
Page 142
Figure 22.
The Spectrophotometer and Archimedes computer combination
used in the assay of antiprotease activity
A standard curve was drawn using results of absorbance from wells
1-5, and their known percentage of elastase activity. The absorbance of
unknown samples were then related to percentage elastase activity using this
standard curve. The three known calibrator samples were used to validate the
results obtained by each plate of assays. Only if good separation was obtained,
was the curve used to read unknown samples.
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Standardisation of assay.
The method given to us differed from that detailed above, as
originally in Sheffield the assay was carried out using a dilution of porcine
elastase of 0.1 mg/ml as 'stock'. In setting up this assay on microtitre plates for
this study, we pursued the method exactly as originally described to us. This
led to a deep colour change in all of the wells containing sample serum,
indicating one of several problems with the assay technique. These, and the
solution to the problem, are outlined below.
(a) Too much elastase enzyme - the most likely fault. If the enzyme was too
concentrated it would fail to be inhibited by the relatively dilute samples, and
act on the standard substrate load to produce the deep colour change
obtained.
(b) No inhibition of elastase - unlikely option. For the initial setting up of the
assay we were using standard samples of serum of known phenotype given to
us by Sheffield. These had already been assayed by Sheffield, and the
antitrypsin funtional assay result known.
(c) Too much substrate - not likely either. Substrate availability is not a rate
limiting step of the reaction.
In order to verify this, and to choose a suitable elastase
concentration for our assay, we went on to produce calibration curves using
known dilutions of elastase. 'Stock' elastase concentrations of 0.02 mg/ml, 0.01
mg/ml, 0.005 mg/ml, and 0.002 mg/ml were made up to replace the original 0.1
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mg/ml concentration. Each of these stock solutions was then diluted in turn to
25%, 50% and 75% with TRIS buffer. When blank samples (TRIS only) and
100% samples (neat stock solution) were added to each series, this resulted in
0-100% dilutions of each of the four stock solutions, or 16 samples in all. The
16 samples were assayed as described above, and the results plotted as elastase
activity vs. absorbance. The following graph was obtained (Figure 23). This
resulted in the choice of 0.02 mg/ml as a working 'stock' elastase dilution, as
any change in elastase activity early in the curve is accompanied by a relatively
large change in absorbance.
Figure 23.




0.02 mg/ml ~~1~ 0.01 mg/ml
0.005 mg/ml " 0.0025 mg/ml
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Having set up the assay, its sensitivity had also to be ensured.
Standardisation of the assay in our laboratory was carried out using eight
plasma samples from Sheffield of known antitrypsin phenotype and inhibitor
assay. The eight samples used for standardisation were of mixed phenotypes
for alpha-1-antitrypsin, there being two Z types, two MZ types one MS type,
and two M types.
Using the method and reagent dilutions outlined and verified
above, each of eight known samples were assayed. These included 2 x Z
phenotype, 2 x M phenotype, 3 x MZ phenotype and 1 x MS phenotype. An
adequate separation of phenotypes was sought. The results are shown below,
with each phenotyped sample plotted and named (Figure 24). It can be seen
that adequate separation of known phenotypes was obtained.
These results verified the standardisation of the assay, and its
sensitivity in differentiating between samples of known and differing activity.
To ensure the standardisation of each assay run, three of the
Sheffield Standards were assayed each time a batch of patient samples were
assayed. This not only acted as a quality control, but provided results which
could be used as an indirect check on reproducibility. In addition, a number of
samples were used to assess the inter-assay plate co-efficient of variation.










This assay was carried out in the Laboratoire de Biochimie du Tissu
Conjonctif, Faculte de Medecine, Universite Paris Val de Marne, by kind
permission of Dr. L. Robert. The method has not been published in any
Journal, so is described here in detail.
Principle.
The principle of E.L.I.S.A. inhibition assay is illustrated in Figure
25, and references in brackets in the following paragraph refer to parts of that
Figure.
The E.L.I.S.A. inhibition assay depends upon the interaction of
specific antibodies to elastin fragments (Ab 1) and elastin fragments in patients
plasma (Ag 1). Fixed amounts of known dilutions of each are used, with an
excess of antibody (a). In this case, all of the elastin fragments in the patients
plasma are bound by antibody, leaving a proportion of antibody 'free' (b).
This mixture is then exposed to further, synthetic elastin fragments (Ag K)
bound on solid medium (the microtitre plate). Only antibody remaining free
from the first reaction binds to the plate (c). The amount of antibody binding
to the plate is therefore inversely proportional to the amount of elastin
fragments (Ag 1) in the patients plasma. The plate is then washed to remove
all but antibody bound to synthetic elastin fragments attached to the plate (d).
In order to assay the amount of antibody bound to the plate, a
second antibody (Ab 2), conjugated with peroxidase is used. This binds
specifically to the first antibody (e). A substrate for peroxidase is then used to
produce a colour change measured by absorbance spectrophotometry (f).
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Figure 25.
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This assay was carried out on a limited number of patients. The
logistic difficulties of transporting frozen samples to Paris, and the expense of
the assay meant that only 50 samples could be analysed. Those assayed
included samples from 10 patients with inflammatory aneurysm, 20 with simple




Reagents requiring preparation are Ag K - a preparation
containing human elastin fragments, and Ab 1 - an antibody against human
elastin fragments.
Ag K is a heterogeneous mix of elastin peptides produced by the
digestion of Human Aortic Elastin by potassium hydroxide. The elastin is
incubated at 37°C with 1 molar KOH (20%)/Ethanol (80%) for 3.5 hours. The
resulting preparation, also known as Kappa Elastin is made up in several
dilutions in Phosphate Buffered Saline for coating microtitre plates.
Ab 1, also known as first antibody, is obtained by innoculating
goats with Ag 1 (Kappa Elastin). It is an antibody against Kappa elastin, and
therefore against human aortic elastin fragments.
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Other reagents required are Ab 2, peroxidase substrate and a solid
support medium.
Ab 2 or second antibody is available as Rabbit anti-goat-IgG
conjugated with horseradish peroxidase (Miles Laboratories). The solid
support medium used was plastic Micro-E.L.I.S.A. microtitre assay plates
(Dynatech Laboratories). The peroxidase substrate was 1,2 phenylene
diamine dihydrochloride.
Standardisation of Assay.
The sensitivity and reproducibility of the E.L.I.S.A. inhibition assay
depends upon the concentration of Ag K used to coat the microtitre plate
wells, and upon the concentration of Ab 1 used in the first part of the assay
(see a - c in figure 25), both of which are determined empirically. It is for this
reason that standardisation and calibration procedures are described before
the procedure for patient sample assay.
From the laboratory's experience of performing hundreds of elastin
fragment estimations, the two most frequently suitable concentrations of Ag K
were found to be 0.4 ju,l/ml and 1.1 yxl/ml.
Similarly, two suitable antibodies had been found for use as Ag 1.
Both were polyclonal goat antibodies to Kappa elastin - SS3 and S13.
In order to determine the optimal combination of Ag K and Ab 1,
the two dilutions of Ag K (0.4 /xl/ml and 1.1 /xl/ml) were each exposed to serial
dilutions of each of the Ab 1 antibodies SS3 and S13. This required the
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preparation of two microtitre plates - one coated with an Ag K concentration of
0.4 jug/ml, and one coated with a concentration of 1.1 yxg/ml.
Each of these plates was treated in the same way, and exposed in
one half to SS3 in serial dilutions, and in the other half to S13 in serial
dilutions. In this way, four combinations ofAg K and Ab 1 were examined.
Further details of the preparation of the plates and other reagents
are given below under the heading of 'Procedure 1'. Following preparation of
the two plates described above, they were each exposed to Ab 2, and then
peroxidase substrate, as described in 'Procedure 2' below.
Procedure 1.
1. Preparation ofmicrotitreplates
100 pA Antigen at appropriate dilution added to each well. Plates incubated at
37°C for 2 hours, then maintained at 4°C until required. Immediately before
use the plates are washed with Phosphate Buffered Saline containing Tween
20 (PBST) to stop non-specific protein binding.
2. Preparation ofSerialAb 1 Dilutions
100 pA of antibody added to 1 ml of PBST, to make dilution of 1/10. Serial
dilutions then made in PBST to final dilution of 1/2560. This procedure
carried out for each of the two enzyme systems SS3 and S13.
3. Preparation ofPeroxidase Substrate/Buffer.
10 ml citrate/phosphate buffer 0.15M, pH 5.0
5 mg 1,2 phenylene diamine dihydrochloride
20 p1 hydrogen peroxide.
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4. Preparation ofAb 2.
65 /xl rabbit anti-goat-IgG diluted in 10 mis PBST to final dilution of 1/1500.
Procedure 2
Plate washed with PBST and aspirated to dryness. 4 cycles.
According to worksheet, serial dilutions of antibodies added to
plate. (100/Ltl)
Incubated at 37° for 1 hour.
Plate washed with PBST and aspirated to dryness. 4 cycles.
Second antibody added to each well. (100 /xl)
Incubated at 37° for 1 hour.
Plate washed with PBST and aspirated to dryness. 4 cycles.
Peroxidase substrate added to each plate. (lOOyxl)
Plate incubated 37° for 15 minutes.
Reaction stopped by addition of 50 fil of 2M hydrochloric acid to
each well.
The light absorbance of each well read at 490 nm using Dynatech
5000 spectrographic microtitre plate reader.
The optimal coating antigen concentration and first antibody titre
combination was chosen by selecting a combination which gave a final optical
density at 490 nm of 1.1 - 1.3. A combination of 0.4 ju.g/ml of coating antigen




Henceforth, Ag K shall refer to a solution of 0.4 /ig/ml of Kappa
Ab 1 will refer to a 1/100 dilution of SS3 antibody (goat anti-kappa-
Assay of Patient Samples and standards.
Five microtitre plates were coated using the technique descibed
above. An Ag K concentration of 0.4 yxg/ml was used, having been found to be
optimal.
Five separate, corresponding plates were prepared. These were
not coated, but served to mix patients plasma with Ab 1 before addition to the
coated plate. The plate assignment was chosen to provide 12 assays of plasma
each in triplicate. Rows were reserved for serial dilutions of antigen to
produce a standard curve for each plate.
Serial dilutions of Kappa elastin were prepared in order to produce
a standard curve. 132^1 of Kappa elastin (2 mg/ml) was added to 1068 ml of
bovine serum albumin (60 mg/ml in PBS), to make a total volume of 1.2 ml.
Serial 1/3 dilutions of this were made X 11, to give 12 known concentrations of
Kappa elastin.
60 ix\ of samples of plasma, or 60 /jl 1 of standard dilutions were
added to each well according to the worksheet.
60 fil of first antibody at 1/50 dilution was then added to each well,
giving a final first antibody concentration of 1/100.
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The plates were covered and incubated at 37° for 1 hour, following
which transfer of aliquots of each antibody/antigen mixture were made from
the mixing plates to the coated microtitre plates.
Aliquots of 100 /il from each well of the mixing plates were
transferred to corresponding wells in the coated plates. The mixing plates
were discarded. The coated plates were covered and incubated at 37° for 1
hour, following which they were washed and aspirated to dryness for 4 cycles.
100 /xl of 1/1500 dilution of second antibody was added to each well,
and the plates incubated as before for 1 hour. They were once again washed
and aspirated to dryness for 4 cycles.
100 jul of peroxidase substrate was added to each well, and the
plates incubated at 37°C for 15 minutes, after which the reaction was stopped
by the addition of 50 /jl\ of 2M hydrochloric acid to each well.
The optical density of each well was read and recorded by the
Dynatech microtitre plate spectrophotometer. Resident software in the
Dynatech machine drew the standard concentration curve represented by
standard antigen samples, and calculated the equation of the line. Using this,
it also calculated the concentration of antigen (elastin fragments) in the
'unknown' samples. The mean elastin fragment concentrations for each
sample were calculated from the triplicate readings.
Results were stored on computer for later analysis, and can be
found in Chapter 8. Because of time and financial constraints in the




Isoelectric focussing was used to determine the antitrypsin
phenotype present in the serum of each study patient. This method is well
established, and is the standard technique used for antitrypsin phenotyping.
Enzymes, as proteins, possess a large number of chemical groups
which are capable of existing in different ionic forms. Some of these groups
are situated on the outside of the protein molecule, and respond to differences
in pH by altering their charge state.
Isoelectric focussing is a form of electrophoresis in which an
electric current is applied to a protein mixture dissolved in a suitable medium
in a pH gradient. The proteins separate according to their isoelectric points.
The medium used for electrophoresis of antitrypsin phenotypes is
agarose gel. The gel is placed between two solutions of differing pH values; an
anolyte (at the anode end of the gel) and a catholyte (at the cathode end).
This provides the pH gradient. Samples of patient and standard serum are
placed in the gel, and an electric current passed through the gel. When
focussing has taken place, the agarose gel is removed, and stained to display





















The principle of isoelectric focussing applied to alpha-l-antitrypsin
(a-l-at). A pH gradient is created in a gel sheet ranging from acidic to basic.
Samples of patients serum are placed at the basic end of the gel, giving the
contained a-l-at molecules a net negative charge. When a voltage is applied
across the gel (anode at the acidic end, cathode at the basic end) the a-l-at
moves toward the anode. In moving through the pH gradient, the net charge
on the a-l-at changes, becoming more positive until there is no net charge; it
therefore stops migrating through the gel. The pH (and therefore the point on
the gel) at which this occurs is the isoelectric point. As this differs for each
phenotype, each stops at a different point on the gel.
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Patients.
Antitrypsin phenotyping was performed on stored samples of
serum from 15 patients with inflammatory aneurysms, 36 with simple




0.259g IEF agarose (Pharmacia 17-0468-01)
2.03g sucrose
0.075g Aminoethyl sulphonic acid (Sigma A9758)
15 ml distilled water
Place in boiling water bath until completely dissolved, then cool to 65°C before
adding 1 ml of Pharmalyte pH 4.5-6.5 (Pharmacia 17-0452-01)
Pour into pre-heated casting plates using 0.75mm former, and cool in
refrigerator at 4°C for at least 1 hour.
Sample preparation.
Patient samples stored in -80°C freezer until required, then .
Immunofixation - use serum diluted 1:3 with distilled water.
Gel staining - use neat serum.
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Assay of Patient samples and standards.
Anolyte - 0.05 molar sulphuric acid.
Catholyte -1 molar sodium hydroxide.
Allow the gel to come to room temperature, before placing in the isoelectric
focussing (I.E.F.) tank. Apply samples and standards 1.5 cm from cathodic
edge of gel, and allow to soak into gel.
Soak wick in catholyte, and place on cathodic edge of gel.
Soak wick in anolyte, and place on anodic edge.
Close tank and apply current (8mA) between anode & cathode wicks.
Focussing takes approx. 2 hours.
Gel Staining
Fixative - 17.3g sulphosalicylic acid
- 57.5g trichloroacetic acid
- 500 ml distilled water
Destain -1125 ml methanol
- 250 ml glacial acetic acid
-1125 ml distilled water
Place focussed gel in fixative for 15 minutes, then press dry, and wash twice
with destain for 5 minutes each time. Press dry and stain with Page Blue stain
for 10 minutes. Destain and dry.
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Immunofixation.
Immunofixation was used when simple gel staining was unable to
provide adequate definition of phenotypes. This relies on a combination of a
specific antigen antibody reaction between the antitrypsin sample on the
agarose gel and subsequent staining of the antigen-antibody complex rather
than simple nonspecific staining of protein. The antibody used was Atlantic
Antibodies alpha-1-antitrypsin antiserum.
Dilute 0.5 ml of antiserum with 0.5ml of 8% polyethylene glycol-
buffered saline, mix and soak into strip of cellulose acetate wide enough to
cover sample strips to be immunofixed.
Place acetate strip on gel, and leave for 20 minutes.
Remove acetate, and press gel dry for 5 minutes.
Place gel in stirred saline bath of 2 hours to remove all protein not bound to
antiserum.
Press gel dry, and stain in Page Blue stain for 5 minutes.
Destain and dry gel.
Standardisation of Assay.
Standard samples of MM, MZ, MS, and ZZ phenotype sera kept in -80°C
freezer until use. At least 1 standard sample of each phenotype included in
each focussing run.
Results of this assay were stored for later analysis, and can be
found in Chapter 8.
Page 160
RADIOLOGICAL INVESTIGATIONS.
Ultrasound examinations were carried out using either an
Advanced Technology Laboratories Mk. 600 scanner with a 3.75 MHz.
mechanical sector scanning head or a Toshiba SSA-250A scanner with a 3.75
MHz. curvilinear array head. Each scan was performed by a consultant or
senior registrar in radiology with a special interest in vascular imaging.
C.T. Examinations were carried out using a dynamic contrast
enhanced scan technique on a Seimens Somatom DRH C.T. scanner. The
slice width was 8 m.m., with a 20 m.m. slice gap. Patients were scanned from
xiphisternum to pubis, according to the likely extent of the aneurysm.
M.R.I, images were acquired using a Picker Vista MR2055 scanner
operating at 0.5 Tesla with a helium/nitrogen supercooled magnet.
The images were obtained using saggital and coronal spin echo
acquisition (Time to echo [TE] 26, Repetition time [TR] 500-600 msec.)
Transverse images were ungated multi-echo and S.T.I.R. sequences. The
multiecho sequences had first-echo images at TE 20, TR 1800, the second
image at TE 80, TR 1800. The S.T.I.R. sequences were acquired with a TE of
30, Time to inversion (TI) 100, and TR of 1500. On the majority of the images,
the field of view was between 40 and 45 cm, slice thickness was 10 m.m.







The following Chapter contains the results of each investigation in










A total of 47 patients with inflammatory aneurysms and 162 with
non-inflammatory aneurysms were included in the retrospective study.




Aneurysm 66 (Male) 5 Female
(n=47) Range 46-85
Simple 69 (Female)
Aneurysm 70 (Male) 18 Female
(n=162) Range 46-85
Concomitant disease was also surveyed in the retrospective
populations, and the details of these are given in the tables below. Diabetes
was regarded as present if the patient was under treatment by diet, oral
hypoglycaemic drugs or injected insulin. A history of claudication, myocardial
infarction, angina pectoris or stroke (or T.I.A.) was taken as evidence of
occlusive vascular disease.
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Concomitant disease in retrospective patients.
Occlusive
Disease Ex/Current vascular
type Diabetes Smokers disease
Inflamm.
Aneurysm 0 47 (100%) 18 (38%)
Simple
Aneurysm 4(2%) 140(86.5%) 63(38%)
These differences did not reach statistical significance.
Systolic and diastolic blood pressures did not differ between the
groups, nor did the incidence of known or apparent hypertension. This was
taken as either a documented history of hypertension with or without
treatment, or a persistently raised diastolic blood pressure of > 100 mm.Hg.
In the following tables, means are given, with standard deviation (SD)
Blood Pressure in retrospective patients.
Known or
Disease Systolic Diastolic Apparent
Type B.P.(mmHg) B.P.(mmHg) Hypertension
Inflamm.
Aneurysm 148W*200 90 ft®*"20 25 (53%)
Simple
Aneurysm 150^om26° 88§3^°"150 91 (56%)
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Pre-operative investigations 1. Symptoms of disease.
With regard to symptoms of disease, 43% of patients with
inflammatory aneurysms were discovered to have aneurysmal disease
incidentally during investigation for other pathology, and 56% presented
because of symptoms caused by their aneurysm. Pain in the abdomen or back
was a significant feature of the history in 82% of cases.
Pain was only a feature of the history in 56% of cases in the group
with simple aneurysms, significantly fewer than in the inflammatory group,
(p< 0.001, X2)
The presence of abdominal or back pain had a sensitivity of 82%
for the detection of inflammatory aneurysm, and a specificity of 44%. The
Positive Predictive Value was 0.31, and the Negative Predictive Value 0.88.
There was no difference in the stated incidence of weight loss
between the two groups, (22% inflammatory vs. 36% non-inflammatory)
Eight patients displayed symptoms of systemic illness, with malaise,
anorexia and weight loss. All of these patients had a plasma viscosity above
1.75 mPa. In six cases, other organs were involved in fibrosis in addition to the
duodenum (ureters in 3 cases, left renal vein in 2, and inferior mesenteric vein
in 1.
In the three cases with ureteric involvement, one had bilateral
hydronephrosis, and two had unilateral hydronephrosis, and all required
operative ureterolysis.
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Pre-operative investigations 2. Haematology and biochemistry
Haematological parameters were also measured, and are shown
below as means and standard deviation (SD). The plasma viscosity value was
significantly greater in the inflammatory group, using the Mann-Whitney u-
test.
Haematological parameters in retrospective patients.
Disease Hb WCC Platelets Plasma
Type (xlO /l) (xlO /l) (xlO H) Viscosity
Inflamm.
Aneurysm 13.1 sd 1.68 8.9 sd 2.2 319 sd 98 1.84 sd 0.19
Simple
Aneurysm 13.0sdi,7 7.7 sdi2 248sd<>&9 1.70sdo.i3
As a practical measure, the numbers in each group were tabulated
for plasma viscosity above 1.72 mPa. When subject to Chi-square testing, the
inflammatory group showed a significantly greater number of patients with
raised viscosity (0.001>p>0.01).
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Raised plasma viscosity therefore had a sensitivity of 75%, and
specificity of 56% in the detection of inflammatory aneurysm. The Positive
Predictive Value was 0.42, and the Negative Predictive Value 0.84.
Pre-operative biochemical disturbance compatible with poor renal
function, as defined by a plasma creatinine over 120 yu,mol/l and/or a creatinine
clearance under 40ml min m2 with appropriate electrolyte disturbance, was
present in 9 patients in the inflammatory group. This failed to predict
involvement of the ureters in the inflammatory process.
Ten patients underwent ureterolysis as part of their operative
procedure. Nine of these patients had no preoperative biochemical evidence of
renal failure or electrolyte disturbance.
Pre-operative investigations 3. Radiology
Rapid sequence contrast enhanced abdominal C.T. was carried out
in 25 of the 47 patients with inflammatory aneurysms. This failed to make the
diagnosis of inflammatory change in 12 cases. Abdominal ultrasound failed in
all cases, as did plain abdominal radiography.
Operative Findings
At operation, other structures were involved in the inflammatory
mass in every case. In all cases of abdominal inflammatory aneurysm the
duodenum was adherent to the aneurysm wall. Ten patients had involved
ureters, 3 dense peri-aortic adhesions, 2 stenosed IVC, and 5 involved left
renal vein. In 1 case, the inflammatory aneurysm was solely thoracic.
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Operative Technique
In 42 cases of inflammatory aneurysm, operative replacement of the
aneurysmal aorta was carried out transperitoneally using the inlay technique.
The single thoracic aneurysm was resected through an eighth rib thoracotomy.
In the remaining 4 cases, extension of the inflammatory process up to
or above the diaphragm required extension of the abdominal incision to a full
thoraco-abdominal approach for supradiaphragmatic aortic clamping. In all 4
cases, aneurysmal dilation was confined to the infrarenal aorta but involved
the area immediately adjacent to the renal vessels making exposure from the
front impossible.
Cases 1+2:
Encasement of the left renal vein in the inflammatory process
precluded safe infradiaphragmatic dissection and clamping of the aorta.
Following supradiaphragmatic control of the aorta in the thorax, using an eighth
rib thoraco-abdominal incision, the aortic prosthesis was anastomosed to the
infrarenal aorta.
Cases 3+4:
The inflammatory change was found to extend to include the origin of
the superior mesenteric artery. Aortic clamping was carried out using the same
site and technique as for cases 1 & 2, and the prosthesis anastomosed to the
thoracic aorta.
Operations involving abdominal inflammatory aneurysms took
significantly longer than for simple abdominal aneurysms taking an average of 3.4
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hours to complete, compared to 2.9 hours for simple aneurysms (p< 0.005,
Mann-Whitney). Significantly more blood (2.9 litres vs. 1.6 litres p<0.001, M-
W) and colloid (1.6 litres vs. 1.1 litres p<0.05, M-W) was infused per-
operatively in the case of inflammatory abdominal aneurysms.
36% of patients with inflammatory aneurysms underwent tube
grafting, while 63% had bifurcated grafts. This constituted a significantly higher
incidence of bifurcation grafting than in the non-inflammatory group, (66%
tube grafts, 34% bifurcated. p< 0.001, X2 test).
Post-operative course
The 30 day mortality for inflammatory aneurysms was 13% (6
patients), with another two deaths within 6 months of operation. The major
cause of death within 30 days was myocardial infarction (4 patients).
Pulmonary embolus (1), and acute renal failure (1) accounted for the other
two deaths. One of the further deaths occurring within 6 months was due to
myocardial infarction; the cause of the other is unknown.
The hospitalmortality of the non-inflammatory group was 4.3%. The
cause of death was myocardial infarction in 5 cases, with acute renal failure and
intractable left ventricular failure accounting for one each.
Life table analysis of patients with simple and inflammatory
aneurysms can be seen in Figure 25 (overleaf). No follow-up data were
available for 3 patients.
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Figure 27.








The results of this prospective study have shown that inflammatory
change continues to complicate a significant proportion of all aortic
aneurysms.
Inflammatory aneurysms are indistinguishable from their simple
counterparts on grounds of age, risk factors or symptoms. Routine
biochemical investigations are of no benefit, and do not predict entrapment of
the ureters, one of the major complications of inflammatory aneurysms. The
only haematological investigation differing between simple and inflammatory
disease is the plasma viscosity, but even this is not sufficiently sensitive to act as
a diagnostic test.
Radiological investigation was equally unsuccessful. Ultrasound
failed in all cases to reveal the presence of inflammatory change, while
contrast-enhanced computerised tomography made the diagnosis in just over
50% of subsequently confirmed cases.
Findings at operation for inflammatory aneurysms confirmed the
presence of a high incidence of involvement of other organs such as the ureters
and duodenum. This was associated with longer operation times, increased
blood and colloid requirement, and increased use of bifurcated grafts. The
necessity for major intra-operative changes in technique to deal with
unsuspected inflammatory change has been illustrated.
Although the long term post-operative survival of patients with
inflammatory and simple aneurysms is similar, operative mortality is increased






The following Chapter contains the results of the investigations
carried out on the prospectively studied series of patients.
As with the preceding Chapter, the first part of this Chapter is







The second part of the Chapter is concerned with the results of the
original biochemical investigations detailed in Chapter 5. It includes both
results of reproducibility studies and results of patient samples.




The prospective study group consisted of 15 patients with
inflammatory aneurysms, 83 patients with simple, non-inflammatory
aneurysms, and 37 patients with severe aorto-iliac occlusive disease. Their age
and sex distribution is shown below.
One patient in the 'inflammatory' group died pre-operatively of ruptured
aneurysm, having undergone all pre-operative investigations. Post mortem
confirmed the inflammatory nature of the aneurysm. For the sake of clarity, other
post-mortem findings are included in the 'operative findings' section.
Age and Sex Distribution - Prospective Patients.
Disease Mean Median
Type Age (yrs) Age (yrs) Sex
Inflamm
Aneurysm 67.36 'MSSfg53"80 67.14 2 Females
Simple
Aneurysm 72.22 %TO5S_88 73.47 11 Females
Occlusive
Disease 64.62 %B&55"78 65.24 5 Females
Other patient characteristics are summarised in the succeeding pages.
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Risk Factors in Patient Groups.
Known
Disease Hyper- Systolic Diastolic
Type Diabetes Smokers tension B.P. B.P.
Inflamm.
Aneurysms 0 13 5 163M0"220 93'W,^120
Simple
Aneurysms 5 68 28 151 HS®.^220 89RSM8P
Occlusive
Disease 4 37 7 146MP 83R?Sfi&P
Diabetics include those controlled by diet alone, oral hypoglycaemics, and insulin.
Smokers are those patients who are either current smokers or have stopped
smoking in the last 5 years. In the case of hypertensives, patients are regarded as
such if they are under treatment for hypertension, or were found to be so
consistently pre-operatively, but were untreated before admission. Mean blood
pressures are calculated from readings for each patient taken in the ward pre-
operatively when measurement had been consistent on three occasions.
Symptoms ofDisease
While only 26% of inflammatory aneurysm patients were discovered
to have aneurysms incidentally during investigation for other illnesses, this group
accounted for 67% of patients with simple aneurysms. All other patients in each
group presented with symptoms directly attributable to their aneurysm.
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Pain was a feature in 80% of inflammatory aneurysms, but was
present in only 45% of simple aneurysm patients, while weight loss occurred
more frequently in inflammatory aneurysm patients (53%) than in patients
with simple aneurysms (29%).
Pre-operative investigations
Haematology Results.
White Cell Platelet Plasma
Disease Hb. Count. Count. Viscos.
Type (g/dl) (x 1071) (x 109/1) (mPa)
Inflamm.
Aneurysm ^.bbSS1®7-545-4 8.19 IM54e<^7"10-9
Simple









Plasma Viscosity - Contingency Tables.
Plasma Inflamm. Simple Occlusive
Viscosity Aneurysm Aneurysm Disease
> 1.72 mPa 9 21 8
< 1.72 mPa 6 62 29
There was no statistical difference between the groups in pre-operative
haemoglobin or total white cell count. Platelet counts for the simple aneurysm
group were significantly lower than the other groups (p < 0.02 in each case,
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Mann-Whitney). Mean plasma viscosity was significantly raised in the group of
patients with inflammatory aneurysms compared to the other two groups (P <
0.03 Mann-Whitney in both cases). Chi-square testing for a viscosity over 1.72
mPa showed a significantly increased incidence in the inflammatory group over
the other two groups with a p value of 0.01 < p < 0.05.
Using the same criteria as in chapter 7 to define renal functional
compromise, that is either a serum creatinine above 120/nmol/l or a creatinine
clearance below 40 ml/min with appropriate electrolyte disturbance, 6 of the
15 patients with inflammatory aneurysms displayed some compromise. This
compares with 11 of the 83 patients with simple aneurysms. Of the six patients
in the inflammatory group, only 2 had ureteric involvement in fibrosis.
Operative Findings.
In the 15 cases of inflammatory aneurysm, 6 patients had
involvement of the ureters either unilaterally or bilaterally, while the inferior
vena cava was involved in three cases, and the left renal vein in three.
Operative Technique.
The transperitoneal abdominal approach was used in all but three
cases of inflammatory aneurysm. In two cases, the aneurysm was solely
thoracic, and in the other, the aneurysm was suprarenal but below the
diaphragm, and a thoraco-abdominal approach was made.
In the group of simple aneurysms, 5 aneurysms were approached
through a thoraco-abdominal incision. Two were solely thoracic, and two
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extended proximally to the diaphragm. The fifth extended from the lower
thoracic aorta to the mid-abdominal aorta.
The remaining aneurysms were confined to the abdomen, and were
approached transperitoneally.
Of those undergoing resection of an abdominal aneurysm in each
group, it was possible to insert a tube graft in 54% of patients with simple
aneurysms, but only 23% of patients with inflammatory aneurysms.
Six patients with inflammatory aneurysms had either unilateral or
bilateral involvement of the ureters in fibrosis. Only two of these patients had
hydronephrosis, but all underwent ureterolysis.
The results for intra-operative blood loss are as follows, excluding
patients in whom a thoraco-abdominal approach was used:
Intra-operative Blood Loss & Transfusion - Transperitoneal Approach.
Blood Colloid Crystalloid Operative
Disease Blood Transfused Infusion Infusion Time
Type Loss (ml) (ml) (ml) (ml) (hrs)
Simple 1900 1984 1591 1750 3.85
Aneurysm fffMf4400 i6nffi§<?W000 gmf0"4000 IffM^3000 15-615
Inflamm. 4160 3454 2172 1600 4.18
Aneurysm ^miS0"13000 f&lUrf-10500 ^mT000 gffM00"3000 imf7-5
Values for blood loss and blood transfused are significantly greater
for operations involving inflammatory aneurysms than simple aneurysms (p <
0.02, Mann-Whitney).
Differences in other values do not reach statistical significance.
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Very extreme values for blood loss and blood transfusion are found
in one of the cases of inflammatory aneurysms. If this case is excluded, figures
for blood loss and blood transfusion remain significantly greater in the
inflammatory group. Mean blood loss falling to 3177 ml, and blood transfusion
to 2750 ml.
Post-operative Outcome
1. - Simple aneurysms
The post-operative mortality will be dealt with separately for
patients undergoing transabdominal resection of simple aneurysms, and for
thoraco-abdominal approaches. The 30 day mortality for the 78 patients
undergoing transabdominal resection of simple aneurysms was 7.6% (six
patients of 78). Causes of death were:
Myocardial infarction (3)
Acute renal failure (2)
Septicaemia (1)
There was only one other death within 6 months, but the cause in
this case is unknown. The overall six month mortality for this group was
therefore 8.9%.
Life table survival analysis for patients with simple aneurysms
resected transabdominally is shown below (Fig 28). The survival of the 5
patients with aneurysms resected using a thoracoabdominal approach are
marked separately. 3 of the 5 died within 30 days of operation: 2 of
myocardial infarction, 1 of acute renal failure. 2 are still alive.
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Figure 28.
Life table analysis for prospectively studied simple aneurysms.




_D_ Simple (n = 78)
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2. - Inflammatory aneurysms
One patient died pre-operatively, and excluding thoraco-abdominal
approaches, this leaves 11 patients to consider, with transabdominally resected
inflammatory aneurysms. None died within 30 days, and only 2 within 6
months. One death was due to renal failure, the other cause of death was
unknown. Of three patients undergoing thoracoabdominal resections of
inflammatory aneurysms, two died: One at 2 days post-operatively of a stroke,
the other at 121 days ofmyocardial infarction.
Neutrophil Elastase Assay.
In all cases, assayswere carried out in duplicate. Manufacturers Batch
numbers for each kit varied, and the elastase concentration of "standard" and
"control" sera was not constant between all kits. There was therefore potential
for variation in a number of factors, including also assay tube coating and
substrate concentration.
In order to assess the reproducibility of the assay between kits, 22
samples selected as detailed in 'Methods' (above) were assayed in two kits each.
Each kit contained at least two 'repeat' samples.
The co-efficient of variation between assays was calculated as












1 50.73 50.12 0.372
2 44.12 37.02 50.41
3 53.7 55.38 2.82
4 79.72 67.87 140.42
5 154.89 142.87 144.48
6 81.45 81.2 0.0625
7 248.45 231.77 278.22
8 85.33 68.98 267.32
9 70.03 63.4 43.95
10 61.70 65.46 14.13
11 68.59 67.32 1.61
12 92.7 90.25 6.00
13 104.9 93.62 127.23
14 44.92 45.23 0.096
15 35.75 39.03 10.75
16 70.23 77.73 56.25
17 45.18 47.39 4.89
18 53.73 50.12 13.03
19 52.16 58.24 36.96
20 64.3 67.58 10.75
21 101.02 103.05 4.12
22 53.58 55.29 2.92
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For this data,
Value mean (?T ) - 76.72
2 2 -1216.79 v
n=44












2. Control Plasma Values (ng/l)
Kit No. Known value Calculated
Value
% E
*1 125 169 35.2
*2 60 72.24 20.4
*3 60 75.77 26.2
4 135 145.99 8.1
5 135 128.24 5.0
6 60 65.61 9.3
7 60 66.62 11.0
8 60 65.75 9.5
9 60 64.37 7.2
10 60 55.99 6.6
11 60 61.91 3.1
*12 60 45.86 23.5
13 55 52.04 5.3
14 60 56.53 5.7
15 55 59.79 8.7
16 55 61.6 12.0
Kits marked with * were deemed inaccurate, and results not included in study
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Summarised data for all patient groups are given here. The
statistical significance values given use the Mann-Whitney u-test in each case.
Because of the presence of extreme values in the elastase results
for inflammatory aneurysms, means and significances have been calculated
with and without the two highest values of 124 and 248 ju.g/1. Calculation
without extremes reduces the co-efficient of variation and standard error of
values for inflammatory aneurysms to values considerably closer to the other
two groups.
Elastase Assays - Including Extreme Results.
Disease Mean Standard Standard Co-eff
Type (/xg/1) Deviation Error ofvar. Number
Inflamm.
Aneurysms 88.15 49.35 12.74 55.99 15
Simple
Aneurysms 59.69 25.29 3.11 42.36 66
Occlusive
Disease 61.04 32.52 5.75 53.28 32
Comparison of groups using Mann-Whitney U-test gives the following results:
Inflammatory vs. Simple aneurysms -
U = 248, z = -3.0031, p = 0.003
Inflammatory aneurysms vs. Occlusive disease -
U = 117, z = -2.8072, p = 0.005
Simple aneurysms vs. Occlusive disease -
U = 1011, z = -0.3409, p = 0.732
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Calculation of the same parameters without the two extreme values
in the inflammatory group is as follows:
Elastase Assays - Excluding Extreme Results.
Disease Mean Standard Standard Co-eff
Type (/xg/l) Deviation Error ofvar Number
Inflamm.
Aneurysms 73.00 18.44 5.11 25.26 13
Simple
Aneurysms 59.69 25.29 3.11 42.36 66
Occlusive
disease 61.04 32.52 5.75 53.28 32
Comparison of the groups, again using the Mann-Whitney U-test Gives -
Inflammatory vs. simple aneurysms:
U = 247, z = -2.4064, p = 0.016
Inflammatory aneurysms vs. occlusive disease:
U = 116, z = -2.3040, p = 0.021
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Elastin Fragment Assay
Elastin Fragments were assayed as described above. Limited
numbers from each patient group were assayed because of restrictions in the
time and facilities available to perform the assay. Elastin fragment assay was
performed in the University of Paris, Creteil, Paris. It was made possible by
the kind permission of Dr. L. Robert, Director of Research, with whom Dr.
Marie-Paule Jacob developed the technique.
Disease Mean Standard Standard Co-eff
Type (jjbglmX) Deviation Error ofVar. Number
Simple
Aneurysms 0.36 0.49 0.11 135.67 20
Inflamm.
Aneurysms 0.77 0.67 0.21 87.21 10
Occlusive
Disease 0.24 0.30 0.08 123.86 13
Comparison of the three groups by the Mann-Whitney test gives the
following-
Inflammatory aneurysms vs. Simple aneurysms:
U = 54, z = -2.0240, p = 0.043
Inflammatory aneurysms vs. Occlusive disease:
U = 26
Simple aneurysms vs. Occlusive disease:
U = 113, z = -0.6265, p = 0.530
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The complexity, expense, and time consuming nature of the assay
for elastin fragments precluded the production of reproducibility figures for
this data. Assays were carried out in triplicate, and the figure given for each
patient is a mean of these three assays.
Because of this, and the small numbers investigated, the data and
statistical tests of inter-group differences cannot be regarded as definitive.
They should be regarded as data useful in the sense of a pilot study, and will be
discussed later in this work.
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Antitrypsin Phenotyping
Antitrypsin phenotyping was carried out using a standard
isoelectric focussing technique as described above. 14 patients with
inflammatory aneurysms, 36 patients with simple aneurysms, and 33 patients
with aorto-iliac occlusive disease were tested. The results in terms of total










MM 10 26 28
MS 2 4 2
MZ 1 4 2
FM - 1 -
SS 1 1 -
zz - - 1
TOTAL 14 36 33
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There are no clear cut differences in the frequency of inactive or
partially active antitrypsin phenotypes between the three groups. Contingency
tables were constructed for this data (see Below).
Contingency tables were made to compare simple with
inflammatory aneurysms, and simple aneurysms with occlusive disease.
Because of the small numbers in each of the groups other than MM
phenotype, the table shown above was collapsed to include all phenotypes
apart from MM in a separate group.
The small numbers involved in the construction of the second table
demanded that Fishers Exact Test was used to calculate the probability of
















The Null Hypothesis is therefore accepted: There is no difference between
the groups.
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Chi-squared Test: X2 = 2.44 (1 d.f. and Yates Correction)
P > 0.5
The null hypothesis is accepted: There is no difference between groups
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Acute Phase Proteins.
These assays were performed on a calibrated immuno-
turbidometer used routinely for clinical purposes. The techniques have been
described above. The results for each acute phase protein will be dealt with in
turn.
C-Reactive Protein.
Results ofC-reactive protein assay.
Disease Mean Standard Standard Co-eff
Type (mg/1) Deviation Error ofVar Number
Inflamm.
Aneurysms 37.47 42.63 11.01 113.77 15
Simple
Aneurysms 21.37 28.08 3.10 131.42 82
Occlusive
Disease 18.05 20.61 3.39 114.17 37
Comparison of the three groups using the Mann-Whitney test gives the
following results -
Inflammatory aneurysms vs. Simple aneurysms:
U = 403, z = -2.2474, p = 0.025
Inflammatory aneurysms vs. Occlusive disease:
U = 163, z = -2.4542, p = 0.014
Simple aneurysms vs. Occlusive disease:




Disease Mean Standard Standard Co-eff
Type (g/1) Deviation Error ofVar Number
Inflamm.
aneurysms 2.31 0.5 0.13 21.89 15
Simple
aneurysms 1.94 0.61 0.07 31.26 82
Occlusive
disease 1.88 0.48 0.08 25.41 37
Comparison of the three groups using the Mann-Whitney test gives the
following results -
Inflammatory aneurysms vs. Simple aneurysms:
U = 383, z = -2.3191, p = 0.020
Inflammatory aneurysms vs. Occlusive disease:
U = 126, z = -3.0721, p = 0.002
Simple aneurysms vs. Occlusive disease:




Disease Mean Standard Standard Co-eff
Type (g/1) Deviation Error of Var Number
Inflamm.
aneurysms 2.20 0.49 0.13 22.33 15
Simple
aneurysms 2.47 0.77 0.09 31.23 82
Occlusive
disease 2.46 0.74 0.12 29.91 37
Comparison of the three groups using the Mann-Whitney test gives the
following results -
Inflammatory aneurysms vs. Simple aneurysms:
U = 485, z = -1.2992, p = 0.194
Inflammatory aneurysms vs. Occlusive disease:
U = 226, z = -1.0429, p = 0.297
Simple aneurysms vs. Occlusive disease:




Disease Mean Standard Standard Co-eff
Type (g/l) Deviation Error ofVar Number
Inflamm.
aneurysms 0.45 0.10 0.02 21.24 15
Simple
aneurysms 0.40 0.12 0.01 29.26 82
Occlusive
disease 0.39 0.10 0.02 26.78 37
Comparison of the three groups using the Mann-Whitney test gives the
following results -
Inflammatory aneurysms vs. Simple aneurysms:
U = 414, z = -2.0067, p = 0.04
Inflammatory aneurysms vs. Occlusive disease:
U = 181, z = -1.9513, p = 0.05
Simple aneurysms vs. Occlusive disease:
U = 1471, z = -0.2643, p = 0.79
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Elastase Inhibitor Assay
This assay was originally given to us by the University of Sheffield.
The original protocol has been used there in an experimental sense for some
time and has been found to be highly accurate, reproducible, and to give
excellent separation of phenotypes in alpha-l-antitrypsin assay. It is essentially
an assay of the ability of human serum to inhibit the action of elastase upon a
substrate molecule. In this case, the elastase used is highly purified porcine
elastase, and the substrate SANA (see Methods section). For practical
purposes over 90% of the antiprotease activity in human serum is due to
alpha-l-antitrypsin, and the assay can be regarded as a functional assay of that
molecule to all intents and purposes.
Inter-assay Reproducibility.
Details of the standardisation studies of this assay can be found in
the Methods section above. Since reproducibility studies were performed in
tandem with assays of patient samples, the results are given below.
Reproducibility was studied using the same technique as detailed
above for the assay of Elastase-antitrypsin complex. In this case, 24 samples
were rendered anonymous by a colleague and identified by number only. Each
'unknown' sample was assayed twice, in different assay batches, and the
coefficient of variation calculated.
Reproducibility was also checked indirectly using the results of the
three Sheffield standards included in each batch of patient assays as quality
control. The results are given below.
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Inter-Assay Reproducibility of Unknown Samples.
The results of the elastase inhibition assay for the 24 anonymous
samples chosen for reproducibility studies are shown below.
Assay 1 Assay 2 Difference
Sample (%) (%) Squared
1 9 11 4
2 24.4 23.62 0.608
3 27.15 29.7 6.5
4 26.8 29.4 6.76
5 26.04 28.02 3.92
6 14.9 16.08 1.392
7 14 16.5 6.25
8 20.41 20.3 0.012
9 20.14 16.62 12.39
10 21.34 23.96 6.86
11 26.7 26.9 0.04
12 25.43 20.6 23.32
13 19.94 16.75 10.17
14 25.39 22.8 6.7
15 18.73 15.38 11.22
16 29.74 28.04 2.89
17 28.24 25.46 7.72
18 17.21 13.4 14.51
19 30.68 29.4 1.63
20 23.37 20.9 6.1
21 16.73 18.25 2.31
22 34.12 31.9 4.92
23 21.81 19.91 3.61
24 13.29 11.02 5.15
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For the above data, the co-efficient of variation has been
calculated using the same method as before.
Value mean (jF ) - 21.90
X 2 -148.98
n=48







Each figure represents residual elastase activity as a percentage of the total
remaining after exposure to the sample serum.













In the table above, Sample Z can be seen, as the least active
phenotype of the three, to leave most residual elastase activity. In common
with the reproducibility studies on unknown samples, the reproducibility of
repeated assay of the Sheffield standards is good. The ability of the assay to
separate phenotypes was also maintained.
Summarised results for the study patients are given below.
Elastase Inhibition Assay - Results ofAssays ofPatient Samples.
Disease Mean Standard Standard Co-eff
Type (%) Deviation Error ofVar. Number
Inflamm.
Aneurysms 13.40 3.79 0.98 28.30 15
Simple
Aneurysms 21.35 10.25 1.25 48.00 67
OrrliKivp
disease 19.47 12.46 2.17 64.02 33
Mean (%) refers to the mean percentage of residual elastase remaining after
exposure to patients sample serum.
Comparison of the three groups using the Mann-Whitney test
gives the following results:
Inflammatory aneurysms vs. Simple aneurysms:
U = 196, z = -3.6763, p <0.001
Inflammatory aneurysms vs. Occlusive disease:
U = 144, z = -2.3022, p = 0.021
Simple aneurysms vs. Occlusive disease:
U = 938, z = -1.2279, p = 0.219
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Radiology
Radiological investigations were carried out as detailed in 'Methods'.
Each was scrutinised for its ability to detect the following characteristics, as
detailed in 'Methods', above:
1. Presence of aneurysm
2. Upper extent of aneurysm related to the
renal arteries
3. Origins of the renal arteries
4. Diagnostic features of inflammatory change
The study group comprised 79 patients in all, and included 15 patients
with inflammatory aneurysms proven at operation and subsequent
histopathological examination.
MRI was not available for use for some months following initiation of
this work. Throughout the study, accessibility was limited by available time on the
scanner. In some cases study patients did not undergo all 3 radiological
investigations. For this reason, study group numbers are displayed as a Venn
Diagram to clearly highlight the numbers of patients undergoing each
combination of investigation.
Results for each modality are presented separately. Detailed
comparisons are made between modalities later in this work.
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Study Groups
This Venn Diagram (Figure 26) indicates the number of patients
undergoing each combination of investigations. Total numbers of patients
undergoing each investigation are therefore:
Ultrasound (US) - 67
Computed tomography (CT) - 78
Magnetic Resonance (MRI) - 61
Figure 29.
Venn diagram illustrating numbers of patients undergoing each
radiological investigation.
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56 patients underwent all 3 investigations. This included 15 patients
with inflammatory aortic aneurysms. In all cases, radiology is correlated with
results of inspection and histological investigation at and following operative
treatment of the aneurysm. In the following 3 tables, numbers refer to the




























It can be seen that ultrasound failed to differentiate simple from
inflammatory aneurysms in all cases. It also failed to visualise the origin of the
renal arteries in all cases. In all cases where a statement of the level of the
aneurysm neck was made, this inference was made either from the aneurysms
position in relation to other intra-abdominal organs, or, most commonly, from
visualisation of the superior mesenteric artery origin. In 3 cases of
inflammatory aneurysm, the level of the aneurysm neck as estimated by
ultrasound was unavailable or incorrect. In two cases, this was due to
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overlying bowel gas. In the third case, the level was unclear, but appeared to
involve the renal arteries on ultrasound. It was clearly infrarenal at operation.
In the simple aneurysm group, 18 patients had incorrect or
unavailable estimation of the level of the aneurysm. The commonest cause for
lack of definition of the upper level of the aneurysm was that it simply could
not be clearly seen on realtime ultrasound examination. This accounted for 8
cases. In five cases, the upper end of the aneurysm was obscured by gas, and
visualisation of the entire aortic aneurysm was impaired. In two cases, the level
of the aneurysm neck was wrongly stated as being above the level of the renal
artery origins, and in two cases wrongly stated as being below. In one patient
his stocky bodily habitus made estimation of the level of the neck impossible.
In summary, ultrasound was useful in the preliminary detection of
aneurysmal change in the abdominal aorta and in the initial estimation of the
level of the neck of the aneurysm in relation to the level of the renal arteries.
It failed in the detection of inflammatory change and in visualising the origins
of the renal arteries.
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2. Computerised Tomography.
Results ofContrast Enhanced Computerised Tomography
In Determining Aneurysm Characteristics.
Presence Renal
of Level Artery Diagnosis
Aneurysm of Neck Origins of Type
Inflam.
Aneurysm 16 11 2 7
(16)
Simple
Aneurysm 62 56 8 53(3)
(62)
As expected, C.T. succeeded in determining the presence of
aneurysmal change in all cases. It offered improved detection of the level of
the neck of the aneurysm, diagnosis of type, and visualisation of the origins of
the renal arteries.
Errors in estimation of the level of the aneurysm neck were made
in 5 cases of inflammatory aneurysm. In 3 cases, the upper end of the
aneurysm was simply unclear or not seen on CT, while in 2 cases, the neck was
incorrectly stated as lying above the level of the renal arteries. In the 6 cases
of simple aneurysms where CT failed in this respect, 2 cases were due to lack
of clarity, and 4 were wrongly called supra or juxta renal.
C.T. failed to show the origin of the renal arteries in most cases.
Successful visualisation was largely by chance, and the likely reasons for this
are discussed below.
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Diagnosis of aneurysm type, and the recognition of 'typical'
features of inflammatory change by C.T. was moderately accurate. 7 cases of
inflammatory aneurysm were correctly diagnosed by C.T. by the presence of
contrast-enhancing anterior soft tissue masses and distortion of surrounding
anatomy. In the group of simple aneurysms, results were less good. In 6 cases,
C.T. incorrectly showed features compatible with inflammatory change, and
were therefore false positives. In a further 3 cases, leakage of the aneurysm
was suggested when none was present at subsequent operation. These 3 cases
are included in parentheses in the table above.
In summary, as expected, C.T. made the diagnosis of aneurysm in
all cases, but was disappointing in its ability to assess the level of the aneurysm
neck, and to image the renal artery origins. It was moderately accurate in
making the diagnosis of inflammatory change, but there were a disturbing
number of false positives in the simple aneurysm group.
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3. Magnetic Resonance Imaging.
Results ofMagnetic Resonance Imaging in
Determining Aneurysm Characteristics.
Presence Renal
of Level Artery Diagnosis
Aneurysm ofNeck Origins of Type
Inflam.
Aneurysm 15 15 15 15
(15)
Simple
Aneurysm 46 46 44 46
(46)
Magnetic Resonance Imaging was as successful in the diagnosis of
aneurysmal change as the other two modalities. It was accurate in the
assessment of neck level and imaging the renal artery origins. There were two
failures in the imaging of the renal artery origins in the simple aneurysm group.
In one case, the renal arteries could not be found with transverse, saggital or
coronal scans. In the other case, the patient, initially fearful of the enclosed
nature of the M.R.I, scanning apparatus, was able to tolerate only initial pilot
scans before asking to stop the examination. This was the only failure of the
M.R.I, scanning programme on the grounds of claustrophobia, but even pilot
scans were able to detect the presence and level of the aneurysm.
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Figure 30.
Renal artery visualisation using MRI. The figure shows a
transverse abdominal scan above the level of the aneurysm. The renal arteries
are labelled.
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It became apparent during the initial experience of M.R. imaging
that there were specific differences in the appearance of the wall of
inflammatory aneurysms compared with the appearance of simple aneurysms.
Following acquisition of the M.R. scans on the first four patients with
inflammatory aneurysms, it was noted that the inflammatory aneurysms
appeared as arrays of concentric alternating layers of high and low signal
intensity, best seen on the T1 weighted images and STIR sequences.
Comparison with the scans of simple aneurysms obtained to that
date suggested that the presence of three or more high signal intensity layers
external to the vessel lumen was highly suggestive of inflammatory change,
whereas fewer layers indicated a simple origin to the aneurysm, (Figure 31
b+c). Using these features as diagnostic criteria, the remaining patients in the
study series were scanned, and a pre-operative diagnosis declared in all cases,
as in studies of the other two modalities.
Assessment of aneurysm type in the single case with claustrophobia
was made on the basis of spin-echo sequences rather than the images found to
be most accurate i.e. STIR or T1 weighted.
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Figure 31a.
Inflammatory aneurysm seen on transverse abdominal CT. The
rind of inflammatory tissue enhances on contrast injection. In this case, the
inflammatory tissue (arrow) encases the inferior vena cava (V).
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Figure 31b.
Inflammatory aneurysm on transverse abdominal MRI scanning
using the STIR sequence. Inflammatory tissue is displayed as concentric rings
of high signal density (arrow).
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Figure 31c.
Simple (non-inflammatory) aneurysm on transverse abdominal
MRI scanning using the STIR sequence. There is no evidence of the complex
multi-layering in this case. The aorta is indicated (arrow).
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In addition to this new diagnostic finding, M.R.I, was useful in the
demonstration of a number of special features in selected cases. These are
illustrated below.
Figure 32.
Saggital MRI scan of a simple thoracic aneurysm, showing the
unique view of a posterior 'blow-out' (arrow). At operation, the posterior wall
of the aneurysm was found to be deficient at this point.
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Figure 33a.
A horseshoe kidney (arrow) in a case of aortic aneurysm. Detailed
study of the MR images revealed that this aneurysm has a complex




Renal artery visualisation using MRI in coronal section of the same
patient as Fig 30a. The positions of the renal arteries are indicated (arrows).
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In Vitro M.R.I. Studies
The laminated appearance of inflammatory aneurysms was distinct,
but the reason for it obscure. In an effort to determine the reason for it, 4
specimens of aneurysm wall obtained at operation were subjected to M.R.I,
imaging. These were compared to images obtained of 4 specimens of simple, or
non-inflammatory, aneurysm. The technique was as detailed in Methods above.
Figure 34a.
In vitro MR images of wall samples from inflammatory aneurysms.
The samples (arrowed) are immersed in water, and supported on water
saturated foam rubber. The wall appears layered.
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Figure 34b.
Similar images of wall samples from non-inflammatory aneurysms.
No evidence ofwall complexity or layering is seen.
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The inflammatory specimens appear laminated. Bearing in mind
that thrombus was removed from the lumenal surface of these specimens
during preparation, factors in the fibrous wall itselfmust be responsible for this
appearance.
Histology.
Slides for histological examination were made from each of the four specimens
of inflammatory tissue, and examined. The results are shown below.
Figure 35a.
Histology slides of inflammatory aneurysm wall (H&E). These are
the same specimens as shown in Fig 30. Once again, there is a layered




Another specimen of aortic wall prepared as in Figure 32a above,
and showing the same features of layering.
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SUMMARY.
15 patients with inflammatory aneurysms, 83 patients with simple
aneurysms and 37 patients with severe aorto-iliac occlusive disease are
included in the prospective studies.
Diagnosis of inflammatory aneurysm is impossible on the basis of
risk factor analysis, clinical examination, or haematological investigation.
Raised plasma viscosity, pain and weight loss occur more frequently in
association with inflammatory aneurysm than simple aneurysm, but the
differences are not sufficient to be diagnostic.
Prospective findings on the operative appearances of inflammatory
aneurysms, operative technique required and graft type confirm the results of
the retrospective study. The 30 day mortality for operative treatment of
inflammatory aneurysms was improved considerably.
Detailed biochemical studies of the peripheral blood of all three
groups of patients revealed increases in the levels of neutrophil elastase,
elastin fragments, acute phase proteins, and total antielastase activity in the
group with inflammatory aneurysms. The distribution of alpha-1-antitrypsin
phenotypes did not differ between the groups.
The investigation of Magnetic Resonance Imaging in aneurysms
disease has resulted in improved definition of the physical extent and
relationships of both simple and inflammatory aneurysms. In addition, unique
diagnostic appearances of inflammatory aneurysm wall have been described.
The clinical and pathological significance of these results will be






This discussion will consider inflammatory aortic aneurysms under
three main headings: Current problems, Diagnosis/treatment, and Aetiology.
Inflammatory Aneurysms - Current Problems.
Inflammatory aortic aneurysms represent an interesting but under-
researched aspect of surgery and are recognised as a distinct entity both
clinically and pathologically. To date however, much research effort has been
directed at their histological characteristics and the technical aspects of their
repair rather than questions of aetiology or pathogenesis.
Currently, radiological diagnosis of inflammatory aneurysm uses
computerised tomography (CT) as the 'gold standard'. Most major series in
the literature, however, suggest that diagnostic accuracy is poor, making the
correct diagnosis in approximately 50% of cases.195,241 No information is
available to date on the use of more recently introduced modalities such as
magnetic resonance imaging (MRI).
It is apparent from major studies that the presence of an
unsuspected inflammatory aneurysm at operation may lead to abandonment of
the procedure, or a marked increase in operative mortality.193,196
New information from the retrospective series included in this
work, which has not previously been apparent suggests that operations
performed for inflammatory aneurysm disease take longer and require more
blood and colloid infusion. Major intra-operative changes in technique may
also be required when the presence and extent of the inflammatory change is
not apparent pre-operatively.
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Operative (30 day) mortality for inflammatory aneurysms was
higher than that for simple aneurysms in this retrospective study, the principle
cause of death being myocardial infarction. Even outwith the 30 day period,
post-operative survival remained worse in the inflammatory group.
These findings confirm that operations on inflammatory aneurysms
are more difficult and dangerous than those for simple aneurysms. It is therefore
in the best interest ofboth patient and surgeon that the diagnosis of inflammatory
change should be made accurately pre-operatively. With a reliable diagnosis, an
appropriate operative approach can be planned. Facilities can also be made
available for the increased demands on intra- and post-operative care required,
and for more detailed long term follow-up.
A number of proposals have been made linking biochemical
changes with the formation of both simple and inflammatory aneurysms, and
these are outlined in Chapters 2 & 3. Despite this, little is known about the
metabolic activity of inflammatory aneurysm, its relationship to pathogenesis
or its effect on patients. If more is known of its precise nature, then more
sensitive diagnostic techniques and more specific forms of non-operative
treatment may be possible, either prior to surgery, or instead of it.
The biochemical and haematological investigations included in the
prospective part of this work were designed to examine some of the questions




A number of major studies of inflammatory aneurysms have
commented on the clinical and haematological and radiological features
associated with the presence of inflammatory aneurysms.102,193,195,207 None have
been successful in identifying any characteristic sensitive enough to be used in
diagnosis.
In this study, a five year retrospective series was used to highlight
difficulties in diagnosis, operative management and outcome of inflammatory
aneurysms, and to compare the results with a similar series of simple
aneurysms.
There were no patient characteristics in terms of age, sex,
symptoms or concomitant disease which were reliable enough to be used as
screening or diagnostic criteria for inflammatory aneurysms. Systemic illness
in the presence of a palpable aortic aneurysm more strongly suggests the
diagnosis of inflammatory aneurysm. These systemic symptoms, however, are
non-specific and, being present in a minority of inflammatory aneurysms, are
insufficient to make a certain diagnosis in the absence of any objective
evidence.
The easiest and cheapest useful haematological technique was
plasma viscosity or E.S.R. This in itself was not sufficient to make the
diagnosis, being a non-specific indicator of inflammation but was enough to
raise suspicion, and prompt further radiological investigation in many cases.
Unfortunately, both ultrasound and contrast-enhanced CT have
proved disappointing in their ability to provide objective evidence. They
missed almost half of subsequently confirmed cases of inflammatory aneurysm
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in the retrospective series. Both this and the insensitivity of haematological
techniques resulted in many aneurysms proceeding to operation without the
diagnosis of inflammatory change being made.
In respect of presentation, clinical features, and diagnostic
accuracy, this retrospective study simply confirmed the findings of the largest
clinical and radiological studies available from the literature.
In the prospective part of this work, three radiological modalities
were assessed for their sensitivity in the detection of the physical
characteristics of aneurysms and the diagnosis of inflammatory change. It was
considered likely that because of its enhanced ability to display differences in
soft tissue characteristics, the use of Magnetic Resonance Imaging would
improve the pre-operative diagnosis of inflammatory change in aortic
aneurysms.
While it was not anticipated that detection of specific features of
inflammation would be good, ultrasound failed to detect any of the
inflammatory aneurysms in this series. It was, however, moderately successful
in the diagnosis of the level of the aneurysm neck, albeit by indirect assessment
rather than by visualisation of the level of the renal artery origins.
Computerised tomography was only as good as ultrasound in
assessment of the level of the aneurysm, and this was somewhat surprising. It
may be because, while ultrasound is performed in realtime, is to some extent
interactive, and is able to image in different planes, C.T. is limited practically to
transverse imaging. Image plane is then affected by patient positioning and,
because of the inability of this modality to image in realtime, the usefulness of a
change of position of the patient can only be assessed after a further scan.
Page 225
It is for the same reason that imaging the origins of the renal
arteries was inadequate using CT. The renal arteries were only seen on a few
scans where the scan plane happened to include them. While it is possible to
image the renal artery origins using CT, this involves the use of more scan
time, more radiation for the patient because of repeat scans, and repeated
contrast injection. In the context in which visualisation of the renal arteries is
specifically required, large doses of contrast material may compromise renal
function.
C.T. wrongly estimated the level of the aneurysm neck to be above
or to include the renal arteries in 6 cases (2 inflammatory aneurysms and 4
simple aneurysms). Had only C.T. evidence been available, then either the
operative approach would have been more aggressive, or (more likely), the
patients would have been exposed to further contrast material and radiation in
the form of angiography, a procedure not without morbidity and mortality.
The number of false positive examinations both for evidence of
leaking aneurysms and inflammatory change is alarming. It is likely to be related
to the inability ofCT to distinguish the nature of soft tissue masses with sufficient
detail. Enhancing masses of soft tissue anterior of lateral to the aneurysm were
seen in all cases of false positive CT scans. None of thesewere apparent onMRI,
which showed simple wall structures in all cases.
Magnetic Resonance Imaging (MRI) excelled in the detection of the
level of the aneurysm, the origin of the renal arteries, and detection of specific
features of inflammation. Direct visualisation of the origin of the renal arteries
is of use in determining the level of the aneurysm neck and its relationship to
the renal arteries with accuracy.
Limited information is also available from the MRI scan about the
state of patency of the renal arteries, as flowing blood leaves a so-called flow
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void onMRI scanning, appearing as a low signal or black area.
The most prominent finding of this study of the use of MRI in
inflammatory aneurysm disease was the ability of MRI to detect specific
features of inflammatory change. The multi-layered 'onion-skin' appearance
produced using MRI scanning was characteristic, and highly sensitive in
detecting inflammatory tissue.
STIR sequences as used in the imaging for this study are most
sensitive at showing differences in proton density, essentially water content, in
tissue. That it should produce such detailed images of the wall of aneurysms
was something that was not expected. Although preliminary evidence shows
that the layering on these MRI images correspond to histological layering seen
on light microscopy, further work will need to be done in this regard.
In cases inwhich the diagnosis of inflammationwasmade onMRI but
not on CT, MRI made the correct diagnosis in all cases using the criteria of
complex wall structure. In 3 cases, it also showed soft tissue masses anterior or
lateral to the aorta not shown on contrast enhanced CT.
MRI displays all the information necessary for the diagnosis and
'staging' of both simple and inflammatory aneurysm disease without the use or
necessity of injected contrast material or ionising radiation. In addition, the
coronal and saggital images are most useful in displaying the exactmorphology of
an extensive aneurysm in an easily assimilated form.
There are limitations to the use of MRI for the assessment of
aneurysm disease. Currently it cannot be used in the emergency situation in
the anaesthetised patient because of the presence ofmetallic parts on the
anaesthetic machine. Care must be taken in patients with cardiac pacemakers
and other metallic implants, although with appropriate precautions there is no
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contra-indication to scanning these patients.
In this study the only patient who could not be scanned was
claustrophobic.
All patients in both the retrospective and prospective arms of this
work were treated operatively, and had no adjunctive treatment. Treatment
with corticosteroids remains the only active alternative to operation, but the
response is uncertain, and the results anecdotal. There are theoretical dangers
in the use of steroids, and no major series has been reported dealing with their
use.203
Operative treatment of inflammatory aneurysms in the
retrospective series was associated with a higher operative mortality. The
prognosis was improved in the prospective group. Although this did not
appear to be due to any reduction in blood loss transfusion requirements or
operation time, the availability of detailed radiological investigation and the
reliable diagnosis of inflammatory change allowed planning of the operative
approach. Improvements in prognosis may also have been due to changes
made in anaesthetic techniques in the light of the possible diagnosis, which
were not assessed in this study.
Aetiology of Inflammatory Aneurysms.
There is histological evidence of inflammation within the wall of
inflammatory aneurysms. The cellular picture is of 'chronic' inflammation,
with an abundance of lymphocytes, plasma cells and macrophages.102,106,195197
The progressive nature of inflammation and its failure to resolve without
treatment suggest that the fibrous inflammatory response is active, rather than
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the 'burnt out' and passive result of a short-term insult. The cause of the
inflammation is questionable, but together with the generally accepted theory
that aneurysm leads to fibrosis, the research of Parums and Mitchinson 197201
suggests that inflammation is due to expression of an antigen through severely
damaged medial tissue. This is certainly possible, and might be expected to
lead to the type of response seen in inflammatory aneurysms - that is the active
production of fibrous tissue.
Loss of medial elastin is a prominent feature of inflammatory
aneurysm. This could be a physical effect of aortic dilation, or due to
continuing active destruction by elastases. Increased active elastin destruction
could be due to an absolute increase in elastases, or a decrease in elastase
inhibition. Powell et al. have found increased levels of neutrophil elastase in
inflammatory aneurysm wall, and assay of this enzymes inactive complex in the
peripheral blood has been used clinically in monitoring the activity of both
rheumatoid arthritis and inflammatory bowel disease.162,2%267 Cannon and Read
have attributed aortic aneurysm formation to a defect in elastase inhibitory
mechanisms, and both they and other authors have provided parallel models of
elastin destruction in the lungs of smokers.149"152
The biochemical investigations in the prospective part of this work
were chosen to investigate -
1. Evidence for a systemic response to inflammation in
patients with inflammatory aneurysms.
2. Differences in some aspects of peripheral blood
biochemistry in patients with inflammatory aneurysms indicating differences in
elastin metabolism compared to patients with simple aneurysms.
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Simple aneurysms represent a degenerative disease. This is to
some extent borne out by the results of the biochemical investigations in the
prospectively studied series, as levels of acute phase proteins in the peripheral
blood of patients with simple aneurysms approximate to those seen in severe
aorto-iliac occlusive disease. On the other hand, there is evidence to suggest
that active inflammation is present in patients with inflammatory disease, with
raised levels of the acute phase proteins c-reactive protein, caeruloplasmin,
and alpha-1-antitrypsin. It therefore seems likely that inflammatory aneurysms
represent an active and ongoing disease process, rather than the inactive end
stage of some previous insult.
One of the acute phase proteins, alpha-1-antitrypsin (a-l-at) is
discussed in more detail below, because of its role in the metabolism of elastin.
As the principal inhibitor of elastase in the peripheral blood, a-l-at
has been implicated in the aetiology of simple aneurysms. The mechanism
which has been proposed is that deficiencies in antitrypsin levels or function
have allowed increased, uninhibited action of elastase in the aortic wall,
leading to aneurysm formation.149"152
The work of Parums & Mitchinson suggests that inflammatory
aneurysm represents an extreme form of degenerative aneurysm in which the
aortic medial coat is excessively thinned. If the mechanism linking defective
antitrypsin with degeneration were to hold, the extreme degeneration of
inflammatory aneurysms might be associated with a more marked defect in
antitrypsin function.
That some defect in antitrypsin is responsible for the formation of
simple aneurysms seems untenable in the light of the results of this study, as
the total assay, phenotypes, and activity of a-l-at are no different in patients
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with simple aneurysms than severe aorto-iliac occlusive disease.
Also contrary to the mechanisms proposed above, alpha-1-
antitrypsin levels are higher in established inflammatory disease than in the
other two groups. Again, there is no excess of inactive phenotypes in the
inflammatory group, and the increase in antitrypsin levels is accompanied by
an increase in antiprotease activity.
This is simply the non-specific 'damage limitation' action of a-l-at
in its role as an acute phase protein, and occurring as a response to
inflammation. It cannot be regarded in any way as specific to inflammatory
aneurysm.
Even though this study is of patients with established disease, and
the rise in alpha-1-antitrypsin is nonspecific, it is possible to hypothesise from
the results presented that defective antiprotease function does not predispose
to inflammatory aneurysm. If it were to, some abnormality in the acute phase
response or antiprotease function might be expected to be present. No
evidence has been found to support this.
Assay of neutrophil elastase complex in this study has suggested
that levels are increased in the peripheral blood of patients with inflammatory
aneurysm disease. This is likely to reflect increased production in the wall of
the inflammatory aneurysm.
Some confirmation that the elastase increase detectable in the
peripheral blood as complex with alpha-1-antitrypsin is resulting in increased
elastin destruction is provided by the finding of increased levels of elastin
fragments in the peripheral blood. Although the study of elastin fragments in
this work was limited by small numbers, it provides some support for the
proposal that there is increased and active mural elastin destruction in
inflammatory aneurysms.
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The finding of an association between neutrophil elastase and
inflammatory aneurysms is curious, as in general, neutrophils are not a
prominent feature of the cellular response in the wall of inflammatory
aneurysms.
Unpublished data from Hornebecke et al in France suggest that this is
not necessarily a contradiction, and that macrophages may elaborate elastases
antigenically indistinguishable from that elaborated by polymorph neutrophils.
Macrophages are a feature of chronic inflammation, and of the walls of
inflammatory aneurysms.
Elastin is a major constituent of vascular media, and evidence has
been presented to support its active destruction. As elastin is destroyed, and
medial destruction proceeds, it is conceivable that more antigen is released,
and that medial inflammation increases as a result. We are therefore left to
speculate that a disease, initially degenerative (Simple aneurysm) provokes an
inflammatory response, which through destructive inflammation serves to self
perpetuate.
The following mechanism is suggested for the pathogenesis of
inflammatory aneurysm. Findings from this study which support each step are
given in bold type:
1. Medial damage in simple aneurysm leading to extrusion of unknown
antigen - likely to be ceroid.
2. Antigen-antibody interaction. Chronic active inflammation in established
disease.
3. Inflammatory reaction with release of elastase and tissue destruction
involving elastin. (Elastase/antitrypsin and elastin fragments increased in
peripheral blood)
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4. Non-specific response to inflammation - release of acute phase proteins.
Normal, non-specific rise in elastase inhibitory activity.
(Increased acute phase proteins, increased assayofphenotypically normal a-l-at,
and increased functional activity of a-l-at)
5. Ongoing destruction of elastin releases more antigen, and cycle
continues.
As inflammation is a gradual and continuous process, there is likely
to be an intermediate clinicopathological type of aneurysm which is neither
simple or established as a 'typical' inflammatory aneurysm.
It is occasionally found that, rather than a full blown inflammatory
response with hard fibrous plaques and ureteric indrawing, there is
nonetheless peripheral organ adherence to the aneurysm. The duodenum may
be 'stuck' to the aneurysm wall by easily separable adhesions rather than
densely adherent and included in a block of fibrous tissue. The wall is
somewhat thinner than established inflammatory aneurysm, and lacks the
white 'sugar icing' appearance.
It is likely that this represents the intermediate stage in the
pathogenesis of inflammatory aneurysm,whichwithout treatmentwill progress to
display the characteristic dense fibrosis and organ involvement.
Summary.
In view of the failure of clinical, biochemical and haematological
investigations to be sufficiently sensitive to serve as diagnostic tests for
inflammatory aneurysm, it is likely that future developments in the diagnosis of
inflammatory aneurysm will be the province of the radiologist. Radiological
investigations carried out for this study have revealed a number of
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shortcomings in the techniques regarded to date as 'Gold Standard'
investigations for both simple and inflammatory aneurysms. MRI has been
shown to be highly successful in the detection of inflammatory change, and in
displaying the physical characteristics of both simple and inflammatory
aneurysms. Its use has resulted in improved operative planning and a
reduction in operative mortality for inflammatory disease.
MRI is currently far from freely available, and is relatively
expensive when compared to CT scanning. It is currently in the same position
as was CT in the mid 1970s, when scanners were scarce and expensive, and its
abilities and limitations under scrutiny. It is almost certain that because of its
detailed and completely non-invasive imaging abilities, MRI will become at
least as commonly available in the future. Already it has the ability to provide
all of the information required in aneurysm disease. With technological
advances already under way, it is probable that MRI will be used even more
extensively to provide even more information, including flow information from
the aneurysm and the distal circulation.
Detailed investigation of peripheral blood biochemistry in patients
with aortic aneurysm disease suggests that inflammatory aneurysms are the site
of active inflammation with elastin destruction. These appear not to be due to
any generalised defect in elastase inhibition, but rather a consequence of
mural inflammation. These findings have reinforced some current theories of
the aetiology of inflammatory aneurysms, such as that of Parums and
Mitchinson and have led to speculation on a self-perpetuating mechanism in
their pathogenesis.
There is already some experimental evidence that aneurysm
disease may be altered by treatment with drugs other than steroids. Much of
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this work is due to a few workers in large centres (ie David Tilson).264 As
knowledge of the mechanisms of the inflammatory process accumulates, it may






From the work presented above, the following conclusions are
drawn.
1. Inflammatory aneurysms remain moderately
common. They may present complex problems in operative management,
and may be associated with increased operative mortality.
2. Although patients with inflammatory aneurysms
display certain symptoms and hasmatological abnormalities more commonly
than patients with simple aneurysms, none of these are sufficiently sensitive
or specific to make the diagnosis with certainty.
3. The surgical treatment of inflammatory aneurysms
may demand considerable changes in operative technique. Operative
treatment also requires more time and blood/colloid transfusion. It is
accompanied by a poorer short term prognosis than for simple aneurysm
disease. This increases the importance of accurate pre-operative diagnosis.
4. Use of commonly available radiological techniques
such as ultrasound and computerised tomography is not sufficiently
sensitive or specific for clinical purposes. Reliance on C.T. features is
potentially dangerous if decisions on operative approach are made on that
basis alone. C.T. may misdiagnose the level of the neck of aneurysms with
regard to the renal arteries, and in this respect also, even angiography is not
completely accurate.
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5. Magnetic Resonance Imaging represents a new
modality for investigation of aortic aneurysm disease of all types. Its
multiplanar imaging capability is useful in gaining a more complete
understanding of the extent of complex aneurysms, especially those
associated with other abnormalities or extending into the thorax.
M.R.I, is particularly accurate in demonstrating the level of the
aneurysm neck in relation to the renal artery origins.
The complex wall structure shown on inversion recovery M.R.I,
images is both sensitive and specific in the detection of inflammatory
aneurysms. The laminated appearance, seen also in in-vitro scans appears
to correspond in general terms with light microscopic findings.
6. The aetiology of inflammatory aneurysms remains
obscure, but evidence presented above tends to confirm current theories of
immunologically mediated inflammation.
7. In cases of inflammatory aneurysm, there is an acute
phase protein response, confirming the presence of active inflammation. As
part of this response, alpha-1-antitrypsin levels are raised non-specifically.
This rise is appropriate and normal. The antitrypsin is phenotypically
normal, and the rise is accompanied by an increase in anti-elastase activity,
suggesting that antitrypsin function is also normal. This evidence presented
tends to refute theories of aneurysm formation based on the premise that
antiprotease function is defective.
8. The presence of an inflammatory aneurysm is
accompanied by a rise in peripheral blood elastase complex. In
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combination with some initial results suggesting a peripheral rise in elastin
fragments, there is reason to believe that active ongoing elastin destruction
is present.
9. It is possible that destructive processes in the wall of
inflammatory aortic aneurysms may be the basis for a mechanism which
tends to perpetuate the inflammation.
Scope for further work
Although this work has demonstrated some of the features
accompanying inflammatory aneurysms, the root cause of this interesting
disease is still unknown.
If the immunological mechanisms of aetiology outlined above are
accepted as the most likely, the nature of the responsible antigen, although
thought to be oxidised lipoprotein products of atheroma (ceroid) is still
obscure. Isolation and tissue culture of lymphocytes from inflammatory
aneurysm wall might be expected to provide the answer to at least some of
the questions surrounding aetiology. If immunoglobulin products could be
isolated from these cells and characterised, the nature of the antigen may be
better understood. With this understanding, it may even be possible to
prevent the development of inflammatory change by immunological
manipulation.
Although evidence of increased elastin destruction in inflammatory
aneurysms is presented, there is still the question ofwhich comes first - the
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inflammatory change or the elastin destruction? Certainly simple
aneurysms show histological evidence of elastin destruction, and it may
simply be that elastin destruction in inflammatory aneurysms is non-
specifically increased secondary to mural inflammation.
Tilson has already produced some experimental evidence that
aneurysm growth can be retarded using chemotherapy. His confirmation of
Bouceks finding that beta-blockers inhibit aneurysm formation in an animal
model by affecting collagen cross-linking suggests the possibility of
prophylaxis in human aneurysm disease.267'268 Small retrospective studies in
this field have been encouraging.269 In the light of these initial results it is
possible that specific chemotherapy for small aneurysms will become
available, which retards growth and prevents rupture. Such agents would
also be expected to prevent inflammatory change.
The clinical staging of aneurysms and diagnosis of inflammatory
change remains a problem. Magnetic resonance imaging has shown itself to
be highly accurate in this respect, and has the advantage of being
completely non-invasive. It is likely that M.R.I, will become at least as
freely available as C.T. is currently, and as it provides all of the information
necessary for safe surgical repair, it is probable that it will become the
imaging method of choice for aneurysm investigation.
Further work is necessary to determine the true nature of the
laminations seen on M.R. images of inflammatory aneurysm wall. Although
it appears to correspond to laminations seen on low-power light microscopy
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Appendix 1. Photocopy of the first paper to describe inflammatory
aneurysm. The author was T.G.I. James, and the article appeared in the
British Journal of Urology in 1935 (see reference 96).
NOTES ON INTERESTING CASES 157
The sequence of events became, of course, quite clear. I can find
no reference to a similar case in the literature in my possession.
My thanks are due to Dr. W. L. Webb, Director of Medical Services,
Zanzibar, for permission to publish this note.
UR&MIA DUE TO ANEURYSM OF THE ABDOMINAL AORTA
bv t. g. xlltyd james, m.ch., f.r.c.s.,
london.
The specimen here described was found at autopsy- in a woman of
fifty-two who had been admitted with symptoms of ura?mia. A detailed
history was not available, and as the patient was stuporose on admission
she was unable to co-operate in examination. A large fixed mass with an
expansile pulsation was found in the abdomen extending from the
ensiform process down to a level just below the umbilicus. A catheter
specimen of urine yielded a specific gravity of 1010 with some albuminuria.
The clinical condition of the patient was that of advanced uraemia.
The patient died the day following admission and the investigations
were therefore incomplete. It was ascertained that she had been under
treatment four years before at another hospital for pain in the back with
a swelling in the abdomen. A diagnosis of aneurysm of the abdominal
aorta had been made. At that time the Wassermann and Sigma reactions
140
were negative and the blood pressure
An autopsy revealed a generalised atheroma of the arteries. The
abdominal aorta presented an unruptured aneurysm extending from the
level of the bifurcation up to the origin of the superior mesenteric artery.
The wall of the aneurysm was very thick, in some parts nearly 1 inch.
The vertebral bodies were deeply eroded. The kidneys were reduced to
one-third the normal size and presented the macroscopic and micro¬
scopic appearances of chronic interstitial nephritis. The renal arteries
ran obliquely upwards in the wall of the aneurysm and would admit only
the finest probe. The ureters were intimately adherent to the wall of the
aneurysm, considerably narrowed and flattened, but not completely
obstructed. The calices were not dilated.
The renal atrophy would appear to be due to a combination of
pressure on the renal arteries and ureters by the gradual increase in the
size of the aneurysm.
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Appendix 2. Letter sent to patients before undergoing CT & MRI scans.






You are on our waiting list to come into hospital for repair of your
aortic aneurysm, the swelling in the main blood vessel in your abdomen. There
ar a few investigations which should be carried out before you come into
hospital, to give us important information about the size and location of your
aneurysm. You may already have had an ultrasound scan, but there are two
more scans which I will arrange for you to have. The first is a CT scan which
will be performed at Bristol Royal Infirmary, and the second is an M.R.I, scan,
which must be performed at Frenchay Hospital.
Neither of these scans are uncomfortable or painful, but it is important
that you let me know if you have any of the following things, as they affect the
M.R.I, scan:
A heart pacemaker
An artificial joint replacement
Any other bits of metal inside you, such as shrapnel, bullets etc.
If you have any questions about either of these scans, or require help to
get to the hospitals, please phone me at the number above. If I am not
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■ietabolic Activity in Inflammatory and Non-inflammatory Aneurysms
of the Abdominal Aorta*
W. G. Tennant, R. N. Baird and M. Horrocks
Vascular Studies Unit, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, U.K.
Inflammatory aneurysms of the abdominal aorta (IAA) comprise 10-15% of all aortic aneurysms (AA) but their aetiology and
pathogenesis are obscure. Destruction ofmural elastin is a prominent feature of IAA, and both increased elastolysis and decreased
inhibition ofelastolysis have been implicated. In order to study thesefactors, we have examined the peripheral blood of three groups
of patients; 15 with inflammatory aortic aneurysms (IAA), 61 with simple aortic aneurysms (SAA) and 35 with aorto-iliac
occlusive disease (OD). In all cases, alpha-l-anti-trypsin (A-l-AT), alpha-2-macroglobulin (A-2-MG), elastase inhibitory activity
(E.I.A.), elastase-anti-trypsin complex, C-reactive protein (CRP), caeruloplasmin (CP) and plasma viscosity were measured.
Patients with IAA had a significantly higher plasma viscosity (Mann-Whitney, p < 0.05), E.I.A. (Mann-Whitney, p < 0.01)
and levels ofA-l-AT, CRP, CP and elastaselanti-trypsin complex (Mann-Whitney, all p < 0.05) than patients in the other two
groups. There was no difference in the levels of A-2-MG between any of the groups. This study refites the theory that reduced
inhibition of elastase activity predisposes to the formation of SAA. In patients with IAA, raised marker levels indicate ongoing
destruction ofelastin, and suggest a difference in pathogenesis between 1AA and SAA. The study also suggests tlrat IAA are highly
active metabolically, as opposed to the more degenerative SAA
Key Words: Aortic aneurysm; Inflammatory aneurysm; Alplm-l-anti-tn/psin; Neutrophil elastase.
Introduction
e possible causes of aortic aneurysms include
itabolic changes leading to destruction of elastin
d/or collagen in the aortic wall. As these are the
o major structural proteins present, a decrease in
her could easily be responsible for aneurysmal dila-
n. From the studies of Dobrin, however, destruc-
n of elastin rather than collagen is more likely to
d to aneurysm formation.1 While there is histologi-
evidence of elastin destruction in simple aneur-
n disease of the aorta, it is most marked in the so
led "inflammatory" variant.2
Inflammatory aortic aneurysms (IAA) are a sub-
making up 10-15% of all aortic aneurysms3,4 and
: frequently recognisable macroscopically at oper-
on, being encased in a thick white "inflammatory"
it of fibrous tissue covering the anterior and lateral
rfaces. In some cases, the fibrous tissue can extend
resented at the 5th Annual Meeting of the European Society for
icular Surgery, Warsaw, September X991.
ase address all correspondence to: M. Horrocks, Vascular Sur-
y Unit, Royal United Hospital, Combe Park, Bath BA1 3NG,
into the retroperitoneum to encase adjacent hollow
organs, such as the inferior vena cava, duodenum
and ureters.5,6 These aneurysms are notoriously diffi¬
cult to detect preoperatively, and repair is more diffi¬
cult with a high operative mortality.5
An increase in elastase activity and a decrease in
elastase inhibition have both been implicated in the
formation of aortic aneurysms.7 Because of the histo¬
logical differences between simple and inflammatory
aneurysms, it is reasonable to believe that there may
be differences in elastin metabolism, which might be
especially true if the inflammation in IAA is active, as
is likely from the clinical appearances and natural
history of the disease.
This study aimed to investigate indirect evidence
of inflammatory activity and elastin metabolism in
the peripheral blood of patients with aneurysmal dis¬
ease (of both simple and inflammatory types), and
aorto-iliac occlusive disease.
Materials and Methods
The following patient groups were studied.
Group 1: 15 patients with IAA, mean age 67
D-821X/92/020199+05 $03.00/0© 1992 Grune & Stratton Ltd.
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years. There were two females in this group. The
inflammatory nature of the aneurysms was detected
preoperatively by radiological investigations, and
confirmed at operation by the typical appearances.
Subsequent histological diagnosis was made in all
cases in accordance with previously published
criteria.8
Group 2: 61 patients with simple, non-inflamma¬
tory aneurysms of the aorta (SAA), mean age 72
years. There were 11 females in this group. Diagnosis
was made on similar criteria to group 1.
Group 3: 35 patients with severe aorto-iliac occlu¬
sive disease (OD) requiring aortic bifurcation graft¬
ing. This group included five females, and had a
mean age of 64 years.
Specific exclusions were made from the study in
cases with malignant or connective tissue disease,
and infective illnesses. A number of biochemical
assays were performed on the peripheral blood of
each patient, and are detailed below.
tic Antibodies Calibrator 7 in six dilutions in bovii
serum albumin; controls: Atlantic Antibodies Calibr
tor 7 prediluted 1:2 and 1:4 with bovine serum alb
min to bring into range of standard curve.
Caeuloplasmin assay. Antibody: Atlantic Antibodi
anti-caeruloplasmin; calibrator: Atlantic Antibodi
Calibrator 1 in six serial dilutions; controls: Atlanf
Antibodies Calibrator 3, Behring protein standa
plasma.
Serum alpha-l-anti-trypsin assay. Antibody: Atlan)
Antibodies anti alpha-l-anti-trypsin; calibrator: Atla
tic Antibodies Calibrator 3, in six serial dilutior
controls: Atlantic Antibodies Calibrator 1, SPSOl.
Serum alpha-2-macroglobulin assay. Antibody: Atlan
Antibodies anti-alpha-2-macroglobulin; calibrate
Atlantic Antibodies Calibrator 1 in six serial dilutior
controls: Atlantic Antibodies Calibrator 3, Behrii
standard human serum.
Collection ofplasma and serum samples
Fasting samples of blood were collected preoperati¬
vely from all patients using the "Vacutainer" system.
Whole blood was sent to the Hospital Haematology
Laboratory for plasma viscosity estimation and the
remainder immediately centrifuged and separated
into 1-ml aliquots of plasma and serum. Samples
were stored at -80°C until used in the assays.
Acute phase proteins
The following acute phase proteins were measured:
C-reactive protein (CRP), caeruloplasmin (CP), alpha-
l-anti-trypsin (A-l-AT) and alpha-2-macroglobulin
(A-2-MG). A standard immunoturbidimetry tech¬
nique on a computer orientated random access
immunoturbidometer (COBAS MIRA, F. Hoffman-
LaRoche, Basle, Switzerland) was used. For each
assay run, one sample in 10 was a control specimen of
known antigen content. Their absorbance and con¬
centration was used to validate the standard absor¬
bance curve for normal laboratory use. Calibration of
the analyser is maintained to give a coefficient of vari¬
ation for protein assays of 2-3%. The specific antibo¬
dies and calibrators for each assay are shown below.
Serum C-reactive protein assay. Antibody: PRU Atlantic
Antibodies anti-C-reactive protein; calibrator: Atlan¬
Elastase-anti-trypsin complex
These were measured using the enzyme-linki
immunosorbent assay. A commercially available 1
(Merck Immunoassay, kit number 12589, 2h versio
was suitable for polymorphonuclear leukocyte ek
tase. In this assay, plastic tubes coated with she*
antibody to neutrophil elastase are used. A standa
volume of serum is added to the tube, and the co
tained elastase-anti-trypsin complex is bound to t
tube wall by its elastase moiety. The amount of bin
ing is proportional to the amount of elastase-an
trypsin complex present in the sample. The tube
then washed, and a conjugate of anti-trypsin an
body/alkaline phosphatase added which in tu
binds to the anti-trypsin moiety of elastase-anti-try
sin complex, forming a complex with an enzyma
"tail" of alkaline phosphatase. After washing, t
tube-bound enzyme activity is measured by its act!
on 4-nitrophenyl phosphate, producing a colo
change at 405 nm.9
All assays were carried out in duplica
Standard solutions of known elastase/anti-tryps
complex content were assayed in order to produce
standard line, which was verified by assay of
control serum. A computer based regression functi
was used to calculate the values of unknown samp1
from their absorbance values. Inter-kit reproducibil
was confirmed by assaying at least two of 22 anor
mous samples in each kit and each anonymo
sample was assayed at least twice.
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rstase inhibitory activity
te principle of this assay depends on the inhibitory
wer of patients' serum on a standard elastase load,
tients serum is added to a fixed amount of porcine
istase, and incubated. During incubation, the
indard elastase load is inhibited to a degree pro-
■rtional to the amount of anti-elastase in the serum.
ie resultant serum/elastase mixture is then used to
jest a fixed amount of elastase substrate, the more
bstrate digested the less elastase inhibitor is
esent in the patient's serum. Digestion of the sub-
ate produces a colour change detectable by spec-
iphotometry at 405 nm.
Calibration of the assay in our laboratory was
rried out using plasma samples of known anti-
'psin phenotype and inhibitor assay. The seven
mples used for calibration were of mixed pheno-
res for A-l-AT, there being two Z types, two MZ
?es one MS type, and two M types. Adequate sep-
ition of phenotypes was obtained using the assay
our laboratory following modification of the tech-
jue. Three disparate known calibration samples
im the seven originally used in assay calibration
.'re also included in order to validate the "spread"
results for unknown samples.
Final results from the assay of known elastase
utions were then used to construct a standard
rve and the results of the assay of the three known
nples were plotted in order to confirm adequate
aaration. Only if good separation was obtained was
5 curve used to read unknown samples.
All the results were obtained by reading the
-sorbance of the samples on a computer controlled
croplate spectrophotometer.
In practice, the principle elastase inhibitor
jsent in human serum is A-l-AT. The assay there-
e essentially measures A-l-AT activity. Because of
non-specific nature, however, it measures the
ility of the entire serum to inhibit elastase. In this
y, small differences in elastase inhibitory activity
e to factors other than A-l-AT are also detected.10
Table 1.
Disease Plasma
type CRP (mgr1) CP (gr1) viscosity
Inflammatory aneurysms 37.47 ± 11.01 0.45 ± 0.02 1.79 ±0.05
Simple aneurysms 21.37 ±3.1 0.40 ±0.01 1.65 ±0.01
Occlusive disease 18.05 + 3.39 0.39 ±0.02 1.64 ±0.02




Disease A-l-AT A-2-MG complex activity
type 3939 (ugl"1) (%)
Inflammatory aneurysms 2.31 2.20 88.15 13.40
(0.13) (0.13) (12.74) (0.98)
Simple aneurysms 1.94 2.47 59.69 21.35
(0.07) (0.09) (3.11) (1.25)
Occlusive disease 1.88 2.46 61.04 19.47
(0.08) (0.12) (5.75) (2.17)
Results
ie results of this study are summarised in Tables 1
d 2 as means, with standard error in parentheses,
all cases, the Mann-Whitney U-test was used to
sess the statistical significance of differences be-
reen groups.
C-reactive protein, CP and A-l-AT (Tables 1 and
2) were all significantly raised in the group of patients
with IAA when compared to both SAA (p < 0.04 for all
proteins) and OD (p < 0.05 for all proteins). Similar
levels were found in patientswith SAA and OD. There
was no significant difference in levels of A-2-MG
(Table 2) between groups. Plasma viscosity (Table 1)
was raised in patients with IAA compared to SAA and
OD (p < 0.03, Mann-Whitney, in both cases).
The assay of elastase anti-trypsin complex
revealed two very high values of 124|xgl_1 and
248 |JLg 1—1 in the inflammatory group. The mean
levels of elastase anti-trypsin complex were signifi¬
cantly higher in inflammatory aneurysms than simple
aneurysms when these two values were included
(Table 2, p < 0.005) and when they were excluded
(p < 0.005).
Values for the elastase inhibitory assay (Table 2)
were significantly lower in the IAA group than the
SAA group (p < 0.001). The figures represent the
amount of residual elastase activity remaining in the
specimen following inhibition by the patient's
plasma, consequently the lower the value, the more
active is the patient's plasma in inhibiting the action
of elastase. Once again, there was no difference be¬
tween the group with SAA and those with OD.
None of the protein or proteinase assays either
singly or in combination were predictive of the
presence of an inflammatory aneurysm.
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Discussion
Data on the role of elastases in the pathogenesis of
aortic aneurysm disease are contradictory. Mechan¬
isms have been proposed by a number of authors in
which the causative defect is either a primary rise in
elastase activity, or decrease in anti-elastase activity
allowing a secondary rise in elastase activity.7
Similarly, little is known about the metabolic
activity of inflammatory aneurysms, or its effect on
the patient. Since it is likely that the presence of an
aneurysm provokes the inflammatory reaction rather
than vice versa, it is essential that the nature of the
inflammatory response be clearly defined. The reason
why only some aneurysms become inflamed is
unknown, and fibrosis in established IAA appears to
progress slowly with time. It is important to consider
the possibility that highly active inflammation and
tissue destruction are present, rather than inert
"burnt out" fibrous tissue. If the inflammation is
active, then it may be possible to detect it. If more is
known of its precise nature, then more specific non-
operative treatment may also be possible.
The levels of acute phase proteins in the peri¬
pheral blood of patients with SAA approximate to
those seen in severe aorto-iliac OD bearing out the
proposition that simple aneurysms represent a dege¬
nerative disease. Tissue destruction, although
present, does not occur either at a rate or to a degree
sufficient to induce a generalised response.
Within the wall of inflammatory aneurysms
there is histological evidence of inflammation. The
cellular picture is of 'chronic' inflammation with an
abundance of lymphocytes, plasma cells and macro¬
phages.2 Together with the generally accepted theory
that an aneurysm leads to fibrosis, the research of
Parums and Mitchinson11 suggests that inflammation
is due to expression of an antigen through damaged
medial tissue. This is certainly possible and might be
expected to lead to the type of response actually seen
in inflammatory aneurysms with the elaboration of
fibrous tissue.
From the results of this study there is biochemical
evidence to suggest that a generalised response to
active inflammation is present in patients with an
inflammatory aneurysm and raised peripheral blood
levels of CRP, CP and A-l-AT are compatible with an
immunologically mediated inflammatory process, and
support theories of aetiology based on this premise.
Destruction of elastin in the aortic wall has been
noted in both SA and IAA, but is more prominent in
IAA. This could be a simple mechanical effect, or be
due to continuing active destruction by elastases.
Powell12 has found increased levels of neutrophil
elastase in the wall of inflammatory aneurysms a
an assay of this enzyme has been used clinically
monitoring the activity of both rheumatoid arthrit
and inflammatory bowel disease.13
Assay of the neutrophil elastase complex in tl
study has suggested that levels are increased in t
peripheral blood of patients with inflammatc
aneurysms compared with both SAA and OD.
elastase levels are similar in SAA and OD, a prime
increase in elastolysis is unlikely as a cause of SA
For the same reason, it is unlikely that a prime
increase in elastolysis is responsible for the inflamn
tory disease. It is much more probable that increas
elastolysis is a consequence rather than a cause of t
inflammatory process. It may either be a part of t
cellular/humoral response to inflammation, or it m
be provoked by the production or exposure
damaged elastin in the aortic wall. In general, neut:
phils are not a prominent feature of the cellular
sponse in the wall of inflammatory aneurysms, a
so it is curious that peripheral blood levels are raist
There remains the possibility that another cell ty
(e.g. macrophages or lymphocytes) may prodr
elastase antigenically indistinguishable from that p:
duced by neutrophils.
In this respect, one of the acute phase proteii
A-l-AT deserves further consideration. As the prin
pal inhibitor of neutrophil elastase in the periphe
blood, A-l-AT has been implicated in the aetiology
simple aneurysms. Such theories have their basis
the interaction between cigarette smoking and ar
trypsin. Oxidants in cigarette smoke are capable
oxidising methionine residues on A-l-AT, resulti
in its inactivation14 which is thought to be the car
of emphysema in smokers. The mechanism whi
had been proposed in aneurysm disease is that df
ciencies in anti-trypsin levels or function ha
allowed an increased, uninhibited action of elasta
leading to aneurysm formation. The high incidence
smoking in all forms of vascular disease precluc
this as a specific cause of aneurysm disease, bul
might be possible that some other cause of reduc
anti-trypsin activity could result in the same mech;
ism of aneurysm formation. In the light of the resu
of this study, however, this seems unlikely, as t
total assay and activity of A-l-AT are no different
patients with simple aneurysms and those w
severe aorto-iliac OD.
Parums and Mitchinson" propose a mechani:
for inflammatory change in which antigen extruc
through a severely damaged aortic media provoki
inflammation. If IAA represents an extreme form
degenerative disease, the assay or function of A-1-,
activity should be more severely defective in th<
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ses. On the contrary, A-l-AT levels are higher in
tablished inflammatory disease than in the other
ro groups, and this increase is accompanied by an
crease in total anti-elastase activity. This is simply
e non-specific "damage limitation" action of A-l-
F in its role as an acute phase protein, and occurring
a response to inflammation. It cannot be regarded
any way as specific to inflammatory aneurysm.
Even though this study is of patients with estab-
hed disease, and the rise in A-l-AT is non-specific,
e results presented suggest that defective anti-
otease function does not predispose to the forma-
>n of either simple or inflammatory aneurysms. If it
?re to do so, then some abnormality in the acute
lase response or anti-protease function might be
pected to be present. No evidence has been found
support this.
In conclusion, in cases of simple non-inflamma-
ry aortic aneurysm, there is no systemic evidence of
sue destruction or inflammation and there is no
rrease in elastase activity, or decrease in anti-
otease function. Where inflammatory change is
esent, there is an acute phase protein response,
iicating active, ongoing tissue destruction and
lammation. This is accompanied by rises in both
tsfase inhibitory activity in the peripheral blood,
d neutrophil elastase complex, both of which are
ely to be secondary to the inflammatory process
her than its cause.
These results refute the theory that progress
im simple to inflammatory aneurysm is due to
Batly decreased anti-protease function. Once estab-
hed, the inflammatory process may perpetuate
elf through local elastase production, and destruc-
n of aortic media, so provoking the cellular
>ponse.
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Identifying Total Carotid Occlusion with Colour Flow Duplex
Scanning*
Mark A. Mattos, Kim J. Hodgson, Don E. Ramsey, Lynne D. Barkmeier and David S. Sumner
Dqoartment ofSurgery, Section ofPeripheral Vascular Surgery, Southern Illinois University School ofMedicine, Springfieli
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A major limitation ofconventional duplex scanning is its inability reliably to differentiate severe stenosisfrom total occlusion of the
internal carotid artery (ICA). Colour flow duplex scanning (CFS) facilitates the identification of internal and external carotid
arteries, enables simultaneous evaluation offlow in multiple vessels in longitudinal and transverse views, and allows more
accurate assessment ofvery low Doppler-shift frequencies with new "slow-flow" software technology. From July 1987 to January
1991, 9731 ICAs (4866 patients) were evaluated with CFS. Arteriography was performed in 483 of these patients (959 ICAs), and
the results of the two studies were compared. Colour flow scanning was highly accurate in differentiating total occlusion from
carotid stenosis. Eighty-two of 87 totally occluded ICAs were detected (sensitivity 94%) and 873 of 878 patent arteries were
properly identified (specificity 99%). Positive and negative predictive values were 93 and 99%, respectively. False positive results
(n = 6) were due to interpreter error (n = 4) and poor scanning technique (n = 2). Allfalse negative results (n = 5) were the result
of interpreter error. During the last 24 months of the study, no false positive or false negative results were detected, giving an
accuracy of100%. We conclude that CFS offers distinct advantages in the diagnosis ofcarotid occlusion, thereby overcoming the
limitations ofconventional duplex scanning in distinguishing total occlusion of the ICA from less severe disease, and is the method
ofchoicefor evaluating the carotid bifurcation.
Key Words: Colour flow scanning; Duplex scanning; Total carotid occlusion.
Introduction
Prevention of stroke and preservation of neurological
function are the goals of treating extracranial carotid
occlusive disease. Appropriate therapy depends on
accurate identification of an internal carotid artery
(ICA) lesion amenable to direct surgical correction.
Recent clinical trials, both in Europe and in North
America, have shown conclusively that carotid
endarterectomy (CEA) substantially reduces the risk
of stroke at 2-3 years compared with "optimal" medi¬
cal therapy in symptomatic patients with 70-99% di¬
ameter stenoses of the internal carotid artery.1,2
Although the results of similar trials in asymptomatic
patients have yet to be published, preliminary data
suggest that the outcome in terms of stroke reduction
is similar.3 On the other hand, surgical treatment of
* Presented at the 5th Annual Meeting of the European Society for
Vascular Surgery, Warsaw, September 1991.
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total carotid occlusion is hazardous and ineffecth
except in rare cases when the occlusion is thrombo
and treatment can be instituted immediate
Methods for evaluating the carotid artery mu
therefore, be able to distinguish between severe ste
osis and total occlusion. During the past decade, cc
ventional duplex scanning has become the diagnos
procedure of choice for the non-invasive evaluati
of the extracranial ICA. While many centres ha
reported excellent results documenting the accun
of duplex scanning,4-7 a major limitation exists in
inability reliably to differentiate severe stenosis frc
total occlusion of the ICA.8,9
Colour flow duplex scanning (CFS) represei
the most recent technological development in nc
invasive vascular evaluation. Although seve
reports have confirmed the accuracy of this modal
for detecting disease of the ICA,10-1'' the only pa]
specifically addressing the issue of total ICA occ
sion did not compare the results of CFS to a "g<
standard".14 To determine whether CFS overcon
the limitations of conventional duplex scanning in 1
differentiation of severe carotid stenosis from tc
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